Dynamique des couplages cardiaques : Publications / Awards
Accueil > Équipe 1 > Publications selectionnées > Liste des publications
Liste des publications
Liste des Publications par ordre alphabétique du premier auteur / List of Publications in alphabetical order of first author
Les divers membres de l’équipe sont en gras / The various team members are in bold
Aarab Y, Debourdeau T, Garnier F, Capdevila M, Monet C, De Jong A, Capdevila X, Charbit J, Dagod G, Pensier J, Jaber S. (2024) . “Management and outcomes of COVID-19 patients admitted in a newly created ICU and an expert ICU, a retrospective observational study “Anaesth Crit Care Pain Med. 2024 Feb;43(1):101321. (IF=3,70). Anesthesiology (Q2); Critical Care Medicine (Q3).
Abramova A, Bride J, Oger C, Demion M, Galano JM, Durand T, Roy J (2024). “Metabolites derived from radical oxidation of PUFA: NEO-PUFAs, promising molecules for health? “ – Atherosclerosis, 2024 sous presse. (IF=4,90). Cardiac and Cardiovascular Systems (Q1). Peripher l Vascular Disease (Q1).
Amedro P, Gavotto A, Huguet H, Souilla L, Huby AC, Matecki S, Cadene A, De La Villeon G, Vincenti M, Werner O, Bredy C, Lavastre K, Abassi H, Cohen S, Hascoet S, Dauphin C, Chalard A, Dulac Y, Souletie N, Bouvaist H, Douchin S, Lachaud M, Ovaert C, Soulatges C, Combes N, Thambo JB, Iriart X, Bajolle F, Bonnet D, Ansquer H, Delpey JG, Cohen L, Picot MC, Guillaumont S; QUALIREHAB Study Group. (2024). “ Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial. “ Eur Heart J. 2024 Apr 21;45(16):1458-1473. (IF= 37,60). Cardiac and Cardiovascular Systems (Q1).
Assouly J, Hayes M, Debien B, Roubille C, Jung B. (2024). “Navigating the challenges: Would onboarding bootcamps enhance comfort and wellbeing of residents in medicine? “ Eur J Intern Med. 2024 May 28:S0953-6205(24)00212-7 sous presse. (IF= 5,90). Medicine General and Internal (Q1).
Azoulay LD, Frapard T, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Bréchot N, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Frere C, Quentric P, Moyon Q, Luyt CE, Combes A, Amoura Z, Pineton de Chambrun M. (2024). “Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients. “ Clin Rheumatol. 2024 Sep;43(9):2889-2898. (IF=2,90). Rheumatology (Q2).
Barateau L, Krache A, Da Costa A, Lecendreux M, Debs R, Chenini S, Arlicot N, Vourc’h P, Evangelista E, Alonso M, Salabert AS, Silva S, Béziat S, Jaussent I, Mariano-Goulart D, Payoux P, Dauvilliers Y. (2024). “Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1. “ Neurology. 2024 May;102(10):e209326. (IF=7,70). Clinical Neurology (Q1).
Barateau L, Krache A, Da Costa A, Lecendreux M, Chenini S, Arlicot N, Vourc’h P, Alonso M, Salabert AS, Beziat S, Jaussent I, Mariano-Goulart D, Payoux P, Dauvilliers Y (2024). “ PET Study of Microglial Activation in Kleine-Levin Syndrome. “ . Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200263.(IF=7,80). Neurology(Q1); Clinical Neurology (Q1).
Bechard E, Arel E, Bride J, Louradour J, Bussy X, Elloumi A, Vigor C, Soule P, Oger C, Galano JM, Durant T, Le Guennec JY, Maha-Ou-Maati H, Demion M (2024). ”Activation of hTREK-1 by polyunsaturated fatty acids involves direct interaction” – Scientific reports, 2024 Jul 2;14(1):15244. (IF=3,80). Multidisciplinary Sciences (Q1).
Bitker L, Dupuis C, Pradat P, Deniel G, Klouche K, Mezidi M, Chauvelot L, Yonis H, Baboi L, Illinger J, Souweine B, Richard JC. (2024). “Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in patients with acute circulatory failure requiring continuous renal replacement therapy: results of the GO NEUTRAL randomized controlled trial. “ Intensive Care Med. 2024 Oct 17. Sous presse. (IF=27,10). Critical Care medicine (Q1).
Boileve A, Romito O, Hof T, Levallois A, Brard L, d’Hers S, Fouchet A, Simard C, Guinamard R, Brette F, Sallé L. (2024). “EPAC1 and 2 inhibit K+ currents via PLC/PKC and NOS/PKG pathways in rat ventricular cardiomyocytes. “ Am J Physiol Cell Physiol. 2024 Jul 10.sous presse. (IF=5,00). Cell Physiology (Q2); Physiology (Q1).
Bonello L, Tardivel C, Laine M, Roubille F. (2024). “Percutaneous thrombectomy with the FlowTriever for pulmonary embolism with right heart thrombi: a retrospective two centres study. “ Eur Heart J Open. 2024 Nov 22;4(6):oeae092. (IF=2,87). Cardiology and Cardiovascular Medicine (Q1); Surgery (Q1)
Bougouin W, Lascarrou JB, Chelly J, Benghanem S, Geri G, Maizel J, Fage N, Sboui G, Pichon N, Daubin C, Sauneuf B, Mongardon N, Taccone F, Hermann B, Colin G, Lesieur O, Deye N, Chudeau N, Cour M, Bourenne J, Klouche K, Klein T, Raphalen JH, Muller G, Galbois A, Bruel C, Jacquier S, Paul M, Sandroni C, Cariou A (2024). “Performance of the ERC/ESICM-recommendations for neuroprognostication after cardiac arrest: Insights from a prospective multicenter cohort. “ . Resuscitation. 2024 Sep;202:110362. Sous presse. (IF=6,50). Critical Care Medicine (Q1) ; Emergency Medicine (Q1).
Bredy C, Werner O, Helena H, Picot MC, Amedro P, Adda J. (2024). “Cardiac magnetic resonance ventricular parameters correlate with cardiopulmonary fitness in patients with functional single ventricle. “ Int J Cardiovasc Imaging. 2024 May;40(5):1041-1048. (IF=1,50). Cardiac and Cardiovascular Systems (Q3); Radiology, Nuclear Medicine and Medical Imaging (Q3).
Bredy C, Werner O, Huguet H, Guillaumont S, Auer A, Requirand A, Lavastre K, Abassi H, De la Villeon G, Vincenti M, Gavotto A, Vincent R, Pommier V, Dulac Y, Souletie N, Acar P, Karsenty C, Guitare A, Berge M, Marguin G, Masseron MP, Pages L, Bourrel G, Engberink AO, Million E, Huby AC Leobon B, Picot MC Amedro P(2024). ” Efficacy of a Transition Program in Adolescents and Young Adults With Congenital Heart Disease: The TRANSITION-CHD Randomized Controlled Trial ”- Journal of Adolescent Health 2024 Aug;75(2):358-367. (IF=5,50) . Pediatrics (Q1); Psychology, Developmental (Q1).
Brette F, Cantelmo AR, Coronas V, Demion M, El Bini I, Girault A, Hilaire C, Inquimbert P, Legendre C, Mesirca P, Rubera I, Rodat-Despoix L. (2024). “The 32nd Ion Channels Meeting, 17th-20th September 2023, Sète, France. “Bioelectricity. 2024 Jun 12;6(2):136-142. (IF=1,60). Biochemistry and Molecular Biology (Q3); Electrochemistry (Q3).
Cambonie G, Aujogues Dit Baron L, Combes C, Chanal C, Mazurier E, Toubin RM, Fortier M, Polito A, Fuchs F, Gavotto A (2424). “ Management of neonates exposed prenatally to opioids: Impact of a developmental care program implementation. “. Early Hum Dev. 2024 Oct 18;198:106132.(IF=2,20). Obstetrics and Gynecology (Q2); Pediatrics (Q2).
Cardelli LS, Magaldi M, Agullo A, Richard G, Nogue E, Berdague P, Galiner M, Georger F, Picard F, Prunet E, Molinari N, Bourdin A, Jaffuel D, Roubille F, (2024) “Sacubitril/valsartan has an underestimated impact on the right ventricle in patients with sleep-disordered breathing, especially central sleep apnoea syndrome – “ Archives of Cardiovascular Disease 2024 Jun-Jul;117(6-7):409-416. (IF=2,30). Cardiac and Cardiovascular Systems (Q2).
Cardelli LS , Laumont T, Beghian J, Achahli Y, Cardoso M, Bacle M , Pasquié JL and Granier M. (2024) “ Radiofrequency Lesion in the Atrial Wall: How Variable Is It? 9.4 Tesla MRI Analysis of Radiofrequency Lesion Volume in a Swine Model “ JMC, 2024 sous presse. (IF= 3,00)Medicine General and Internal (Q1).
Champeroux P, Thireau J, Le Guennec JY, Fares R (2024). “ In silico modelling of stroke volume, cardiac output and systemic vascular resistance in cardiovascular safety pharmacology studies by telemetry. “ J Pharmacol Toxicol Methods. 2024 May-Jun:127:107512.. (IF=1,30). Pharmacology (Q3); Toxicology (Q3)
Cherbi M, Bouisset F, Bonnefoy E, Lamblin N, Gerbaud E, Bonello L, Levy B, Lim P, Joffre J, Beuzelin M, Roland Y, Niquet L, Favory R, Khachab H, Harbaoui B, Vanzetto G, Combaret N, Marchandot B, Lattuca B, Leurent G, Lairez O, Puymirat E, Roubille F, Delmas C (2024) “Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry. “Int J Cardiol. 2024 Jan 15:395:131578. (IF=3,20). Cardiac and Cardiovascular Systems (Q2).
Cherbi M, Bonnefoy E, Puymirat E, Lamblin N, Gerbaud E, Bonello L, Levy B, Lim P, Muller L, Merdji H, Range G, Ferrari E, Elbaz M, Khachab H, Bourenne J, Seronde MF, Florens N, Schurtz G, Labbé V, Harbaoui B, Vanzetto G, Combaret N, Marchandot B, Lattuca B, Leurent G, Faguer S, Roubille F, Delmas C (2024). “Cardiogenic shock and chronic kidney disease: Dangerous liaisons. . Arch Cardiovasc Dis. 2024 Apr;117(4):255-265. (IF=2,30). Cardiac and Cardiovascular Systems (Q2).
Cherbi M, Merdji H, Labbé V, Bonnefoy E, Lamblin N, Roubille F, Levy B, Lim P, Khachab H, Schurtz G, Harbaoui B, Vanzetto G, Combaret N, Marchandot B, Lattuca B, Biendel-Picquet C, Leurent G, Gerbaud E, Puymirat E, Bonello L, Delmas C (2024). ”Cardiogenic shock and infection: A lethal combination. ” Arch Cardiovasc Dis. 2024 Jul 4:S1875-2136(24)00218-3. Sous presse (IF=2,30). Cardiac and Cardiovascular Systems (Q2).
Chiche L, Truchetet ME, Cornec D, Immediato Daien C. (2024). “[Between the normal and the pathological: The concept of pre-disease applied to systemic autoimmune rheumatic diseases]. “ Rev Med Interne. 2024 Nov 25:S0248-8663(24)01282-7. (IF=0,70). Medicine General and Internal (Q4).
Daelman B, Van Bulck L, Luyckx K, Kovacs AH, Van De Bruaene A, Ladouceur M, Yang HL, Moon JR, Schmidt A, Lykkeberg B, Callus E, de Hosson M, Sandberg C, Johansson B, Hlebowicz J, Areias ME, Amedro P, Coats L, Mandalenakis Z, Kaneva A, Moons P, Goossens E; APPROACH-IS II consortium; International Society for Adult Congenital Heart Disease. Avec Abassi H comme collaborateur (2024). “Frailty and Cognitive Function in Middle-Aged and Older Adults With Congenital Heart Disease. “ J Am Coll Cardiol. 2024 Mar 26;83(12):1149-1159. (IF=21,70). Cardiac and Cardiovascular Systems (Q1).
De Groote P, Thuny F, Blanchart K, Gueffet JP, Habib G, Salvat M, Leclercq C, Mouquet F, Roncalli J, Sebbag L, Cassagneau R, Peyrol M, Sabatier R, Gazzola C, Henderson J, Adamson PB, Roubille F. (2024).“ Remote haemodynamic-guided heart failure management in France: Results from the CardioMEMS HF System Post-Market Study (COAST) French cohort. “ Arch Cardiovasc Dis. 2024 Sep 12:S1875-2136(24)00309-7.sous presse. (IF=2,30). Cardiac and Cardiovascular System (Q2).
Delinière A, Bessière F, Placide L, Pasquié JL, Haddad C, Tirel S, Mokhtar H, Morel E, Gardey K, Dulac A, Ditac G, Sacher F, Denjoy I, Chevalier P. (2024). “ Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study “- Archives of Cardiovascular Diseases 2024 May;117(5):313-320. (IF=2,30) Cardiac and Cardiovascular Systems (Q2).
Delmas C, Ughetto A, Lebreton G, Roubille F. (2024) “Venting strategies for extracorporeal membrane oxygenation patients: More questions than answers but a plea for more clinical trials on the topic! “ Eur J Heart Fail. 2024 May;26(5):1261-1264. (IF= 16,90).. Cardiac and Cardiovascular Systems (Q1).
Dillinger JG, Pezel T, Delmas C, Schurtz G, Trimaille A, Piliero N, Bouleti C, Lattuca B, Andrieu S, Fabre J, Rossanaly Vasram R, Dib JC, Aboyans V, Fauvel C, Roubille F, Gerbaud E, Boccara A, Puymirat E, Toupin S, Vicaut E, Henry P; ADDICT-ICCU trial. (2024). “Carbon monoxide and prognosis in smokers hospitalised with acute cardiac events: a multicentre, prospective cohort study. “ EClinicalMedicine. 2024 Jan 3:67:102401. (IF=9,60). Medicine, General and Internal (Q1).
Derridj N, Calderon J, Bonnet D, Khoshnood B, Monier I, Guedj R (2024). “Neurodevelopmental outcomes of preterm and growth-restricted neonate with congenital heart defect: a systematic review and meta-analysis. “ . Eur J Pediatr. 2024 May;183(5):1967-1987. (IF=3,00). Pediatrics, Perinatology and Child Health (Q1).
Echivard M, Sellal JM, Ziliox C, Marijon E, Bordachar P, Ploux S, Benali K, Marquié C, Docq C, Klug D, Eschalier R, Maille B, Deharo JC, Babuty D, Genet T, Gandjbakhch E, Da Costa A, Piot O, Minois D, Gourraud JB, Mondoly P, Maury P, Boveda S, Pasquié JL, Martins R, Leclercq C, Guenancia C, Laurent G, Becker M, Bertrand J, Chevalier P, Manenti V, Kubala M, Defaye P, Jacon P, Desbiolles A, Badoz M, Jesel L, LelloucheN, Milliez PU, Ollitrault P, Fareh S, Bercker M, Mansourati J, Guy-Moyat B, Chabert JP, Luconi N, Winum PF, Anselme F, Extramiana F, Delahaye C, Jourda F, BizeauO, Nasarre M, Olivier A, Fromentin S, Villemin T, Levavasseur O, Hammache N, Magnin-Poull I, Blangy H, Sadoul N, Duarte K, Girerd N, and De Chillou C. 2024). “ Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study “ – European Heart Journal, 2024 sous presse. (IF=37,60). Cardiac and Cardiovascular Systems (Q1).
Elloumi A, Mas-Normand L, Bride J, Reversat G, Bultel-Poncé V, Guy A, Oger C, Demion M, Le Guennec JY, Durand T, Vigor C, Sánchez-Illana Á, Galano JM (2024). “From MS/MS library implementation to molecular networks: Exploring oxylipin diversity with NEO-MSMS. “. Sci Data. 2024 Feb 13;11(1):193. (IF=5,80). Multidisciplinary Sciences (Q1).
Fauvel C, Damy T, Berthelot E, Bauer F, Eicher JC, de Groote P, Trochu JN, Picard F, Renard S, Bouvaist H, Logeart D, Roubille F, Sitbon O, Lamblin N (2024) .”Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study. ”. Eur Heart J. 2024 Jul 26:ehae467”sous presse. (IF=37,60). Cardiac and Cardiovascular Systems (Q1).
Fauvel C, Dillinger JG, Rossanaly Vasram R, Bouleti C, Logeart D, Roubille F, Meune C, Ohlmann P, Bonnefoy-Coudraz E, Albert F, Attou S, Boukhris M, Pommier T, Merat B, Noirclerc N, Bouali N, Aghezzaf S, Schurtz G, Mansencal N, Andrieu S, Henry P, Pezel T; ADDICT-ICCU Investigators (2024). “ In-hospital prognostic value of TAPSE/sPAP in patients hospitalized for acute heart failure. “. Eur Heart J Cardiovasc Imaging. 2024 Jul 31;25(8):1099-1108. (IF=6,70). Cardiac and Cardiovascular Systems (Q1); Radiology, Nuclear Medicine and Medical imaging (Q1).
Feat-Vetel J, Suffee N, Bachelot F, Dos Santos M, Mougenot N, Delage E, Saliou F, Martin S, Brunet I, Sicard P, Monceau V. (2024). “X-ray Radiotherapy Impacts Cardiac Dysfunction by Modulating the Sympathetic Nervous System and Calcium Transients. “ Int J Mol Sci. 2024 Aug 31;25(17):9483. (IF=4,90).biochemistry and Molecular Biology (Q1); Chemistry Multidisciplinary (Q2).
François C, Bonafé I, Carra MC, Bertrand C, Micoulaud-Franchi JA, d’Incau E. (2024). “Dental sleep medicine education among undergraduate dental students in France. “ Eur J Dent Educ. 2024 Feb;28(1):148-153. (IF=1,70). Dentistry, Oral Surgery and Medicine (Q3); Education, Scientific Discipline (Q3).
François M, Daubin D, Menouche D, Gaillet A, Provoost J, Trusson R, Arrestier R, Hequet O, Richard JC, Moranne O, Larcher R, Klouche K. (2024). Adverse Events and Infectious Complications in the Critically Ill Treated by Plasma Exchange: A Five-Year Multicenter Cohort Study. Crit Care Explor. 2023 Oct 27;5(11):e0988. (IS=2,00). Critical Care and Intensive Medicine (Q3).
Fautrel B, Kedra J, Rempenault C, Juge PA, Drouet J, Avouac J, Baillet A, Brocq O, Alegria GC, Constantin A, Dernis E, Gaujoux-Viala C, Goëb V, Gottenberg JE, Goff BL, Marotte H, Richez C, Salmon JH, Saraux A, Senbel E, Seror R, Tournadre A, Vittecoq O, Escaffre P, Vacher D, Dieudé P, Daien C (2024). “ 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis. “. Joint Bone Spine. 2024 Oct 8:105790. Sous presse. (IF=3,80) . Rheumatology (Q2).
Gall E, Pezel T, Lattuca B, Hamzi K, Puymirat E, Piliero N, Deney A, Fauvel C, Aboyans V, Schurtz G, Bouleti C, Fabre J, El Ouahidi A, Thuaire C, Millischer D, Noirclerc N, Delmas C, Roubille F, Dillinger JG, Henry P; ADDICT-ICCU Investigators (2024). “Profile of patients hospitalized in intensive cardiac care units in France: ADDICT-ICCU registry. “. Arch Cardiovasc Dis. 2024 Feb 11:S1875-2136(24)00024-X. sous presse. (IF=2,30). Cardiac ad Cardiovascular Systems (Q2).
Garin E, Tselikas L, Guiu B, Chalaye J, Rolland Y, de Baere T, Assenat E, Tacher V, Palard X, Déandreis D, Mariano-Goulart D, Amaddeo G, Boudjema K, Hollebecque A, Meerun MA, Regnault H, Vibert E, Campillo-Gimenez B, Edeline J. (222024). “Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial. “ J Nucl Med. 2024 Feb 1;65(2):264-269. (IF=9,10). Radiology, Nuclear Medicine and Medical Imaging (Q1).
Goual L, Bounasri E . Le Guennec JY, Thireau J (2024). “Torsade de pointe : implications de l’axe neuro-cardiaque “ Archives des Maladies du Coeur et des Vaisseaux – Pratique .2024 sous presse. (IF=.0,40). Cardiac and Cardiovascular Systems (Q4) ; Peripheral Vascular Diseases (Q4). .
Guillaumont, Vincenti M, Thomas F, Huguet H, Picot MC, Abassi H, Huby AC, Laux D, Chabaneix JT, Cohen L, Gavotto A, Mamedro P, the ARCADE study group (2024);“Implications of right aortic arch prenatal diagnosis: the multicentric nationwide ARCADE cohort“ – Archives of Disease in Childhood…, 2024 sous presse. (IF=4,30). Pediatrics ‘Q1).
Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, de Backer T, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-Bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Jaén Águila F, Járai Z, Kahan T, Kantola I, Kociánová E, Limbourg F, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, MacIntyre I, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-Dias V, Papadakis I, Papadopoulos D, Perl S, Polónia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Václavík J, van der Giet M, der Niepen PV, Veglio F, Venzin R, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, Vogt L. (2024). “Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney. “ Blood Press. 2024 Dec;33(1):2368800. Sous presse. (IF=2,30)Peripheral Vascular Disease (Q3).
Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, de Backer T, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-Bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Águila FJ, Járai Z, Kahan T, Kantola I, Kociánová E, Limbourg FP, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, MacIntyre IM, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-Dias V, Papadakis I, Papadopoulos D, Perl S, Polónia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Václavík J, van der Giet M, Van der Niepen P, Veglio F, Venzin RM, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, Vogt L; European Society of Hypertension Working Group on Hypertension, the Kidney. (2024). “Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire. “ J Hypertens. 2024 Sep 1;42(9):1544-1554 (IF=3,30) Peripheral Vascular Disease (Q2).
Hamzi K, Gall E, Roubille F, Trimaille A, Elbaz M, El Ouahidi A, Noirclerc N, Fard D, Lattuca B, Fauvel C, Goralski M, Alvain S, Chaib A, Piliero N, Schurtz G, Pommier T, Bouleti C, Tron C, Bonnet G, Nhan P, Auvray S, Léquipar A, Dillinger JG, Vicaut E, Henry P, Toupin S, Pezel T; ADDICT-ICCU Investigators . (2024). “Phenotypic clustering of patients hospitalized in intensive cardiac care units: Insights from the ADDICT-ICCU study. “. Arch Cardiovasc Dis. 2024 Jun-Jul;117(6-7):392-401.(IF=2,30) Cardiac and Cardiovascular System (Q2).
Hédon C, Gouzi F, Padovani C, Schuster I, Maufrais C, Cade S, Cransac F, Bui G, Morcillo S, Ayoub B, Thireau J, Izem O, Reboul C, Walther G, Hayot M, Nottin S, Cazorla O (2024). “Cardiac Fatigue in Male Athletes with Exercise-Induced Pulmonary Impairments After a Very Long-Distance Triathlon. “ . Sports Med. 2024 Oct 16. Sous presse. (IF=9,30). Sport Sciences (Q1).
Hermida A, Jedraszak G, Ader F, Denjoy J, Fressart V Maury P, PhD, Beyls C, Bloch A, Clerici G, Daire E, Defaye P,Dupin-Deguine D, Garçon L, Klug D,Ginglinger E, Hermida JS, Jesel L, Khraiche D, Kubala M, Lacotte J, Laredo, M, Leenhardt A, Le Guillou X, Lesaffre F, Maltret A, Magnin-Poull I, Marijon E, Nambot S, Neyroud N, Ninni S, Palmyre A, Pasquie JL, Proukhnitzky J, Reant P, Richard P, Rollin A, Rooryck C, Sacher F, Schaefer E, Vernier A, Winum PF, Wahbi K, Waintraub X, Waldmann V, Weber S, Zouaghi A, Charron P, Extramiana F, Gandjbakhch E, (2024). “Systematic analysis of SCN5A variants associated with inherited cardiac diseases. “ – Heart Rhythm, 2024 sous presse, (IF=5,60). Cardiac and Cardiovascular Systems (Q1).
Hireche K, Canaud L, Peyron PA, Sakhri L, Serres I, Kamel S, Lounes Y, Gandet T, Alric P. (2024). “Ex Vivo Comparison of the Elastic Properties of Vascular Substitutes Used for Pulmonary Artery Replacement. “ Journal of Surgical Research, 2024, 295, pp.222-230. (IF=1,80). Surgery (Q3).
Huet F, Mariano-Goulart D, Aguilhon S, Delbaere Q, Lacampagne A, Fauconnier J, Leclercq F, Macia JC, Akodad M, Jammoul N, Prunier F, Mewton N, Angoulvant D, Lozza C, Soltani S, Rodier A, Grandemange S, Dupuy AM, Cristol JP, Amico M, Nagot N, Roubille F. Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial. Eur Heart J. 2024 Mar 1;45(9):725-727. (IF=37,60). Cardiac and Cardiovascular Systems (Q1).
Immediato Daien C, Georgescu V, Decarriere G, Mercier G, Morel J (2024). “ Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study. “ RMD Open. 2024 Oct 2;10(4):e004490. (IF=5,10). Immunology (Q1); Immunology and Alergy (Q1); Rheumatology (Q1).
Jammoul N, Dupasquier V, Akodad M, Meunier PA, Moulis L, Soltani S, Macia JC, Robert P, Schmutz L, Steinecker M, Piot C, Targosz F, Benkemoun H, Lattuca B, Roubille F, Cayla G, Leclercq F. (2024). “Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial. “ Am Heart J. 2024 Apr:270:13-22. (IF=3,70). Cardiac and Cardiovascular Systems (Q2).
Kedra J, Dieudé P, Giboin C, Marotte H, Salliot C, Schaeverbeke T, Perdriger A, Soubrier M, Morel J, Constantin A, Dernis E, Royant V, Salmon JH, Pham T, Gottenberg JE, Pertuiset E, Dougados M, Devauchelle-Pensec V, Gaudin P, Cormier G, Goupille P, Mariette X, Berenbaum F, Alcaix D, Rouidi SA, Berthelot JM, Monnier A, Piroth C, Lioté F, Goëb V, Gaujoux-Viala C, Chary-Valckenaere I, Hajage D, Tubach F, Fautrel B; CRI-IMIDIATE clinical research network. (2024). “Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission. “ Arthritis Rheumatol. 2024 Apr;76(4):541-552.. (IF=11,40). Rheumatology (Q1).
Klouche K, Brunot V, Larcher R, Lautrette A. (2024). “ Weaning from Kidney Replacement Therapy in the Critically Ill Patient with Acute Kidney Injury. “ J Clin Med. 2024 Jan 19;13(2):579. (IF= 3,00). Medicine, General and Internal (Q1).
Lacampagne A. (2024) “[The ryanodine receptor, a central player in the multi-systemic disorders associated with heart failure]. “Med Sci (Paris). 2024 May;40(5):417-419. (IF=0,60). Medicine, Research and Experimental (Q4).
Laffont-Lozes P, Naciri T, Pantel A, Martin A, Pruvot-Occean AS, Haignere V, Loubet P, Sotto A, Larcher R. (2024). “ First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion. “ Front Pharmacol. 2024 Oct 30;15:1347306. (IF=4,40) . Pharmacology and Pharmacy (Q1).
Leyba KA, Chan H, Loesch O, Belec S, Sicard P, Goergen CJ. (2024). “Automatic Segmentation for Analysis of Murine Cardiac Ultrasound and Photoacoustic Image Data Using Deep Learning. “ Ultrasound Med Biol. 2024 Aug;50(8):1292-1297 (IF=2,40). Acoustics (Q2); Radiology, Nuclear Medicine and Medical Imaging (Q2).
Logeart D, Doublet M, Gouysse M, Damy T, Isnard R, Roubille F. (2024). “Development and validation of algorithms to predict left ventricular ejection fraction class from healthcare claims data. “ ESC Heart Fail. 2024 Jun;11(3):1688-1697. (IF=3,20). Cardiac and Cardiovascular Systems (Q1).
Loiodice A, Bailly PharmD S, Ruckly S, Buetti N, Barbier F, Staiquly Q, Tabah A, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network; East Asia and Pacific; Australia; National Coordinator; Scientific Committee; Participating ICUs:; Brunei; National Coordinator; Participating ICUs; China; National Coordinator; Participating ICUs; Hong Kong; National Coordinator; Participating ICUs; Japan; National Coordinator; Participating ICUs:; Malaysia; National Coordinator; Participating ICUs:; Philippines; National Coordinator; Participating ICUs:; Republic Of Korea; National Coordinator; Participating ICUs:; Singapore; National Coordinator; Participating ICUs:; Taiwan; National Coordinator; Participating ICUs:; Thailand; National Coordinator; Participating ICUs:; Middle East and North Africa; Dubai; National Coordinator; Participating ICUs:; Egypt; National Coordinator; Participating ICUs:; Iran; National Coordinator; Participating ICUs:; Iraq; Participating ICUs:; Israel; National Co avec Larcher R et Klouche K comme participants (2024). “Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on ICU patient prognosis: a causal inference approach using data from the Eurobact2 study. “… See abstract for full author list ➔ Clin Microbiol Infect. 2024 Sep 24:S1198-743X(24)00443-9. (IF=10,90) Medicine General and Internal (Q2).
Magaldi M, Nogue E, Molinari N, De Luca N, Dupuy AM, Leclercq F, Pasquie JL, Roubille C, Mercier G, Cristol JP, Roubille F. (2024). “ Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS). “ J Clin Med. 2024 Mar 30;13(7):2018. (IF=3,00). Medicine, General and Internal (Q1).
Manzo-Silberman S, Martin AC, Boissier F, Hauw-Berlemont C, Aissaoui N, Lamblin N, Roubille F, Bonnefoy E, Bonello L, Elbaz M, Schurtz G, Morel O, Leurent G, Levy B, Jouve B, Harbaoui B, Vanzetto G, Combaret N, Lattucca B, Champion S, Lim P, Bruel C, Schneider F, Seronde MF, Bataille V, Gerbaud E, Puymirat E, Delmas C; FRENSHOCK investigators. (2024). “Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. “J Crit Care. 2024 Aug:82:154785. . (IF=3,20) Critical Care Medicine (Q2).
Matsushita K, Delmas C, Marchandot B, Roubille F, Lamblin N, Leurent G, Levy B, Elbaz M, Champion S, Lim P, Schneider F, Khachab H, Carmona A, Trimaille A, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Biendel C, Labbe V, Combaret N, Mansourati J, Filippi E, Maizel J, Merdji H, Lattuca B, Gerbaud E, Bonnefoy E, Puymirat E, Bonello L, Morel O (2024). “Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry. “ . J Am Heart Assoc. 2024 Mar 5;13(5):e030975. (IF=5,00). Cardiac and Cardiovascular Systems (Q1).
Michalet M, Tétreau R, Pasquié JL, Chabre O, Azria D. (2024). “ Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report. “ Cancer Radiother. 2024 Apr;28(2):202-205. (IF=1,50). Radiology, Nuclear Medicine & Medical Imaging (Q4); Oncologie (Q4)
Milesi C, Nogue E, Baleine J, Moulis L, Pouyau R, Gavotto A, Brosssier D, Mortamet G, Cambonie G; GFRUP Respiratory Study Group. (2024). “ROX (Respiratory rate-OXygenation) index to predict early response to high-flow nasal cannula therapy in infants with viral bronchiolitis. “ Pediatr Pulmonol. 2024 Apr;59(4):982-990. (IF=2,70). Pediatrics (Q2); Respiratory Systems (Q3).
Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Bergé E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, Sène D, Dieudé P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Gottenberg JE, Mariette X, Seror R. (2024). “Identification of distinct subgroups of Sjögren’s disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts. “ Lancet Rheumatol. 2024 Apr;6(4):e216-e225. . (IF=15,00). Rheumatology (Q1).
Ninni S, Algalarrondo V, Brette V, Lemesle G, Fauconnier J, on behalf of the Groupe de Reflexion sur la Recherche Cardiovasculaire (2024). ““..Left atrial cardiomyopathy: Pathophysiological insights, assessment methods and clinical implications. “ – Archives of Cardiovascular Diseases2024 Apr;117(4):283-296. (IF=2,30).Cardiac and Cardiovascular Systems (Q2).
Peschanski N, Zores F, Boddaert J, Douay B, Delmas C, Broussier A, Douillet D, Berthelot E, Gilbert T, Gil-Jardiné C, Auffret V, Joly L, Guénézan J, Galinier M, Pépin M, Le Conte P, Girerd N, Roca F, Oberlin M, Jourdain P, Rousseau G, Lamblin N, Villoing B, Mouquet F, Dubucs X, Roubille F, Jonchier M, Sabatier R, Laribi S, Salvat M, Chouihed T, Bouillon-Minois JB, Chauvin A, Le Borgne P; Société française de médecine d’urgence (SFMU); Groupe insuffisance cardiaque et cardiomyopathies de la Société française de cardiologie (GICC-SFC); Société française de gériatrie et gérontologie (SFGG). (2024). “ 2023 SFMU/GICC-SFC/SFGG expert recommendations for the emergency management of older patients with acute heart failure. Part 1: Prehospital management and diagnosis. “ Arch Cardiovasc Dis. 2024 Sep 2:S1875-2136(24)00288-2 sous presse. (IF=2,30). Cardiac and Cardiovascular Systems (Q2).
Peschanski N, Zores F, Boddaert J, Douay B, Delmas C, Broussier A, Douillet D, Berthelot E, Gilbert T, Gil-Jardiné C, Auffret V, Joly L, Guénézan J, Galinier M, Pépin M, Le Borgne P, Le Conte P, Girerd N, Roca F, Oberlin M, Jourdain P, Rousseau G, Lamblin N, Villoing B, Mouquet F, Dubucs X, Roubille F, Jonchier M, Sabatier R, Laribi S, Salvat M, Chouihed T, Bouillon-Minois JB, Chauvin A; Société française de médecine d’urgence (SFMU); Groupe insuffisance cardiaque et cardiomyopathies de la Société française de cardiologie (GICC-SFC); Société française de gériatrie et gérontologie (SFGG) (2024). “2023 SFMU/GICC-SFC/SFGG expert recommendations for the emergency management of older patients with acute heart failure. Part 2: Therapeutics, pathway of care and ethics. “ Arch Cardiovasc Dis. 2024 Oct 15:S1875-2136(24)00334-6. Sous presse. (IF=2,30) . Cardiac and Cardiovascular Systems (Q2).
Rasing I, Voigt S, Koemans EA, de Kort AM, van Harten TW, van Etten ES, van Zwet EW, Stoops E, Francois C, Kuiperij HB, Klijn CJM, Schreuder FHBM, van der Weerd L, van Osch MJP, van Walderveen MAA, Verbeek MM, Terwindt GM, Wermer MJH. (2024). “Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy. “ Alzheimers Res Ther. 2024 Apr 23;16(1):86. (IF=7,90). Clinical Neurology (Q1); Neurosciences (Q1).
Rempenault C, Lukas C, Tardivon L, Daien CI, Combe B, Guilpain P, Morel J (2024). “ Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease. “ RMD Open. 2024 Jan 30;10(1):e003415. (IF=5,10). Immunology (Q1); Immunology and Allergy (Q1); Rheumatology (Q1).
Roubille F. (2024). “ Risk Factors, Comorbidities, and Prevention of Cardiovascular Diseases: Don’t Forget the Primary Cause! “. J Clin Med. 2024 Nov 6;13(22):6652.(IF=3,00). Medicine General and Internal (Q1).
Roubille F (2024)“Colchicine in Patients with Stable Coronary Disease: should we consider basal inflammation – and how? “ . Eur J Prev Cardiol. 2024 Nov 15:zwae376. (IF=8, 40). Epidemyology (Q1); Cardiology, Cardiovascular Medicine (Q1).
Roubille F, Mercier G, Lancman G, Pasche H, Alami S, Delval C, Bessou A, Vadel J, Rey A, Duret S, Abraham E, Chatellier G, Durand Zaleski I. (2024). “ Weight telemonitoring of heart failure versus standard of care in a real-world setting: Results on mortality and hospitalizations in a 6-month nationwide matched cohort study. “ Eur J Heart Fail. 2024 sous presse. (IF=16,90). Cardiac and Cardiovascular System (Q1).
Roubille F, Bouabdallaoui N, Kouz S, Waters DD, Diaz R, Maggioni AP, Pinto FJ, Grégoire JC, Gamra H, Kiwan GS, Berry C, López-Sendón J, Koenig W, Delorme L, Elbaz M, Coste P, Provencher M, Bassevitch Z, Blondeau L, L’Allier PL, Guertin MC, Tardif JC (2024). “ Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). “ Diabetes Care. 2024 Jan 5:dc231825. (IF=14,80). Endocrinology and Metabolism (Q1).
Roubille F, Fauconnier J (2024). “ Gliflozins’ pleiotropic protective effects including the vascular tree: Is it the common trunk? “ – Atherosclerosis, 2024 sous presse. (IF=4,90). Cardiac and Cardiovascular Systems (Q1); Peripheral Vascular Diseases (Q1).
Roubille F, Cherbi M, Kalmanovich E, Delbaere Q, Bonnefoy‑Cudraz E, Puymirat E, Schurtz G, GerbaudE, Bonello L, Lim P, Leurent G, Roubille C and Delmas C, (2024) ” The admission level of CRP during cardiogenic shock is a strong independent risk marker of mortality. ” Scientific Reports 2024 Jul 16;14(1):16338. (IF=3,80). Multidisciplinary Science (Q1).
Roubille F, Labarre JP, Georger F, Galinier M, Herman F, Berdague P, Nogue E, Petroni T, Delbaere Q, Malak A, Robin M, Prunet E, Leclercq F, Pasquie JL, Papinaud L, Mercier G, Ricci JE, Cayla G, Duflos C (2024). “PRADOC: A Multicenter Randomized Controlled Trial to Assess the Efficiency of PRADO-IC, a Nationwide Pragmatic Transition Care Management Plan for Hospitalized Patients With Heart Failure in France. “ . J Am Heart Assoc. 2024 Aug 6;13(15):e032931.. (IF=5,00). Cardiac and Cardiovascular Systems (Q1).
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, Salliot C, Poiroux L, Nguyen M, Roux CH, Richez C, Saraux A, Vergne-Salle P, Morel J, Flipo RM, Piperno M, Gottenberg JE, Marotte H, Soubrier M, Gossec L, Dieudé P, Lassoued S, Zabraniecki L, Couture G, Boyer JF, Jamard B, Degboe Y, Constantin A (2424). “Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial. . “ Ann Rheum Dis. 2024 Oct 29:ard-2024-226620. (IF=20,30)Rheumatology (Q1).
Ruyssen-Witrand A, Dimeglio C, Nogue E, Molinary N, Pham T, Gaujoux-Viala C, Miceli-Richard C, Fogel O, Herin F, Martin-Blondel G, Berenbaum F, Breuil V, Chary-Valckenaere I, Confavreux C, Devauchelle-Pensec V, Fautrel B, Flipo RM, Mulleman D, Richez C, Tournadre A, Vittecoq O, Constantin A, Izopet J, Morel J. (2024). “ Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts. “ Clin Exp Rheumatol. 2024 Oct 17. Sous presse. (IF=3,40) Rheumatology (Q2).
Souidi M, Resta J, Dridi H, Sleiman Y, Reiken S, Formoso K, Colombani S, Amédro P, Meyer P, Charrabi A, Vincenti M, Liu Y, Soni RK, Lezoualc’h F, Stéphane Blot DVM, Rivier F, Cazorla O, Parini A, Marks AR, Mialet-Perez J, Lacampagne A, Meli AC (2024). “ Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy. “ . J Cachexia Sarcopenia Muscle. 2024 Jan 14. Sous presse. (IF=9,40). Geriatrics and Gerontology (Q1); Medicine General and Internal (Q1).
Souilla L, Larsen AC, Juhl CB, Skou ST, Bricca A. (2024). “ Childhood and adolescence physical activity and multimorbidity later in life: A systematic review. “ J Multimorb Comorb. 2024 Feb 7:14:26335565241231403.. (IF=à voir)
Souilla L, Amedro P, Morrison SA (2024). “ Children With Cardiac Disease and Heat Exposure: Catastrophic Converging Consequences? “. Pediatr Exerc Sci. 2024 Jan 3:1-5. (IF=1,40). Pediatrics (Q3); Physiology (Q4).
Souilla L, Guillaumont S, Auer A, Metzler G, Requirand A, Vincenti M, De La Villeon G, Pasquie JL, Mottet D, Amedro P (2024). ” Cardiac rehabilitation in children and adolescents with long QT syndrome: the RYTHMO’FIT pilot study. ” . BMC Sports Sci Med Rehabil. 2024 Jul 12;16(1):152. (IF=2,10) Physical Therapy, Sports Therapy and Rehabilitation (Q2); Rehabilitation (Q2); Orthopedics and Sports Medicine (Q3).
Tchakerian S, Besnard N, Brunot V, Moulaire V, Benchabane N, Platon L, Daubin D, Corne P, Machado S, Jung B, Bendiab E, Landreau L, Pelle C, Larcher R, Klouche K. (2024). “ Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves. “ Pneumonia (Nathan). 2024 Nov 5;16(1):27. (IF=8,50). Respiratory System (Q1).
Teiger E, Eschalier R, Amabile N, Rioufol G, Ducrocq G, Garot P, Lepillier A, Bille J, Elbaz M, Defaye P, Audureau E, Le Corvoisier P; French Left Atrial Appendage Closure-2 registry (FLAAC-2) investigators. Avec Pasquié JL comme collaborateur. (2024). “Left atrial appendage closure in very elderly patients in the French National Registry. “ Heart. 2024 Jan 29;110(4):245-253. (IF=5,10). Cardiac and Cardiovascular Disease (Q1).
Titeca-Beauport D, Diouf M, Daubin D, Vong LV, Belliard G, Bruel C, Zerbib Y, Vinsonneau C, Klouche K, Maize l J. (2024). “The combination of kidney function variables with cell cycle arrest biomarkers identifies distinct subphenotypes of sepsis-associated acute kidney injury: a post-hoc analysis (the PHENAKI study). “Ren Fail. 2024 Dec;46(1):2325640. (IF=3,00). Critical Care and Intensive Care Medicine (Q2); Medicine (miscellaneous) (Q2); Nephrology (Q2)
Torre E, Mangoni ME, Lacampagne A, Meli AC, Mesirca P. (2024) “ State-of-the-Art Differentiation Protocols for Patient-Derived Cardiac Pacemaker Cells “ – International Journal of Molecular Sciences 2024 Mar 16;25(6):3387. (IF=4,90). Biochemistry and Molecular Biology (Q1). Chemistry, Multidisciplinary(Q2).
Volle K, Merdji H, Bataille V, Lamblin N, Roubille F, Levy B, Champion S, Lim P, Schneider F, Labbe V, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Quentin C, Combaret N, Marchandot B, Lattuca B, Biendel C, Leurent G, Bonello L, Gerbaud E, Puymirat E, Bonnefoy E, Aissaoui N, Delmas C; FRENSHOCK Investigator. Avec Gaudard P , Klouche K comme collaborateurs. (2024). “ Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry. “ Clin Res Cardiol. 2024 Oct 23. Sous presse. (IF=3,80). Cardiac and Cardiovascular Systems (Q1).
Wendling D, Al Tabaa O, Chevet B, Fakih O, Ghossan R, Hecquet S, Dernis E, Maheu E, Saraux A, Besson FL, Alegria GC, Cortet B, Fautrel B, Felten R, Morel J, Ottaviani S, Querellou-Lefranc S, Ramon A, Ruyssen-Witrand A, Seror R, Tournadre A, Foulquier N, Verlhac B, Verhoeven F, Devauchelle-Pensec V. (2024). “Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica. “Joint Bone Spine. 2024 Jul;91(4):105730. (IF=3,80). Rheumatology (Q2).
Werner O, Ichay L, Djouadi N, Vetromile F, Vincenti M, Guillaumont S, Germain DP Fila M (2024). “Use of T1 mapping in cardiac MRI for the follow-up of Fabry disease in a pediatric population“ – Molecular Genetics and Metabolism Reports Volume 38, March 2024, 101044 (IF=1,80). Genetics and Heredity (Q4).
Alami S, Courouve L, Lancman G, Gomis P, Al-Hamoud G, Laurelli C, Pasche H, Chatellier G, Mercier G, Roubille F, Delval C, Durand-Zaleski I. (2023). “Organisational Impact of a Remote Patient Monitoring System for Heart Failure Management: The Experience of 29 Cardiology Departments in France. “ Int J Environ Res Public Health. 2023 Feb 28;20(5):4366. (IF=4,61). Enviroment Sciences (Q2) ; Public Enviromental and Occupational Health (Q2) .
Amedro P, Matecki S, Pereira Dos Santos T, Guillaumont S, Rhodes J, Yin SM, Hager A, Hock J, De La Villeon G, Moreau J, Requirand A, Souilla L, Vincenti M, Picot MC, Huguet H, Mura T, Gavotto A. “Reference Values of Cardiopulmonary Exercise Test Parameters in the Contemporary Paediatric Population. “ Sports Med Open. 2023 Aug 1;9(1):68.(IF=4,60) Sport Sciences (Q1).
Arfi F, Courbis AL, Lambolais T, Bughin F, Hayot M (2023). “Formal verification of a telerehabilitation system through an abstraction and refinement approach using UPPAAL” IET Software 2023;1–18. (IF=1,60). Computer graphics and Computer-Aided Design (Q2).
Arrestier R, Chaba A, Mabrouki A, Saccheri C, Canet E, Pineton de Chambrun M, Stoclin A, Picard M, Wallet F, Perier F, Turpin M, Argaud L, Decavèle M, Issa N, Cadoz C, Klouche K, Cohen J, Mokart D, Grouille J, Urbina T, Hua C, Chosidow O, Mekontso-Dessap A, Azoulay E, de Prost N. (2023). “Necrotizing soft tissue infections in critically ill neutropenic patients: a French multicentre retrospective cohort study. “ Ann Intensive Care. 2023 Apr 28;13(1):34. (IF=8,10). Critical Care Medicine (Q1).
Avouac J, Fogel O, Hecquet S, Daien C, Elalamy I, Picard F, Prati C, Salmon JH, Truchetet ME, Sellam J, Molto A; French Society of Rheumatology. (2023). “Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases. “ Joint Bone Spine. 2023 Sep;90(5):105592. (IF=5,26). Rheumatology (Q2).
Bainton J, Trachtenberg F, McCrindle BW, Wang K, Boruta R, Brosig CL, Egerson D, Sood E, Calderon J, Doman T, Golub K, Graham A, Haas K, Hamstra M, Lindauer B, Sylvester D, Woodard F, Young-Borkowski L, Mussatto KA (2023). ”Prevalence and associated factors of post-traumatic stress disorder in parents whose infants have single ventricle heart disease. ”. Cardiol Young. 2023 Jan 5:1-10. (IF=1,00). Cardiac and Cardiovascular Systems (Q4) ; Domaine de Recherche: Pediatry (Q4).
Berger M, Daubin D, Charriot J, Klouche K, Le Moing V, Morquin D, Halimi L, Jaussent A, Taourel P, Hayot M, Cristol JP, Nagot N, Fesler P and Roubille C (2023). “Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study“ – Journal of Clinical Medicine, 2023 Jan 28;12(3):1000.. (IF=3,90). Medicine, General and Internal (Q1).
Borges GSM, Sicard P, de Mello Gomides Loures C, Evangelista FGC, Sales CC, de Paula Sabino A, Fernandes C, Ferreira LAM, Richard S. (2023). “ Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide. “ AAPS PharmSciTech. 2023 Mar 14;24(3):79. (IF=3,30). Pharmaceutical Science (Q2).
Bouvet J, Broner J, Arnaud E, Dumain C, Holubar J, Costa D, Fesler P, Fages M, Goulabchand R. (2023) “[Easing the patients’ trajectories from private practice to hospital: One-year experiment of the RAPIDO project]. “ Rev Med Interne. 2023 Jul;44(7):328-334. (IF=0,90). Medicine General and Internal (Q4).
Bredy C, Deville F, Huguet H, Picot MC, De La Villeon G, Abassi H, Avesani M, Begue L, Burlet G, Boulot P, Fuchs F, Amedro P. (2023). “Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease? “ Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):177-183.. (IF=5,20). General Medicine (Q1).
Bughin F, Mendelson M, Jaffuel D, PépinJL, Gagnadoux F, Goutorbe F , Abril B , Ayoub B , Aranda A , Alagha K, Pomiès P , Roubille F, Mercier J , Molinari N , Dauvilliers J , Héraud N and Hayot M (2023). “ Impact of a telerehabilitation programme combined with continuous positive airway pressure on symptoms and cardiometabolic risk factors in obstructive sleep apnea … “ – DIGITAL HEALTH, 2023 Apr 6:9:20552076231167009. (IF=3,90). Health Policy (Q1); Computer Science Applications (Q2); Health Informatics (Q2); Health Information Management (Q2)
Buzancais A, Brunot V, Larcher R, Tudesq JJ, Platon L, Besnard N, Amalric M, Daubin D, Corne P, Moulaire V, Jung B, Canaud B, Cristol JP, Klouche K. (2023). “Sodium flux during hemodialysis and hemodiafiltration treatment of acute kidney injury: Effects of dialysate and infusate sodium concentration at 140 and 145 mmol/L. “ Artif Organs. 2023 Jun;47(6):999-1006. (IF=2,40). Engineering Biomedical (Q3) ; Transplantation (Q3).
Cadour F, Quemeneur M, Biere L, Donal E, Bentatou Z, Eicher JC, Roubille F, Lalande A, Giorgi R, Rapacchi S, Cortaredona S, Tradi F, Bartoli A, Willoteaux S, Delahaye F, Biene SM, Mangin L, Ferrier N, Dacher JN, Bauer F, Leurent G, Lentz PA, Kovacsik H, Croisille P, Thuny F, Bernard M, Guye M, Furber A, Habib G, Jacquier A. (2023). “Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. “ J Cardiovasc Magn Reson. 2023 Feb 6;25(1):7. (IF= 6,90) Cardiology and Cardiovascular Medicine (Q1); Family Practice (Q1); Radiological and Ultrasound Technology (Q1); Radiology, Nuclear Medicine and Imaging (Q1).
Cambonie G, Desage C, Thaller P, Lemaitre A, de Balanda KB, Combes C, Gavotto A. (2023). “ Context of a neonatal death affects parental perception of end-of-life care, anxiety and depression in the first year of bereavement. “ BMC Palliat Care. 2023 May 13;22(1):58.(IF=3,10). Health Care Sciences and Services (Q2) ; Health Policy and Services (Q2).
Cambonie G, Desage C, Thaller P, Lemaitre A, de Balanda KB, Combes C, Gavotto A. (2023) “Correction: Inulin diet uncovers complex diet-microbiota-immune cell interactions remodeling the gut epithelium. “ Microbiome. 2023 May 31;11(1):122. (IF=15,50) Microbiology (Q1).
Cardelli LS, Cherbi M, Huet F, Schurtz G, Bonnefoy-Cudraz E, Gerbaud E, Bonello L, Leurent G, Puymirat E, Casella G, Delmas C, Roubille F. (2023). Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry. Pharmaceuticals (Basel). 2023 Dec 18;16(12):1740. (IF=4,60). Pharmacology and Pharmacy (Q1).
Cardelli LS, Delbaere Q, Massin F, Granier M, Casella G, Barbato G, Dupasquier V, Macia JC, Leclercq F, Pasquie JL, Roubille F. (2023). “Wearable Cardioverter Defibrillator Shortens the Lengths of Stay in Patients with Left Ventricular Dysfunction after Myocardial Infarction: A Single-Centre Real-World Experience. “ J Clin Med. 2023 Jul 25;12(15):4884. (IF=3,90). Medicine, General and Internal (Q1).
Cariou E, Griffier R, Orieux A, Silva S, Faguer S, Seguin T, Nseir S, Canet E, Desclaux A, Souweine B, Klouche K, Guisset O, Pillot J, Picard W, Saghi T, Delobel P, Gruson D, Prevel R, Boyer A. (2023). “Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study. “ Ann Intensive Care. 2023 Mar 24;13(1):22. (IF=8,10). Critical Care Medicine (Q1).
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC; MINT Investigators. Avec Roubille F parmi les collaborateurs. (2023). “Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. “ Am Heart J. 2023 Mar;257:120-129. (IF=5,70). Cardiac and Cardiovascular Systems (Q2).
Cherbi M, Bonnefoy E, Lamblin N, Gerbaud E, Bonello L, Roubille F, Levy B, Champion S, Lim P, Schneider F, Elbaz M, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Combaret N, Labbe V, Marchandot B, Lattuca B, Biendel-Picquet C, Leurent G, Puymirat E, Maury P, Delmas C (2023). “One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry. “. Front Cardiovasc Med. 2023 Sep 5;10:1167738. (IF=3,60). Cardiac and Cardiovascular Systems (Q2).
Cherbi M, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, Elbaz M, Champion S, Lim P, Schneider F, Cariou A, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Quentin C, Delabranche X, Aissaoui N, Combaret N, Tomasevic D, Marchandot B, Lattuca B, Henry P, Gerbaud E, Bonnefoy E, Puymirat E, Maury P, Delmas C. (2023); “One-year outcomes in cardiogenic shock triggered by ventricular arrhythmia: An analysis of the FRENSHOCK multicenter prospective registry. “ Front Cardiovasc Med. 2023 Jan 26;10:1092904. (IF=3,60). Cardiac and Cardiovascular Systems (Q2).
Cholley B, Bojan M, Guillon B, Besnier E, Mattei M, Levy B, Ouattara A, Tafer N, Delmas C, Tonon D, Rozec B, Fellahi JL, Lim P, Labaste F, Roubille F, Caruba T, Mauriat P; ARCOTHOVA study group.Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study. Ann Intensive Care. 2023 Sep 29;13(1):94. (IF=8,10). Critical Care Medicine (Q1).
Cholley B, Bojan M, Guillon B, Besnier E, Mattei M, Levy B, Ouattara A, Tafer N, Delmas C, Tonon D, Rozec B, Fellahi JL, Lim P, Labaste F, Roubille F, Caruba T, Mauriat P; ARCOTHOVA study group. (2023)..”Overview of the current use of levosimendan in France: a prospective observational cohort study. “. Ann Intensive Care. 2023 Aug 8;13(1):69. (IF=8,10). Critical Care Medicine (Q1).
Choquet C, Sicard P, Vahdat J, Nguyen THIM, Kober F; Varlet I, Bernard M , Richard S , Kelly RG, Lalevée N, and Miquerol L. (2023) “Nkx2-5 Loss of Function in the His-Purkinje System Hampers Its Maturation and Leads to Mechanical Dysfunction “- Journal of Cardiovascular Development and Disease, 2023 Apr 27;10(5):194 (IF=3,95). Cardiac and Cardiovascular Systems (Q2).
Coustal C, Vanoverschelde J, Quantin X, Lesage C, Michot JM, Lappara A, Ederhy S , Assenat E, Faure M, Issa N, Lambotte O, Puyade M, Dereure O, Tosi D, Rullier P, Serre I, Larcher R, Klouche K, Chanques G, Vernhet-Kovacsik H, Faillie JL, Agullo A, Roubille F, Guilpain P, ATJ Maria. (2023).” Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series” – Journal for ImmunoTherapy of Cancer , 2023 May;11(5):e004792.. (IF=12,48). Immunology (Q1); Oncology (Q1).
Coutance G, Racapé M, Baudry G, Lécuyer L, Roubille F, Blanchart K, Epailly E, Vermes E, Pattier S, Boignard A, Gay A, Bruneval P, Jouven X, Van Huyen JD, Loupy A (2023).” Validation of the clinical utility of microRNA as non-invasive biomarkers of cardiac allograft rejection: A prospective longitudinal multicenter study. ”. J Heart Lung Transplant. 2023 Jul 22:S1053-2498(23)01939-3. (IF=13,57). Cardiac and Cardiovascular Systems (Q1). Respiratory Systems (Q1); Surgery (Q1); Transplantations (Q1).
Delbaere Q, Chapet N, Huet F, Delmas C, Mewton N, Prunier F, Angoulvant D, Roubille F. (2023). “Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. “ Pharmaceuticals (Basel). 2023 Jan 4;16(1):78. (IF=4,60). Pharmacology and Pharmacy (Q1); Chemistry, Medicinal (Q1).
Delmas C, Bonello L, Roubille F. (2023). “For the best management, please ask for assistance! “ Eur J Heart Fail. 2023 Apr;25(4):573-575.. (IF=18,20). Cardiac and Cardiovascular Systems (Q1).
Delmas C, Laine M, Schurtz G, Roubille F, Coste P, Leurent G, Hraiech S, Pankert M, Gonzalo Q, Dabry T, Letocart V, Loubière S, Resseguier N, Bonello L. (2023). “ Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock. “Am Heart J. 2023 Nov:265:203-212. (IF=4,80). Cardiac and Cardiovascular Systems (Q2).
Delmas C, Barbosa H, David CH, Bouisset F, Piriou PG, Roubille F, Leick J, Pavlov M, Leurent G, Potapov EV, Linke A, Mierke J, Lanmüller P, Mangner N. (2023). “Impella for the Management of Ventricular Septal Defect Complicating Acute Myocardial Infarction: An European Multicenter Registry. “ ASAIO J. 2023 Nov 8. Sous presse. (IF=4,20). Energing, Biomedical (Q2); Transplantation (Q2).
Devauchelle V, Mariette X, Benyoussef AA, Boisrame S, Cochener B, Cornec D, Nocturne G, Gottenberg JE, Hachulla E, Labalette P, Le Guern V, M’Bwang Seppoh R, Morel J, Orliaguet M, Saraux A, Seror R, Costedoat-Chalumeau N; Collaborators. (2023).” French national diagnostic and care protocol for Sjögren’s syndrome. ” Rev Med Interne. 2023 Jul 13:S0248-8663(23)00679-3. (IF=0,90) Medicine General and Internal (Q4).
Dridi H, Liu Y, Reiken S, Liu X, Argyrousi EK, Yuan Q, Miotto MC, Sittenfeld L, Meddar A, Soni RK, Arancio O, Lacampagne A, Marks AR. (2023). “Heart failure-induced cognitive dysfunction is mediated by intracellular Ca2+ leak through ryanodine receptor type 2. “ Nat Neurosci. 2023 Aug;26(8):1365-1378. . (IF=25,00). Neurosciences (Q1).
Dridi H, Yehya M, Barsottid R, Liu Y, Reiken S, Azriac L, Yuana Q, Bahloulia L, Kumar-Soni R, Marks AR, Lacampagne A and Matecki S. (2023). “Aberrant mitochondrial dynamics contributes to diaphragmatic weakness induced by mechanical ventilation“ PNAS Nexus, 2023 Nov 7;2(11):pgad336 (IF=à venir)
Eduin B, Roubille C, Badiou S, Cristol JP, Fesler P. (2023). “Association between Elevated Plasma Vitamin B12 and Short-Term Mortality in Elderly Patients Hospitalized in an Internal Medicine Unit. “ Int J Clin Pract. 2023 Dec 18;2023:6652671. Sous presse. (IF=3,15) Medicine General and Internal (Q2).
Ehrler M, Bellinger DC, Cassidy AR, Newburger JW, Calderon J. (2023). “ Social cognition and behavioral outcomes in congenital heart disease: profiles and neuropsychiatric comorbidities. “ Child Neuropsychol. 2023 Apr 5:1-23. (IF=2,20). Medicine Pediatrics, Perinatology and Child Health (Q1). Psychology – Developmental and Educational Psychology (Q2) ; Psychology – Neuropsychology and Physiological Psychology (Q2).
Fartoukh M, Nseir S, Mégarbane B, Cohen Y, Lafarge A, Contou D, Thille AW, Galerneau LM, Reizine F, Cour M, Klouche K, Navellou JC, Bitker L, Rousseau A, Tuffet S, Simon T, Voiriot G; MultiCoV collaborative trial group; Elabbadi A, Turpin M, Verdet C, Préau S, Wallet F, Loiez C, Voicu S, Jacquier H, Tandjaoui-Lambiotte Y, Jaureguy F, Alloui C, Azoulay E, Bercot B, Plantefeve G, Claudinon-Courpon A, Henry A, Pichon M, Schwebel C, Tadié JM, Auger G, Argaud L, Chabchoub M, Kolenda C, Vandenesch F, Godreuil S, Piton G, Jeannot K, Danjou W. (2023). “Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicenter randomised controlled trial. “ Clin Microbiol Infect. 2023 Jun;29(6):734-743 (IF=14,20). Infectious Disease (Q1) ; ” Microbiology (Q1).
Fauvel C, Giraldo CIS, Barassa A, Shchendrygina A, Mapelli M, Jakus N, Jobbe-Duval A, Meznar AZ, Harbaoui B, Berthelot E, Roubille F, Rosano G, Mewton N. (2023). “Differences between heart failure specialists and non-specialists regarding heart failure drug implementation and up-titration. “ Eur J Heart Fail. 2023 Oct;25(10):1884-1886. (IF=18,20). Cardiac and Cardiovascular Systems (Q1).
Fauvel C, Bonnet G, Mullens W, Giraldo CIS, Mežnar AZ, Barasa A, Tokmakova M, Shchendrygina A, Costa FM, Mapelli M, Zemrak F, Tops LF, Jakus N, Sultan A, Bahouth F, Hadjseyd CE, Salvat M, Anselmino M, Messroghli D, Weberndörfer V, Giverts I, Bochaton T, Berthelot E, Legallois D, Beauvais F, Bauer F, Lamblin N, Damy T, Girerd N, Sebbag L, Pezel T, Cohen-Solal A, Rosano G, Roubille F, Mewton N. (2023). “Sequencing and Titrating Approach of Therapy in Heart Failure with Reduced Ejection Fraction Following the 2021 ESC guidelines: an International Cardiology Survey. “ Eur J Heart Fail. 2023 Feb;25(2):213-222 (IF=18,20). Cardiac and Cardiovascular Systems (Q1).
Femenia V, Pommier V, Huguet H, Iriart X, Picot MC, Bredy C, Lorca L, Villeon GDL, Guillaumont S, Pasquie J-L, Matecki S, Roubertie F, Leobon B, Thambo J-Benoît, Jalal Z, Thomas J, Mouton J-B, Avesani M, Amedro P (2023). “.Correlation between three-dimensional echocardiography and cardiopulmonary fitness in patients with univentricular heart: A cross-sectional multicentre prospective study. “- Archives of Cardiovascular Diseases 2023 Mar 9:S1875-2136(23)00055-4. (IF=3,00). Cardiac ad Cardiovascular Systems (Q2).
Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, Atzeni F, Behrens GM, Bijlsma JW, Böhm P, Constantinou CA, Garcia-Diaz S, Kapetanovic MC, Lauper K, Luís M, Morel J, Nagy G, Poleverino E, van Rompay J, Sebastiani M, Strangfeld A, de Thurah A, Galloway J, Hyrich KL. (2023). “2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. “ Ann Rheum Dis. 2023 Jun;82(6):742-753 (IF=27,40). Rheumatolgy (Q1).
François-Heude MC, Poulen G, Flamand Roze E, Nguyen Morel MA, Gras D, Roch-Toreilles I, Quintard A, Baroux G, Meyer P, Coubes P, Milesi C, Cambonie G, Baleine J, Sola C, Delye B, Dimopoulou E, Sanchez S, Gasnier M, Touati S, Zamora A, Pontal D, Leboucq N, Kouyoumdjian V, Lebasnier A, Sanquer S, Mariano-Goulart D, Roujeau T, Roubertie A. (2023).”Intraputaminal Gene Delivery in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency. ” Mov Disord Clin Pract. 2023 Feb 24;10(5):811-818. (IF=4,00). Clinical Neurology (Q2).
Gallet R, Su JB, Corboz D, Chiaroni PM, Bizé A, Dai J, Panel M, Boucher P, Pallot G, Brehat J, Sambin L, Thery G, Mouri N, de Pommereau A, Denormandie P, Germain S, Lacampagne A, Teiger E, Marbán E, Ghaleh B. (2023). “Three-vessel coronary infusion of cardiosphere-derived cells for the treatment of heart failure with preserved ejection fraction in a pre-clinical pig model. “ Basic Res Cardiol. 2023 Jul 3;118(1):26. (IF=9,50). Cardiac ad Cardiovascular Systems (Q1).
Galvez T, Lotierzo M, Conquet G, Verani Q, Aguilhon C, Rangeard I, Cristol JP, Renard E. (2023). “Factitious hypoglycemia in insulin-treated diabetic patients. “ Ann Endocrinol (Paris). 2023 Mar 23:S0003-4266(23)00065-3. (IF=2,48). Endocrinology et Metabolism (Q4).
Garcia R, Warming PE, Narayanan K, Defaye P, Guedon-Moreau L, Blangy H, Piot O, Leclercq C, Marijon E; WEARIT-France Investigators avec Pasquié JL parmi les collaborateurs (2023). “Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study. “. Europace. 2023 May 19;25(5):euad062. (IF=6,10). Cardiac and Cardiovascular Systems (Q2).
Gaudard P, David H, Bideaux P, Sicard P, Cristol JP, Guillon G, Richard S , Colson P and Virsolvy A (2023). “Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats“ Int. J. Mol. Sci. 2023, 24, 1325. (IF=5,60). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary (Q2).
Gavotto A, Amedro P, Cambonie G (2023). “ Think out of the box: association of left congenital diaphragmatic hernia and abnormal origin of the right pulmonary artery : A train can hide another. “. BMC Pediatr. 2023 Jul 11;23(1):349. (IF=2,40). Pediatrics (Q2).
Gavotto A, Mura T, Rhodes J, Yin SM, Hager A, Hock J, Guillaumont S, Vincenti M, De La Villeon G, Requirand A, Picot MC, Huguet H, Souilla L, Moreau J, Matecki S, Amedro P. (2023). “Reference values of aerobic fitness in the contemporary paediatric population. “ Eur J Prev Cardiol. Jul 12;30(9):820-829. (IF=8,30). Cardiology, Cardiovascular Medicine (Q1); Epidemiology(Q1).
Gavotto A, Ladeveze M, Avesani M, Huguet H, Guillaumont S, Picot MC, Requirand A, Matecki S, Amedro P (2023). “Aerobic fitness change with time in children with congenital heart disease: A retrospective controlled cohort study. “. Int J Cardiol. 2023 Jan 15;371:140-146. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Gavotto A, Dubard V, Avesani M, Huguet H, Picot MC, Abassi H, Guillaumont S, De La Villeon G, Haouy S, Sirvent N, Sirvent A, Theron A, Requirand A, Matecki S, Amedro P. (2023). “ Impaired aerobic capacity in adolescents and young adults after treatment for cancer or non-malignant haematological disease. “ Pediatr Res. 2023 Aug;94(2):626-631. (IF=3,60). Pediatrics, Perinatalogy and child health (Q1).
Gavotto A, Vincenti M, Guillaumont S. (2023). “Isolated Ventricular Inversion: A Rare Complex Congenital Heart Disease With Neonatal Cyanosis. . “ JACC Case Rep. 2022 Nov 3;8:101642. eCollection 2023 Feb 15. (IF=1,20). Cardiology and Cardiovascular Medicine (Q4)
Girerd N, Leclercq C, Hanon O, Bayés-Genís A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F. (2023). “Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts. “ Rev Esp Cardiol (Engl Ed). 2023 Oct;76(10):813-820. (IF=5,90). Medicine (Q3).
Goual L, Bounasri E, Vincenti M, Amédro P, Desprat R, Bernex F, Lemaitre JM, Pasquié JL, Lacampagne A, Thireau J, Meli AC. (2023). “Generation of Patient-Specific Induced Pluripotent Stem Cell Lines with Type 2 Long QT Syndrome and the KCNH2 c. 379C> T Pathogenic Variant“- Stem Cell Research, 2023 sous presse. (IF=1,20). Biotechnology an Applied Microbiology (Q4); Cell and Tissue Engenering (Q4); Cell Biology (Q4).
Goulabchand R, Qian AS, Nguyen NH, Singh AG, Roubille C, Parreau S, Singh N, Singh S. (2023). “Burden, Causes and Outcomes of Hospitalization in Patients with Giant Cell Arteritis: A US National Cohort Study. “ Arthritis Care Res (Hoboken). 2023 Aug;75(8):1830-1837. (IF=4,70). Rheumatology (Q2)
Guellec D, Carvajal-Alegria G, Daïen C, Gossec L, Guillemin F, Berenbaum F, Constantin A, Dieude P, Dougados M, Flipo RM, Goupille P, Mariette X, Richez C, Vittecoq O, Combe B, Saraux A. (2023). “Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort. “ Clin Exp Rheumatol. 2023 Mar;41(3):649-655. . (IF=3,70). Rheumatology (Q2).
Guillot B, Boileve A, Walton R, Harfoush A, Conte C, Sainte-Marie Y, Charron S, Bernus O, Recalde A, Sallé L, Brette F, Lezoualc’h F (2023). “Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation. “ . Front Physiol. 2023 Feb 22;14:1120336. . (IF=4,00). Physiology (Q1).
Grillet PE, Desplanche E, Wynands Q, Gouzi F, Bideaux P, Fort A, Scheuermann V, Lacampagne A, Virsolvy A, Thireau J, de Tombe P, Bourdin A, Cazorla O. (2023) “Diastolic Cardiomyopathy Secondary to Experimentally Induced Exacerbated Emphysema. “ Am J Respir Cell Mol Biol. 2023 Aug;69(2):230-241. (IF=6,40). Biochemistry and Molecular Biology (Q1); Cell Biology (Q2); Respiratory System (Q1).
Gris JC, Guillotin F, Dos Santos TP, Chéa M, Loubet P. Laureillard D, Sotto A , Muller L, Davide-Barbar S, Roger C, Lefrant JY, Jung B, Klouche K, Mure T, Quéré I, Perez-Martin A. (2023). ” Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study”- Thrombosis Research, Volume 222, February 2023, Pages 85-95. (IF=7,50). Hematology (Q1).
Jaffuel D, Mallet JP, Roubille F, Bourdin A. (2023). .” Muscle sympathetic nerve activity and adaptive servo-ventilation: questions remain. .” Eur Respir J. 2023 Apr 20;61(4):2300002. (IF=24,30). Respiratory Systems (Q1).
Jaffuel D, Bouchaut Y, Mallet JP, Vidal C, Molinari N, Bourdin A, Roubille F. (2023). “ Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea. “ ERJ Open Res. 2023 Jun 26;9(3):00123-2023. (IF=4,60). Respiratory Systems (Q2).
Jammoul N, Mercier G, Roubille F. (2023). “Could colchicine reduce cardiovascular events in coronary artery disease without increasing all-cause mortality: Avoid optical illusions! “ Int J Cardiol. 2023 Apr 1;376:125-126.. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Jolly F, Jacquier M, Pecqueur D, Labruyère M, Vinsonneau C, Fournel I, Quenot JP; READIAL Study group. Avec Klouche K parmi les collaborateus. (2023). “Management of renal replacement therapy among adults in French intensive care units: A bedside practice evaluation. “ J Intensive Med. 2023 Jan 13;3(2):147-154. (IF=2,89) Critical Care and Intensive Care Medicine (Q1)
Karsenty C, Touafchia A, Ladouceur M, Roubille F, Bonnefoy E, Bonello L, Leurent G, Levy B, Champion S, Lim P, Schneider F, Cariou A, Khachab H, Bourenne J, Seronde MF, Harbaoui B, Vanzetto G, Quentin C, Delabranche X, Combaret N, Morel O, Lattuca B, Leborgne L, Fillippi E, Gerbaud E, Brusq C, Bongard V, Lamblin N, Puymirat E, Delmas C; FRENSHOCK investigators (2023). “Cardiogenic shock in adults with congenital heart disease: Insights from the FRENSHOCK registry. “ . Arch Cardiovasc Dis. 2023 Aug-Sep;116(8-9):390-396 (IF=3,00) Cardiac and Cardiovascular systems (Q2).
Karsenty C, Guilbeau-Frugier C, Genet G, Seguelas MH, Alzieu P, Cazorla O, Montagner A, Blum Y, Dubroca C, Maupoint J, Tramunt B, Cauquil M, Sulpice T, Richard S, Arcucci S, Flores-Flores R, Pataluch N, Montoriol R, Sicard P, Deney A, Couffinhal T, Senard JM, Galés C (2023). “Ephrin-B1 regulates the adult diastolic function through a late postnatal maturation of cardiomyocyte surface crests. “. Elife. 2023 Jan 17;12:e80904. (IF=7,70). Developental Biology (Q1).
Kedra J, Dieudé P, Giboin C, Marotte H, Salliot C, Schaeverbeke T, Perdriger A, Soubrier M, Morel J, Constantin A, Dernis E, Royant V, Salmon JH, Pham T, Gottenberg JE, Pertuiset E, Dougados M, Devauchelle-Pensec V, Gaudin P, Cormier G, Goupille P, Mariette X, Berenbaum F, Alcaix D, Rouidi SA, Berthelot JM, Monnier A, Piroth C, Lioté F, Goëb V, Gaujoux-Viala C, Chary-Valckenaere I, Hajage D, Tubach F, Fautrel B; CRI-IMIDIATE clinical research network. (2023). “Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission. “ Arthritis Rheumatol. 2023 Nov 9. Sous presse. (IF=13,30). Rheumatology (Q1).
Klein C, Boveda S, De Groote P, Galinier M, Jourdain P, Mansourati J, Pathak A, Roubille F, Sabatier R, Guedon-Moreau L. (2023). “ Remote management in patients with heart failure (from new onset to advanced): A practical guide. “ Arch Cardiovasc Dis. 2023 Nov 30:S1875-2136(23)00523-5. (IF=3 Cardiac and Cardiovascular Systems (Q2).
Klouche K, Monnet X, Zarbock A (2023). “Balanced solution versus saline in critically ill patients: a new piece to the puzzle! “ . Intensive Care Med. 2023 Dec 19. Sous presses. (IF=38,90). Critical Care Medicine (Q1).
Laffont-Lozes P, Laureillard D, Loubet P, Stephan R, Chiaruzzi M, Clemmer E, Martin A, Roger C, Muller L, Claret PG, Goulabchand R, Roux C, Lavigne JP, Sotto A, Larcher R. (2023) . “Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France. “ Antibiotics (Basel). 2023 Jan 4;12(1):88. (IF=4,80). Infectious Diseases (Q1); Pharmacology and Pharmacys (Q1).
Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Loubet P. (2023).” Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review. ” Antimicrob Resist Infect Control. 2023 Sep 12;12(1):100. (IF=5,50) . Infectious Diseases (Q1); Microbiology (medical (Q1); Pharmacology (Q1); Public Health and Enviromental and Occupational Health (Q1).
Laffont-Lozes P, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Larcher R. (2023). “Effect of Antimicrobial Consumption on Escherichia coli resistance: assessment and forecasting using Dynamic Regression models in a French university hospital (2014-2019). “ Int J Antimicrob Agents. 2023 Mar 4:106768. (IF=13,90). Infectious Diseases (Q1); Medicine (Q1); Microbiology(Q1); Pharmacology(Q1).
Larcher R, Bargnoux AS, Badiou S, Besnard N, Brunot V, Daubin D, Platon L, Benomar R, Amalric M, Dupuy AM, Klouche K, Cristol JP. (2023). “ Acute kidney injury in critical COVID-19 patients: usefulness of urinary biomarkers and kidney proximal tubulopathy. “ Ren Fail. 2023;45(2):2292152. (IF=3,00). Urology and Nephrology (Q2).
Larcher R, Laffont-Lozes P, Naciri T, Bourgeois PM, Gandon C, Magnan C, Pantel A, Sotto A. (2023). ” Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance. ” Infection. 2023 Dec;51(6):1835-1840. (IF=7,50). Infectious Diseases (Q2).
Larcher R, Laffont-Lozes P, Loubet P, Laureillard D, Naciri T, Sotto A (2023). “Re: ‘real world clinical outcome of cefiderocol for treatment of multidrug resistant non-fermenting gram-negative bacilli infections’ by Hoellinger et al. “ . Clin Microbiol Infect. 2023 Jun;29(6):812-813. (IF=14,20). Infectious Disease (Q1); Microbiology (Q1).
Larcher R, Boudet A, Roger C, Villa F, Loubet P. (2023). “Mycoplasma pneumoniae is back! Is it the next pandemic? “ Anaesth Crit Care Pain Med. 2023 Dec 8:101338. (IF=5,50). Anesthesiology (Q2); Critical Care Medicine (Q3).
Laredo M, Duthoit G, Sacher F, Anselme F, Audinet C, Bessiere F, Bordachar P, Bouzeman A, Boveda S, Bun SS, Chassignolle M, Clerici G, Da Costa A, Guillebon M, Defaye P, Elbaz N, Eschalier R, Extramiana F, Fauchier L, Hermida A, Gandjbakhch E, Garcia R, Gourraud JB, Guenancia C, Guy-Moyat B, Irles D, Iserin L, Jourda F, Koutbi L, Labombarda F, Ladouceur M, Lagrange P, Lellouche N, Mansourati J, Marquié C, Martins R, Massoulié G, Mathiron A, Maury P, Messali A, Milhem A, Mondoly P, Nguyen C, Ninni S, Pasquié JL, Pierre B, Pujadas P, Sellal JM, Thambo JB, Walton C, Winum P, Zakine C, Zhao A, Jouven X, Combes N, Marijon E, Waldmann V (2023). ” Rapid Ventricular Tachycardia in Patients with Tetralogy of Fallot and Implantable Cardioverter-Defibrillator. Insights from the DAI-T4F Nationwide Registry. ”. Heart Rhythm. 2023 Feb;20(2):252-260. (IF=5,50). Cardiac ad Cardiovascular Systems ( Q1).
Latrille C, Chapel B, Héraud N , Bughin F , Hayot M and Boiché J. (2023). “An individualized mobile health intervention to promote physical activity in adults with obstructive sleep apnea: An intervention mapping approach“DIGITAL HEALTH, Volume 9: 1–17. (IF=3,90). Health Policy (Q3).
Lavenant P, Cacioppo M, Ansquer H, Guillaumont S, Houx L, Brochard S, Amedro P, Pons C. (2023). “Participation in physical activity of adolescents with congenital heart disease. “ Child Care Health Dev. 2023 Mar;49(2):311-320.. (IF=1,90). Pediatrics (Q2); Psychology Developmental (Q3).
Leyba K, Paiyabhroma N, Salvas JP, Damen FW, Janvier A, Zub E, Bernis C, Rouland R, Dubois CJ, Badaut J, Richard S, Marchi N, Goergen CJ, Sicard P. (2023). “Neurovascular hypoxia after mild traumatic brain injury in juvenile mice correlates with heart-brain dysfunctions in adulthood. “ Acta Physiol (Oxf). 2023 Jun;238(2):e13933. (IF=6,30). Physiology (Q1).
Logeart D, Damy T, Doublet M, Salvat M, Tribouilloy C, Bauer F, Eicher JC, Picard F, Roul G, Trochu JN, De Groote P, Bihry N, Berthelot E, Jondeau G, Seronde MF, Roubille F, Isnard R; FRESH investigators (2023). “Feasibility and accuracy of linking a heart failure registry to the national claims database using indirect identifiers. “ . Arch Cardiovasc Dis. 2023 Jan;116(1):18-24.. (IF=3,00). Cardiac ad Cardiovascular Systems (Q2).
Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J; EuroECMO-COVID Study Group. (2023). “In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. “ Lancet Respir Med. 2023 Feb;11(2):151-162.. (IF=76,20); Critical Care Medicine (Q1); Respiratory System (Q1).
Loubet P, Wittkop L, Ninove L, Chalouni M, Barrou B, Blay JY, Hourmant M, Thouvenot E, Laville M, Laviolle B, Lelievre JD, Morel J, Quoc SN, Spano JP, Terrier B, Thiebaut A, Viallard JF, Vrtovsnik F, Circosta S, Esterle L, Levier A, Vanhems P, Tartour E, Parfait B, de Lamballerie X, Launay O; ANRS0001S COV-POPART study group. (2023). “One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. “ Clin Microbiol Infect. 2023 Mar;29(3):388.e1-388.e8. (IF=14,20). Infectious Disease (Q1) ; ” Microbiology (Q1).
Maillard A, Le Goff J, Barry M, Lemiale V, Mercier-Delarue S, Demoule A, Feghoul L, Jaber J, Klouche K, Kouatchet A, Argaud L, Barbier F, Bigé N, Moreau AS, Canet E, Pène F, Salmona M, Mokart D, Azoulay E, (2023). “ Multiplex PCR assay to detect nasopharyngeal viruses in immunocompromised patients with acute respiratory failure. “- CHEST, 2023 Dec;164(6):1364-1377. (IF=9,60). Critical Care Medicine (Q1). Respiratory System (Q1).
Maïmoun L, Bourgeois E, Serrand C, Mura T, Cristol JP, Myzia J, Avignon A, Mariano-Goulart D, Sultan A (2023). “Relationship between Lean Tissue Mass and Muscle Function in Women with Obesity. “ . Nutrients. 2023 Oct 25;15(21):4517. (IF=5,90). Nutrition and Dietetics (Q1).
Maïmoun L, Gelis A, Serrand C, Mura T, Brabant S, Garnero P, Mariano-Goulart D, Fattal C. (2023). “Whole-body vibration may not affect bone mineral density and bone turnover in persons with chronic spinal cord injury: A preliminary study. “ J Spinal Cord Med. 2023 Nov 6:1-13. (IF= 1,7). Clinical Neurology (Q4).
Maïmoun L, Alonso S, Mahadea KK, Boudousq V, Mura T, Mariano-Goulart D (2023). “ Cross-calibration study of the Stratos and Hologic QDR 4500A dual-energy X-ray absorptiometers to assess bone mineral density and body composition – Journal of Clinical Densitometry 2023 Oct 28;26(4):101434(IF=2,96). Endocrinology and Metabolism (Q3).
Maïmoun L, Gelis A, Serrand C, Mura T, Humbert L, Boudousq V, de Santa-Barbara P, Laux D, Fattal C, Mariano-Goulart D. (2023). Alteration of Volumetric Bone Mineral Density Parameters in Men with Spinal Cord Injury. “ Calcif Tissue Int. 2023 Sep;113(3):304-316. (IF=4,20). Endocrinology and Metabolism (Q3).
Maïmoun L, Aouinti S, Puech M, Lefebvre P, Deloze M, De Santa Barbara P, Renard E,Christol JP, Myzia J, Picot MC, Mariano-Goulart D, Nocca D. (2023). “Changes in Lean Tissue Mass, Fat Mass, Biological Parameters and Resting Energy Expenditure over 24 Months Following Sleeve Gastrectomy. “ – Nutrients, 2023 Feb 27;15(5):1201.. (IF=5,90). Nutrition and Dietetics (Q1).
Maïmoun L, Aouinti S, Puech M, Lefebvre P, Deloze M, de Santa Barbara P, Cristol JP, Brabant S, Gautier T, Nedelcu M, Renard E, Picot MC, Mariano-Goulart D, Nocca D. (2023). “Effect of Nutritional Deprivation after Sleeve Gastrectomy on Bone Mass, Periostin, Sclerostin and Semaphorin 4D: A Two-Year Longitudinal Study. “ Nutrients. 2023 Oct 10;15(20):4310. (IF=5,90). Nutrition and Dietetics (Q1).
Maïmoun L, Alonso S, Mahadea KK, Boudousq V, Mura T, Mariano-Goulart D (2023). “ Cross-Calibration Study of The Stratos And Hologic QDR 4500A Dual-Energy X-Ray Absorptiometers to Assess Bone Mineral Density And Body Composition. “. J Clin Densitom. 2023 Oct 28;26(4):101434. (IF=2,50). Endocrinology and Metabolism (Q4).
Maire A, Chapet N, Aguilhon S, Laugier ML, Laffont-Lozes P, Rigoni M, Mathieu B, Audurier Y, Breuker C, de Barry G, Jalabert A, Leclercq F, Pasquié JL, Roubille F, Castet-Nicolas A. (2023). ” Evaluation of vaccination coverage in heart failure patients in a tertiary center. ” Heliyon. 2023 Jul 7;9(7):e18080. (IF=4,00). Multidisciplinary Sciences (Q2).
Mallet F, Poitrasson-Rivière A, Mariano-Goulart D, Agostini D, Manrique A. (2023) ”Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls. ” J Nucl Cardiol. 2023 Oct;30(5):2006-2017. (IF=3,87). Cardiac and Cardiovascular Systems (Q2) ; Radiology, Nuclear Medicine and Medical Imaging (Q2).
Manzo-Silberman S, Chouihed T, Fraticelli L, Charpentier S, Claustre C, Bonnefoy-Cudraz E, Elbaz M, Peiretti A, Taboulet P, Waintraub X, Roubille F, El Khoury C. (2023). “Assessment of atrial fibrillation in European emergency departments: insights from a prospective observational multicenter study. “ Minerva Cardiol Angiol. 2023 Aug;71(4):444-455. (IF=1,60). Cardiology and Cardiovascular Medicine (Q3).
Martin A, Loubet P, Salipante F, Laffont-Lozes P, Mazet J, Lavigne JP, Cellier N, Sotto A, Larcher R. (2023). “Clinical Features and Outcomes of Enterococcal Bone and Joint Infections and Factors Associated with Treatment Failure over a 13-Year Period in a French Teaching Hospital. “ Microorganisms. 2023 May 5;11(5):1213. (IF=4,50). Microbiology (Q2).
Mathieu S, Pereira B, Daïen C, Tournadre A, Soubrier M. (2023). “Omega 3 Fatty Acids Intake Does Not Decrease the Risk of Rheumatoid Arthritis Occurrence: A Meta-Analysis. Comment on Tański et al. The Relationship between Fatty Acids and the Development, Course and Treatment of Rheumatoid Arthritis. Nutrients 2022, 14, 1030. “ Nutrients. 2023 Jan 20;15(3):539. (IF=5,90). Nutrition and Dietetics (Q1).
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK; ESC Scientific Document Group avec Roubille F parmi les collaborateurs. (2023). “ 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. “ Eur Heart J. 2023 Aug 25:ehad195.(IF=39,30). Cardiac and Cardiovascular Systems (Q1).
Merdji H, Gantzer J, Bonello L, Lamblin N, Roubille F, Levy B, Champion S, Lim P, Schneider F, Cariou A, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Quentin C, Curtiaud A, Kurtz JE, Combaret N, Marchandot B, Lattuca B, Biendel C, Leurent G, Bataille V, Gerbaud E, Puymirat E, Bonnefoy E, Aissaoui N, Delmas C. (2023). “Characteristics, management and outcomes of active cancer patients with cardiogenic shock. “ Eur Heart J Acute Cardiovasc Care. 2023 Oct 25;12(10):682-692. (IF=4,10). Cardiac and Cardiovascular Systems (Q2).
Meerun MA, Allimant C, Rivière B, Herrero A, Panaro F, Assenat E, Cassinotto C, Mariano-Goulart D, Guiu B. (2023). “Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery. “Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):351-365. (IF=8,00). Gastroenterology and Hepatology (Q1) ; Nutrition and Dietetics (Q1).
Merdji H, Bataille V, Curtiaud A, Bonello L, Roubille F, Levy B, Lim P, Schneider F, Khachab H, Dib JC, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Marchand S, Gebhard CE, Henry P, Combaret N, Marchandot B, Lattuca B, Biendel C, Leurent G, Gerbaud E, Puymirat E, Bonnefoy E, Meziani F, Delmas C (2023).” Mottling as a prognosis marker in cardiogenic shock. ” . Ann Intensive Care. 2023 Sep 6;13(1):80. (IF=8,10) Critical Care Medicine (Q1).
Mignot M, Huguet H, Cambonie G, Guillaumont S, Vincenti M, Blanc J, Ovaert C, Picot MC, Karsenty C, Amedro P, Kollen L, Gavotto A. (2023). “Risk factors for early occurrence of malnutrition in infants with severe congenital heart disease. “ Eur J Pediatr. 2023 Mar;182(3):1261-1269. (IF=3,60). Pediatrics, Perinatology and Child Health (Q1).
Milesi C, Baleine J, Mortamet G, Apert J, Gavotto A, Cambonie G (2023).” Noninvasive Ventilation in Pediatric Acute Respiratory Distress Syndrome: « Another Dogma Bites the Dust ». ”. Pediatr Crit Care Med. 2023 Sep 1;24(9):783-785. (IF=3,62). Critical care and intensive Care Medicine (Q1).
Moreau J, Socchi F, Renoux MC, Requirand A, Abassi H, Guillaumont S, Matecki S, Huguet H, Avesanni M, Picot MC, Amedro P. (2023). “Cardiopulmonary fitness in children with asthma versus healthy children. “ Arch Dis Child. 2023 Mar;108(3):204-210 (IF=5,20). Pediatrics (Q1).
Morel J (2023). “ Infection prevention and vaccination in the rheumatic diseases. “ Joint Bone Spine. 2023 Mar 27:105568. Sous presse . (IF=5,26). Rheumatology (Q2).
Nguyen TN, Tran QH, Terki F, Charnay C, Dumail X, Reibel C, Cazals G, Valette G, Jay-Allemand C, Bidel LPR. (2023). “Aggregation of magnetic nanoparticles functionalized with trans-resveratrol in aqueous solution. “ Discov Nano. 2023 Apr 19;18(1):64. (IF=à venir)
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, Morel J, Vittecoq O, Constantin A, Flipo RM, Schaeverbeke T, Sibilia J, Ravaud P, Porcher R, Seror R. (2023). “Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry. “ Rheumatology (Oxford). 2023 Sep 19:kead495. Sous presse. (IF=5,50). Rheumotology (Q1).
Palassin P, Faillie JL, Coustal C, Quantin X, Topart D, Roubille F, Maria ATJ (2023). “Underreporting of Major Cardiac Adverse Events With Immune Checkpoint Inhibitors in Clinical Trials: Importance of Postmarketing Pharmacovigilance Surveys. “ . J Clin Oncol. 2023 Feb 10;41(5):1154-1156 (IF=50,74). Oncology (Q1).
Panel M, Fauconnier J. (2023). “Restoring mitochondrial Ca2+ uptake in metabolic cardiomyopathy: A new promising target to treat atrial fibrillation. “ Arch Cardiovasc Dis. 2023 Oct 20:S1875-2136(23)00197-3. (IF=3,00). Cardiac and Cardiovascular Systems (Q2).
Paunet T, Mariano-Goulart D, Deverdun J, Le Bars E, Fourcade M, Kucharczak F. (2023). “ Functional PET Neuroimaging in Consciousness Evaluation: Study Protocol. “ Diagnostics (Basel). 2023 Jun 10;13(12):2026. (IF=3,60). Medicine , General and Internal (Q1).
Pezel T, Dillinger JG, Trimaille A, Delmas C, Piliero N, Bouleti C, Pommier T, El Ouahidi A, Andrieu S, Lattuca B, Rossanaly Vasram R, Fard D, Noirclerc N, Bonnet G, Goralski M, Elbaz M, Deney A, Schurtz G, Docq C, Roubille F, Fauvel C, Bochaton T, Aboyans V, Boccara F, Puymirat E, Batisse A, Steg G, Vicaut E, Henry P; ADDICT-ICCU Investigators (2023). “ Prevalence and impact of recreational drug use in patients with acute cardiovascular events. “. Heart. 2023 Oct 12;109(21):1608-1616. (IF=5,70). Cardiac and cardiovascular Systems (Q1).
Perez L, Corne P, Pasquier G, Konecki C, Sadek M, Le Bihan C, Klouche K, Mathieu O, Reynes J, Cazaubon Y. (2023). “ Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses. “ J Fungi (Basel). 2023 Feb 6;9(2):211. (IF=4,70) Microbiology(Q1) ; Mycology (Q1).
Pisareva E, Badiou S, Mihalovičová L, Mirandola A, Pastor B, Kudriavstev A, Berger M, Roubille C, Fesler P, Klouche K, Cristol JP, Thierry AR (2023). “Persistence of Neutrophil extracellular traps and anti-cardiolipin auto-antibodies in post-acute phase COVID-19 patients. “ J Med Virol. 2023 Jan;95(1):e28209. doi. (IF=20,69). Virology (Q1).
Rastogi T, Duarte K, Huttin O, Roubille F, Girerd N (2022). ”The Prescription Pattern of Heart Failure Medications in Reduced, Mildly Reduced, and Preserved Ejection Fractions. ”. J Clin Med. 2023, 12, 99. (IF=3,90). Medicine, General and Internal (Q1).
Rollins CK, Calderon J, Wypij D, Taylor AM, Davalji Kanjiker TS, Rohde JS, Maiman M, Zambrano LD, Newhams MM, Rodriguez S, Hart N, Worhach J, Kucukak S, Poussaint TY, Son MBF, Friedman ML, Gertz SJ, Hobbs CV, Kong M, Maddux AB, McGuire JL, Licht PA, Staat MA, Yonker LM, Mazumdar M, Randolph AG, Campbell AP, Newburger JW; Overcoming COVID-19 Investigators. (2023).” Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children. ”JAMA Network Open. 2023 Jul 3;6(7):e2324369. (IF=13,8). Medicine, General and internal (Q1).
Roubille C. (2023). “[Management of cardiovascular comorbidities in immune-mediated inflammatory diseases]. “ Rev Med Interne. 2023 Nov 17:S0248-8663(23)01244-4. (IF=0,90). Medicine General and Internal (Q4).
Roubille F, Matzner-Lober E, Aguilhon S, Rene M, Lecourt L, Galinier M, Ricci JE, Molinari N. (2022). “Impact of global warming on weight in patients with heart failure during the 2019 heatwave in France. “ ESC Heart Fail. 2023 Feb;10(1):727-731. (IF=3,80). Cardiac and Cardiovascular Systems (Q1).
Sadhwani A, Butler S, Rofeberg V, Espinosa K, Wood L, Cassidy AR, Calderon J, Rollins CK, Singer J, Henson B, Ullman-Shade C, Clark C, Wypij D, Newburger JW, Bellinger DC, Ware J. (2023). “Sleep Patterns in Young Children with Congenital Heart Disease. “ J Pediatr. 2023 Jan;252:198-203.e2. (IF=6,31). Pediatrics (Q1).
Sagnes J, Battistella P, Paunet T, Mariano-Goulart D, Kucharczak F (2023). “ .Evaluation of 18-FDG PET diagnostic capabilities for cancer screening in heart transplant patients, a retrospective study. “Medicine (Baltimore). 2023 Sep 29;102(39):e35296. (IF=1,60). Medicine, General and Internal (Q3).
Sakkaki S, Cresto N, Chancel R, Jaulmes M, Zub E, Blaquière M, Sicard P, Maurice T, Ellero-Simatos S, Gamet-Payrastre L, Marchi N, Perroy J. (2023). “ Dual-Hit: Glyphosate exposure at NOAEL level negatively impacts birth and glia-behavioural measures in heterozygous shank3 mutants. “ Environ Int. 22023 Oct:180:108201. (IF=11,8). Environmental Sciences (Q1).
Schurtz G, Mewton N, Lemesle G, Delmas C, Levy B, Puymirat E, Aissaoui N, Bauer F, Gerbaud E, Henry P, Bonello L, Bochaton T, Bonnefoy E, Roubille F, Lamblin N. (2023). “ Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion. “ Front Cardiovasc Med. 2023 Nov 16;10:1263482 (IF=3,60). Cardiac and Cardiovascular Systems (Q2).
Sleiman Y, Reiken S, Charrabi A, Jaffré F, Sittenfeld LR, Pasquié JL, Colombani S, Lerman BB, Chen S, Marks AR, Cheung JW, Evans T, Lacampagne A, Meli AC (2023). “Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes. “ . Stem Cell Res Ther. 2023 Sep 23;14(1):266. (IF=7,5). Cell and Tissue engenering (Q1); Cell biology (Q1).
Souilla L, Avesani M, Boisson A, Requirand A, Matecki S, Vincenti M, Werner O, De La Villeon G, Pommier V, Pasquie JL, Guillaumont S, Amedro P (2023). “Cardiorespiratory fitness, muscle fitness, and physical activity in children with long QT syndrome: A prospective controlled study “. Front Cardiovasc Med. 2023 Jan 11;9:1081106. (IF=3,60). Cardiac and Cardiovascular Systems (Q2).
Tan J, Ribeiro RV, Barker C, Daien C, De Abreu Silveira E, Holmes A, Nanan R, Simpson SJ, Macia L. (2023). “ Functional profiling of gut microbial and immune responses toward different types of dietary fiber: a step toward personalized dietary interventions. “ Gut Microbes. 2023 Dec;15(2):2274127. (IF=12,2). Gastroenterology and Hapathology (Q1); Microbiology (Q1).
Tournayre S, Mathieu O, Villiet M, Besnard N, Brunot V, Daubin D, Platon L, Corne P, Klouche K, Larcher R (2023). “Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion. “. Int J Antimicrob Agents. 2023 Aug;62(2):106868.(IF=13,90). Infectious Diseases (Q1); Medicine (Q1); Microbiology(Q1); Pharmacology(Q1).
UGHETTO A, ROUBILLE F, MOLINA A, BATTISTELLA P, GAUDARD P, DEMARIA R, GUIHAIRE J, LACAMPAGNE A, DELMAS C. (2023). “Heart graft preservation technics and limits: An update and perspectives “Front. Cardiovasc. Med Vol 10, 2023 sous presse. (IF=3,60). Cardiac and Cardiovascular Systems (Q2
Vignais ML, Levoux J, Sicard P, Khattar K, Lozza C, Gervais M, Mezhoud S, Nakhle J, Relaix F, Agbulut O, Fauconnier J, Rodriguez AM. (2023). “Transfer of Cardiac Mitochondria Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in a Preclinical Model of Ischemic Heart Disease. “ Cells. 2023 Feb 11;12(4):582. (IF=6,00). Cell Biology (Q2).
Waldmann V, Marquié C, Bessière F, Perrot D, Anselme F, Badenco N, Barra S, Bertaux G, Blangy H, Bordachar P, Boveda S, Chauvin M, Clémenty N, Clerici G, Combes N, Defaye P, Deharo JC, Durand P, Duthoit G, Eschalier R, Fauchier L, Garcia R, Geoffroy O, Gitenay E, Gourraud JB, Guenancia C, Iserin L, Jacon P, Jesel-Morel L, Kerkouri F, Klug D, Koutbi L, Labombarda F, Ladouceur M, Laurent G, Leclercq C, Maille B, Maltret A, Massoulié G, Mondoly P, Ninni S, Ollitrault P, Pasquié JL, Pierre B, Pujadas P, Champ-Rigot L, Sacher F, Sadoul N, Schatz A, Winum P, Milliez PU, Probst V, Marijon E. (2023). “Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease. “ J Am Coll Cardiol. 2023 Aug 15;82(7):590-599. (IF=27,21). Ardiac and ardiovascular Systems (Q1).
Werner O, Pommier V, Guillaumont S, Vincenti M. (2023). “Multimodal imaging for cardiac follow-up and management of giant coronary aneurysm related to Kawasaki disease in childhood: a case report. Eur Heart J Case Rep. 2023 Oct 9;7(10):ytad495. (IF=1,00). Cardiology and Cardiovascular Medicine (Q4).
Yehya M, Boulghobra D, Grillet PE, Fleitas-Paniagua PR, Bideaux P, Gayrard S, Sicard P, Thireau J, Reboul C, Cazorla O. (2023).” Natural Extracts Mitigate the Deleterious Effects of Prolonged Intense Physical Exercise on the Cardiovascular and Muscular Systems. ”Antioxidants (Basel). 2023 Jul 22;12(7):1474. (IF=7,67) Agricultural and Biological Sciences –Food Science(Q1; Biochemistry, Genetics and molecular Biology- Biochemistry (Q2) – Biology (Q2) – Clinical Biochemistry (Q2) – Molecular Biology (Q2).
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentré F, Burdet C; DisCoVeRy Study Group avec Klouche K parmi les collaborateurs. (2022). “Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. “ Lancet Infect Dis. 2022 Jun;22(6):764-765. (IF=56,30). Infectious Diseases (Q1).
Akodad M, Labour J, Nogue E, Delseny D, Macia JC, Gervasoni R, Lattuca B, Nagot N, Roubille F, Cayla G, Leclercq F (2022). “Vascular complications and bleeding after balloon aortic valvuloplasty performed with or without heparin: HEPAVALVE randomized study. “. Int J Cardiol Heart Vasc. 2022 Jan 18;39:100951. (IF=2,90). Cardiology and Cardiovascular Medicine (Q3).
Amedro P, Vincenti M, Abassi H, Lanot N, De La Villeon G, Guillaumont S, Gamon L, Mura T, Lopez-Perrin K, Haouy S, Sirvent A, Cazorla O, Vergely L, Lacampagne A, Avesani M, Sirvent N, Saumet L. (2022). “ Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study. . “ Int J Cardiol. 2022 May 1;354:75-83. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Audo R, Sanchez P, Rivière B, Mielle J, Tan J, Lukas C, Macia L, Morel J, Daien CI. (2022). ” Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control. ” Rheumatology (Oxford). 2022 Aug 10:keac454.sous presse. (IF=5,50). Rheumatology (Q1)
Arel E, Rolland L, Thireau J, Torrente AG, Bechard E, Bride, J.; Jopling, C.; Demion, M.; Le Guennec, J.-Y. (2022). ” The Effect of Hypothermia and Osmotic Shock on the Electrocardiogram of Adult Zebrafish. ”– Biology-Basel 2022 Apr 15;11(4):603. (IF=4,20). Biology (Q1).
Azoulay E, Resche-Rigon M, Megarbane B, Reuter D, Labbé V, Cariou A, Géri G, Van der Meersch G, Kouatchet A, Guisset O, Bruneel F, Reignier J, Souppart V, Barbier F, Argaud L, Quenot JP, Papazian L, Guidet B, Thiéry G, Klouche K, Lesieur O, Demoule A, Guitton C, Capellier G, Mourvillier B, Biard L, Pochard F, Kentish-Barnes N (2022). “Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge. “ . JAMA. 2022 Mar 15;327(11):1042-1050. (IF=120,70). Medicine General and Internal (Q1).
Azoulay LD, Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle F, Raphalen JH, Troger A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Moyon Q, Luyt CE, Kerneis M, Combes A, Amoura Z (2022). “Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.. “ J Autoimmun. 2022 Dec;133:102908. (IF=14,51). Immunity (Q1)
Barc J, Tadros R, Glinge C, Chiang DY, Jouni M, Simonet F, Jurgens SJ, Baudic M, Nicastro M, Potet F, Offerhaus JA, Walsh R, Choi SH, Verkerk AO, Mizusawa Y, Anys S, Minois D, Arnaud M, Duchateau J, Wijeyeratne YD, Muir A, Papadakis M, Castelletti S, Torchio M, Ortuño CG, Lacunza J, Giachino DF, Cerrato N, Martins RP, Campuzano O, Van Dooren S, Thollet A, Kyndt F, Mazzanti A, Clémenty N, Bisson A, Corveleyn A, Stallmeyer B, Dittmann S, Saenen J, Noël A, Honarbakhsh S, Rudic B, Marzak H, Rowe MK, Federspiel C, Le Page S, Placide L, Milhem A, Barajas-Martinez H, Beckmann BM, Krapels IP, Steinfurt J, Winkel BG, Jabbari R, Shoemaker MB, Boukens BJ, Škorić-Milosavljević D, Bikker H, Manevy FC, Lichtner P, Ribasés M, Meitinger T, Müller-Nurasyid M; KORA-Study Group, Veldink JH, van den Berg LH, Van Damme P, Cusi D, Lanzani C, Rigade S, Charpentier E, Baron E, Bonnaud S, Lecointe S, Donnart A, Le Marec H, Chatel S, Karakachoff M, Bézieau S, London B, Tfelt-Hansen J, Roden D, Odening KE, Cerrone M, Chinitz LA, Volders PG, van de Berg MP, Laurent G, Faivre L, Antzelevitch C, Kääb S, Arnaout AA, Dupuis JM, Pasquie JL, Billon O, Roberts JD, Jesel L, Borggrefe M, Lambiase PD, Mansourati J, Loeys B, Leenhardt A, Guicheney P, Maury P, Schulze-Bahr E, Robyns T, Breckpot J, Babuty D, Priori SG, Napolitano C; Nantes Referral Center for inherited cardiac arrhythmia, de Asmundis C, Brugada P, Brugada R, Arbelo E, Brugada J, Mabo P, Behar N, Giustetto C, Molina MS, Gimeno JR, Hasdemir C, Schwartz PJ, Crotti L, McKeown PP, Sharma S, Behr ER, Haissaguerre M, Sacher F, Rooryck C, Tan HL, Remme CA, Postema PG, Delmar M, Ellinor PT, Lubitz SA, Gourraud JB, Tanck MW, George AL Jr, MacRae CA, Burridge PW, Dina C, Probst V, Wilde AA, Schott JJ, Redon R, Bezzina CR. (2022). “Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. “ Nat Genet. 2022 Mar;54(3):232-239. (IF=30,80). Genetics and Heredity (Q1).
Bauer PR, Ostermann M, Russell L, Robba C, David S, Ferreyro BL, Cid J, Castro P, Juffermans NP, Montini L, Pirani T, Van De Louw A, Nielsen N, Wendon J, Brignier AC, Schetz M, Kielstein JT, Winters JL, Azoulay E; Nine-I Investigators, avec Klouche K comme collaborateut. (2022). “Plasma exchange in the intensive care unit: a narrative review. “Intensive Care Med. 2022 Aug 12:1-15. (IF=38,90). Critical Care Medicine (Q1).
Bechard E, Bride J, Le Guennec JY, Brette F, Demion M. (2022). ”TREK-1 in the heart: Potential physiological and pathophysiological roles. ” Front Physiol. 2022 Dec 22;13:1095102. (IF=4,00). Physiology (Q1).
Bernardin AA, Colombani S, Rousselot A, Andry V, Goumon Y, Delanoë-Ayari H, Pasqualin C, Brugg B, Jacotot ED, Pasquié JL, Lacampagne A, Meli AC. (2022). “ Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies. “ Cells. 2022 Nov 25;11(23):3764. (IF=6,00). Cell Biology (Q2).
Bitker L, Pradat P, Dupuis C, Klouche K, Illinger J, Souweine B, Richard JC. (2022). “Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in critically ill patients requiring continuous renal replacement therapy: study protocol of the GO NEUTRAL randomized controlled trial. “ Trials. 2022 Sep 22;23(1):798. (IF=2,50). Medicine, Research and Experimental (Q3).
Brette F, Le Guennec JY, Thireau J. (2022). “ Why are you talking with snakes? To get new evolutionary insights in cardiac electrophysiology! “ J Gen Physiol. 2022 Apr 4;154(4):e202113060. (IF=4,00). Physiology (Q1).
Bughin F, Kovacsik H, Jaussent I, Solecki K, Aguilhon S, Vanoverschelde J, Zarqane H, Mercier J, Gouzi F, Roubille F, Dauvilliers Y. (2022). “ Impact of Obstructive Sleep Apnea Syndrome on Ventricular Remodeling after Acute Myocardial Infarction: A Proof-of-Concept Study. “ . J Clin Med. 2022 Oct 27;11(21):6341. (IF=3,90); Medicine, General and Internal (Q1).
Butler SC, Sadhwani A, Rofeberg V, Cassidy AR, Singer J, Calderon J, Wypij D, Newburger JW, Rollins CK; Cardiac Neurodevelopmental Program at Boston Children’s Hospital Group (2022). “Neurological features in infants with congenital heart disease. “.Dev Med Child Neurol. 2022 Jun;64(6):762-770.. (IF=3,80). Clinical Neurology (Q2) ; Pediatrics (Q1).
Calderon J, Newburger JW, Rollins CK (2022). “Neurodevelopmental and Mental Health Outcomes in Patients With Fontan Circulation: A State-of-the-Art Review. “ . Front Pediatr. 2022 Mar 9;10:826349.. (IF=2,60). Pediatrics (Q1).
Cambonie G, Theret B, Badr M, Fournier P, Combes C, Picaud JC, Gavotto A. (2022). “Birth during on-call period: Impact of care organization on mortality and morbidity of very premature neonates. “ Front Pediatr. 2022 Aug 18;10:977422. Sous presse. (IF=2,60). Pediatrics (Q1).
Champéroux P, Fares R, Bastogne T, Richard S, Le Guennec JY, Thireau J (2020). ”Contribution of hemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs. ” . Br J Pharmacol. 2022 Sep;179(18):4549-4562. (IF=7,30). Pharmacology and Pharmacy (Q1).
Chapel B, Alexandre F, Heraud N, Ologeanu-Taddei R, Cases AS, Bughin F, Hayot M. (2022). “Standardization of the assessment process within telerehabilitation in chronic diseases: a scoping meta-review. “ BMC Health Serv Res. 2022 Aug 2;22(1):984. (IF=2,80). Health Care Sciences and Services (Q3).
Colombani S, Bernardin A.A, Vincenti M, Amédro P, Desprat R, Bernex F, Lemaitre JM, Pasquié JL,Lacampagne A, Meli AC. (2022).” Generation of catecholaminergic polymorphic ventricular tachycardia patient-specific induced pluripotent stem cell line. ” Stem Cell Research, 2022 Feb 25;60:102727. (IF=1,20). Biotecnology and Applied Microbiology (Q4) ; Cell and Time engenneering (Q4) ; Cell Biology (Q4).
Coulibaly I, Cardelli LS, Duflos C, Moulis L, Mandoorah B, Nicoleau J, Placide L, Massin F, Pasquié JL, Granier M. (2022). “Virtual Reality Hypnosis in the Electrophysiology Lab: When Human Treatments Are Better than Virtual Ones. “ J Clin Med. 2022 Jul 5;11(13):3913 (IF=3,90). Medicine, General and Internal (Q1).
Coulon C, Lotierzo M, Fesler P, Roubille C, Badiou S, Dupuy AM, Cristol JP. (2022).”Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays. ” Clin Chem Lab Med. 2022 Sep 13;60(11):1763-1771. (IF=6,80). Medical Laboratory Technology (Q1).
Cour M, Klouche K, Souweine B, Quenot JP, Schwebel C, Perinel S, Amaz C, Buisson M, Ovize M, Mewton N, Argaud L; RECO-Sepsis Trial Investigators (2022). “Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial. “. Intensive Care Med. 2022 Nov;48(11):1563-1572. (IF=38,90) Critical Care Medicine (Q1).
Coustal C, Guillope B, Serrand C, Morel J, Taieb G, Castille E, Meliani K, Darmon O, Goulabchand R, Guilpain P. (2022). “Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review. “ Autoimmun Rev. 2022 Jun;21(6):103099.. (IF=13,30). Immunology (Q1).
Daien C, Krogulec M, Gineste P, Steens JM, Desroys du Roure L, Biguenet S, Scherrer D, Santo J, Ehrlich H, Durez P. (2022). “Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study. “ Ann Rheum Dis. 2022 May 31;81(8):1076-1084. (IF=27,40). Rheumatolgy (Q1).
Daien C, Czernichow S, Letarouilly JG, Nguyen Y, Sanchez P, Sigaux J, Beauvais C, Desouches S, Puillandre RL, Rigalleau V, Rivière P, Romon M, Semerano L, Seror R, Sfedj S, Tournadre A, Vacher D, Wendling D, Flipo RM, Sellam J (2021). “Dietary Recommendations of the French Society for Rheumatology for Patients with Chronic Inflammatory Rheumatic Diseases. “ .Joint Bone Spine. 2022 Mar;89(2):105319. (IF=5,26). Rheumatology (Q2).
Debourdeau E, Gardes G, Nocca D, Carriere I, Chiquet C, Villain M, Roubille C, Du Cailar G, Sardinoux M, Daien V, Fesler P. (2022). “ Longitudinal Effect of Bariatric Surgery on Retinal Microcirculation and Target Organ Damage: the BASTOD Study. “ Obes Surg. 2022 Jul;32(7):1-10. (IF=2,90). Surgery (Q1).
Delbaere Q, Akodad M, Roubille F, Lattuca B, Cayla G, Leclercq F. (2022). “One-Year Follow-Up of Patients Admitted for Emergency Coronary Angiography after Resuscitated Cardiac Arrest. “ J Clin Med. 2022 Jun 28;11(13):3738. (IF=3,90). Medicine, General and Internal (Q1).
Delmas C, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, Elbaz M, Danchin N, Champion S, Lim P, Schneider F, Cariou A, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Quentin C, Delabranche X, Aissaoui N, Combaret N, Manzo-Silberman S, Tomasevic D, Marchandot B, Lattuca B, Henry P, Gerbaud E, Bonnefoy E, Puymirat E. (2021). “Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry. “ ESC Heart Fail. 2022 Feb;9(1):408-419. (IF=3,80). Cardiac and Cardiovascular Systems (Q1).
Derridj N, Bonnet D, Calderon J, Amedro P, Bertille N, Lelong N, Goffinet F, Khoshnood B, Guedj R (2022). “Quality of life of children born with a congenital heart defect. “ .J Pediatr. 2022 May;244:148-153.e5 (IF=6,31). Pediatrics (Q1).
Dillinger JG, Pezel T, Fauvel C, Delmas C, Schurtz G, Trimaille A, Gerbaud E, Roule V, Dib JC, Boccara A, Millischer D, Thuaire C, Fabre J, Levasseur T, Boukertouta T, Darmon A, Azencot R, Merat B, Haugel-Moreau M, Grentzinger A, Charbonnel C, Zakine C, Bedossa M, Lattuca B, Roubille F, Aboyans V, Puymirat E, Cohen A, Vicaut E, Henry P; ADDICT-ICCU investigators. (2022). “Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: Rationale and design of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of Cardiology. “ Arch Cardiovasc Dis. 2022 Oct;115(10):514-520. (IF=3,00). Cardiac ad Cardiovascular Systems (Q2).
Ding WY, Potpara TS, Blomström-Lundqvist C, Boriani G, Marin F, Fauchier L, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators avec Roubille F comme collaborateurs (2022). “Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry. “ Eur J Clin Invest. 2022 Jan 9;e13745. (IF=5,50). Medicine, General and Internal (Q1); Medicine, Research and Experimental (Q2).
Dridi H, Forrester F, Umanskaya A, Xie W, Reiken S, Lacampagne A, Marks A (2022). “Role of oxidation of excitation-contraction coupling machinery in age-dependent loss of muscle function in C. elegans. “ . Elife. 2022 May 4;11:e75529.. (IF=7,70). Developental Biology (Q1).
Dridi H, Santulli G, Gambardella J, Jankauskas SS, Yuan Q, Yang J, Reiken S, Wang X, Wronska A, Liu X, Lacampagne A, Marks AR. (2022). “ IP3 receptor orchestrates maladaptive vascular responses in heart failure. “ J Clin Invest. 2022 Feb 15;132(4):e152859. (IF=19,47). Medicine, Research and Experimental (Q1).
Dumain C, Broner J, Arnaud E, Dewavrin E, Holubar J, Fantone M, Wazières B, Parreau S, Fesler P, Guilpain P, Roubille C, Goulabchand R. (2022). “Patients’ Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study. “ J Clin Med. 2022 May 31;11(11):3115 (IF=3,90). Medicine, General and Internal (Q1).
Du Thanh A, Girard C, Morel J, Roubille C (2022). “Toward a holistic management of skin and joint disorders in PsA patients. “ Rheumatology (Oxford). 2022 Apr 11;61(4):1310-1311.. (IF=5,50). Rheumatology (Q1)
Emeriaud H, Huet F, Roubille F, Pasquié JL. (2022). “Acute Myocarditis Induced by Hepatitis E: An Uncommon Association. “ CJC Open. 2022 Apr 30;4(8):729-731. (IF=1,90). Cardiac and Cardiovascular Systems (Q2).
Escande W, Gourraud JB, Haissaguerre M, Gandjbakhch E, Lavergne T, Martins R, Cheniti G, Krisai P, Hermida JS, Maury P, Merino JL, Pasquié JL, Combes N, Surget E, Duchateau J, Pambrun T, Derval N, Hocini M, Jais P, Postema PG, Nademanee K, Vigmond E, Bernus O, Sacher F, Probst V (2022). ”Malignant Purkinje Ectopy induced by Sodium-channel Blocker. ” Heart Rhythm. Volume 19, Issue 10, October 2022, Pages 1595-1603 (IF=5,50). Cardiac ad Cardiovascular Systems ( Q1).
Fakuade FE, Fauconnier J, Voigt N. (2022). ”Background calcium influx in arrhythmia: lead actor or extra? ” J Physiol. 2022 Jun;600(11):2545-2546. (IF=6,23). Neurosciences (Q1) ; Physiology ( Q1).
Fossier L, Panel M, Butruille L, Colombani S, Azria L, Woitrain E, Decoin R, Torrente AG, Thireau J, Lacampagne A, Montaigne D, Fauconnier J, (2022).“Enhanced mitochondrial calcium uptake suppresses atrial fibrillation associated with metabolic syndrome“JACC , 2022 Dec, 80 (23) 2205–2219 (IF=24,00). Cardiac and Cardiovascular Systems (Q1).
François C, Bonafé A, Roubille C, Roubille F, Dupuy-Bonafé I, Millot S. (2022) ; ”Patients with Obstructive Sleep Apnea and Cardiovascular Diseases: What, When, and Why Is Mandibular Advancement Device Treatment Required? A Short Review. ” J Clin Med. 2022 Nov 19;11(22):6845. (IF=3,90) Medicine, General and Internal (Q1).
Garin E, Pinaquy JB, Bailly C, Sengel C, Mariano-Goulart D, Edeline J, Blanc JF, Bouvier A, Tordo J, Rode A, Becker S, Sefrioui D, de Baere T, Somma C, Mastier C, Goupil J, Chevallier P, Regnault H, Vibert E, Manfredi S, Vicaut E, Patel B, Boucher E, Guiu B; PROACTIF registry group (2022. «Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France. .Cardiovasc Intervent Radiol. 2022 Jan;45(1):1-11. (IF=2,90). Cardiac and Carciovascular Systems (Q3); Radiology, Nuclear Medicine and Madical Imaging (Q3).
Gavotto A, Vincenti M, Guillaumont S . (2022). “ Isolated Ventricular Inversion: A Rare Complex Congenital Heart Disease With Neonatal Cyanosis“ JACC: Case Reports, 2022 Nov 3;8:101642. (IF=1,20). Cardiology and Cardiovascular Medicine (Q4)
Gavotto A, Feuillade V, Bresch S, Guevara N, Mondot L, Almairac F. (2022). “Papilledema secondary to vestibular schwannoma: An atypical case without intracranial hypertension. “ Neurochirurgie. 2022 Apr;68(3):327-330. (IF=1,60). Surgery (Q2).
Gavotto A, Ladeveze M, Avesani M, Huguet H, Guillaumont S, Picot MC, Requirand A, Matecki S, Amedro P (2022). “Aerobic fitness change with time in children with congenital heart disease: A retrospective controlled cohort study. “. Int J Cardiol. 2022 Sep 28:S0167-5273(22)01418-8. Sous presse. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Girerd N, Mewton N, Tartière JM, Guijarro D, Jourdain P, Damy T, Lamblin N, Bayes-Génis A, Pellicori P, Januzzi J, Rossignol P, Roubille F. (2022). “Practical outpatient management of worsening chronic heart failure. “Eur J Heart Fail. 2022 May;24(5):750-761 (IF=18,20). Cardiac and Cardiovascular Systems (Q1).
Goudal A, Karakachoff M, Lindenbaum P, Baron E, Bonnaud S, Kyndt F, Arnaud M, Minois D, Bourcereau E, Thollet A, Deleuze JF, Genin E, Wiart F, Pasquié JL, Galand V, Sacher F, Dina C, Redon R, Bezieau S, Schott JJ, Probst V, Barc J (2022). “Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form associated genes provides new insights for molecular diagnosis and clinical management. Hum Mutat. 2022 Sep;43(9):1333-1342. (IF=3,90). Genetics and Heredity (Q1).
Goulabchand R, Gabelle A, Ayrignac X, Malafaye N, Labauge P, Noël D, Morel J, Roubille C, Barateau L, Guilpain P, Mura T (2022). “ Hospitalization Risks for Neurological Disorders in Primary Sjögren’s Syndrome Patients. “ .J Clin Med. 2022 Apr 1;11(7):1979. (IF=3,90). Medicine, General and Internal (Q1).
Goulabchand R, Makinson A, Morel J, Witkowski-Durand-Viel P, Nagot N, Loubet P, Roubille C, Noel D, Morquin D, Henry K, Mura T, Guilpain P. (2022). “Hospitalizations for infections in primary Sjögren’s syndrome patients: a nationwide incidence study. “ Ann Med. 2022 Dec;54(1):2672-2680. (IF=4,40). Medicine, General and Internal (Q2).
Grandperrin A, Schuster I, Moronval P, Izem O, Rupp T, Obert P, Nottin S. (2021). “Anabolic Steroids Use Is Associated with Impairments in Atrial and Ventricular Cardiac Structure and Performance in Athletes. “ Med Sci Sports Exerc. 2022 May 1;54(5):780-788. (IF=5,41). Sport Sciences (Q1).
Guérin A, Angebault C, Kinet S, Cazevieille C, RojoM, Fauconnier J, Lacampagne A, Mourier A, Taylor N, de Santa Barbara P, Faure S. (2022). “LIX1-mediated changes in mitochondrial metabolism control the fate of digestive mesenchyme-derived cells. “- Redox Biology, 2022 Oct;56:102431. (IF=11,40). Biochemistry and Molecular Biology (Q1).
Hédon C, Schnell F, Sosner P, Chagué F, Schuster I, Julia M, Duparc A, Guy JM, Molinari N, Michaux L, Cransac F, Cade S. (2022) “ Cardiac screening before returning to elite sport after SARS-CoV-2 infection. “ Arch Cardiovasc Dis. 2022 Nov;115(11):562-570. (IF=3,00). Cardiac ad Cardiovascular Systems (Q2).
Henry K, Deligny C, Witkowski Durand Viel P, Morel J, Guilpain P, Goulabchand R (2022). “[Infections in primary Sjögren’s syndrome patients: « Real-life » study of 109 patients from Montpellier university hospital]. “ . Rev Med Interne. 2022 Dec;43(12):696-702. (IF=0,90). Medicine General and Internal (Q4).
Hireche K, Moqaddam M, Lonjon N, Marty-Ané C, Solovei L, Ozdemir BA, Canaud L, Alric P. (2022). “Combined video-assisted thoracoscopy surgery and posterior midline incision for en bloc resection of non-small-cell lung cancer invading the spine. . “ Interact Cardiovasc Thorac Surg. 2022 Jan 6;34(1):74-80. (IF=1,98). Cardiac and Cardiovascular Systems (Q3); Respiratory System (Q4); Surgery (Q3).
Holubar J Dr, Broner J Dr, Arnaud E Dr, Hallé O Dr, Mura T Pr, Chambert B Dr, Sotto A Pr, Roubille C Dr, Gaujoux-Viala C Pr, Goulabchand R Dr. (2022). “Diagnostic performance of 18 F-FDG-PET/CT in inflammation of unknown origin (IUO): A clinical series of 317 patients. “ J Intern Med. 2022 Jun;291(6):856-863. (IF=10,07). Medicine, General and Internal (Q1).
Huet F, Delbaere Q, Fauconnier J, Lacampagne A, Delmas C, Roubille F. (2022). ” Colchicine: protection of the brain beyond the heart? ” Expert Rev Clin Immunol. 2022 Feb;18(2):101-103. (IF=4,40) Immunology (Q2).
Jacquemart E, Combes N, Duthoit G, Bessière F, Ladouceur M, Iserin L, Laredo M, Bredy C, Maltret A, Di Filippo S, Hascoët S, Pasquié JL, Marijon E, Waldmann V (2022). “Cardiac Resynchronization Therapy in Congenital Heart Disease Patients with Systemic Right Ventricle. “ Heart Rhythm. . 2022 Apr;19(4):658-666. (IF=5,50). Cardiac ad Cardiovascular Systems ( Q1).
Kamakura, T, Gourraud, JB, Clementy, N , Maury, P, Mansourati J, Klug, D, Da Costa, A, Pasquie, JL, Mabo, P, Chavernac, P, Laurent, G, Defaye, P, Laborderie, J, Leenhardt, A, Sadoul, N, Deharo, JC, Giraudeau, C, Quentin, A, Jesel, L, Thollet, A, Tixier, R,Derval, N, Haissaguerre, M, Probst, V, Sacher, F. (2022). ” Outcome of Patients with Early Repolarization Pattern and Syncope. ” – Heart Rhythm, 2022 Aug;19(8):1306-1314. (IF=5,50). Cardiac ad Cardiovascular Systems ( Q1).
Karsenty C, Guilbeau-Frugier C, Genet G, Seguelas MH, Alzieu P, Cazorla O, Montagner A, BlumY, Dubroca C, Maupoint J, Tramunt B, Cauquil M, Sulpice T, Richard S, Arcucci S, Flores-Flores R, Pataluch N, Montoriol R, Sicard P, Deney A, Couffinhal T, Sénard JM, Galés C. (2022). . ”Crest maturation at the cardiomyocyte surface contributes to a new late postnatal development stage that controls the diastolic function of the adult heart ” bioRxiv, 2022 sous presse. (sans IF)
Kervella M, Jahier M, Meli AC, Muchir A. (2022); “ Genome organization in cardiomyocytes expressing mutated A-type lamins. “ Front Cell Dev Biol. 2022 Oct 7:10:1030950 (IF=5,50). Cell Biology (Q2); Developmental Biology (Q1).
Klein C, Finat L, Abbey S, Eschalier R, Fossati F, Lazarus A, Marijon E, Pasquié JL, Ploux S, Salerno F, Williatte L, Gras D, Sacher F, Taieb J, Boveda S, Guédon-Moreau L. (2022). “Remote monitoring for cardiac implantable electronic devices: A practical guide. “ Arch Cardiovasc Dis. 2022 Jun-Jul;115(6-7):406-407. (IF=3,00). Cardiac ad Cardiovascular Systems (Q2).
Lanot N, Vincenti M, Abassi H, Bredy C, Agullo A, Gamon L, Mura T, Lavastre K, De La Villeon G, Barrea C, Meyer P, Rivier F, Meli AC, Fauconnier J, Cazorla O, Lacampagne A, Amedro P. (2022). “Assessment of left ventricular dyssynchrony by speckle tracking echocardiography in children with duchenne muscular dystrophy. “ Int J Cardiovasc Imaging. 2022 Jan;38(1):79-89. (IF=2,32). Cardiac and Cardiovascular Systems (Q3) ; Radiology, Nuclear Medicine and Medical Imaging (Q3) .
Larcher R, Maury C, Faivre G, Dagod G, Dumont Y, Moing VL, Villiet M, Capdevila X, Charbit J. (2022). “Acquisition of extended-spectrum cephalosporin-resistant Gram-negative bacteria: epidemiology and risk factors in a 6-year cohort of 507 severe trauma patients. “ J Glob Antimicrob Resist. 2022 Dec;31:363-370. (IF=4,03). Infectious Diseases (Q3); Pharmacology and Pharmacy (Q2).
Laux X, Rondet E, Grabulos J, Dore R, Ollier L, Virsolvy A, Mariano-goulart D, Maimoun L (2022) . ” Ultrasonic transmission through small tubes such as rat tibias for axial Young’s modulus estimation: Discussion and recommendations ” – Applied Acoustics, Volume 188, January 2022, 108573 (IF=3,40). Acoustics (Q2).
Leclercq F, Lorca L, Agullo A, Bouchdoug K, Macia JC, Delseny D, Roubille F, Gandet T, Lattuca B, Robert P, Schmutz L, Cayla G, Duflos C, Akodad M (2022). “Evolution of right ventricular dysfunction and tricuspid regurgitation after TAVI: A prospective study. “ .Int J Cardiol. 2022 Apr 15;353:29-34. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Leclercq F, Meunier PA, Gandet T, Macia JC, Delseny D, Gaudard P, Mourad M, Schmutz L, Robert P, Roubille F, Cayla G, Akodad M (2022). “Simplified TAVR Procedure: How Far Is It Possible to Go? “ . J Clin Med. 2022 May 16;11(10):2793. (IF=3,90). Medicine, General and Internal (Q1).
Llauradó G, Vlacho B, Wargny M, Ruan Y, Franch-Nadal J, Domingo P, Gourdy P, Saulnier PJ, Hadjadj S, Wild SH, Rea R, Cariou B, Khunti K, Mauricio D; CORONADO, the ABCD COVID-19 diabetes national audit, HM Hospitales investigators and the Hospital del Mar – Hospital de la Santa Creu i Sant Pau Diabetes Research Group, avec Klouche K parmi les collaborateurs. (2022). “The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). “ Cardiovasc Diabetol. 2022 Oct 19;21(1):216. (IF=9,30). Cardiac and Cardiovascular Systems (Q1); Endocrynology and Metabolism (Q1).
Lounes Y, Chassin-Trubert L, Hireche K, Freycon-Tardy L, Akodad M, Canaud L, Alric P. (2022). “ Renal artery reimplantation for secondary hypertension due to diaphragmatic crus compression: a case report and literature review. “ Annals of Vascular Surgery Volume 2, Issue 1, March 2022, 100056. (IF=1,50). Surgery (Q4) ; Perypheral Vascular Diseases (Q4).
Louradour J, Bortolotti O, Torre E, Bidaud I, Lamb N, Fernandez A, Le Guennec JY, Mangoni ME, Mesirca P. (2022). ”L-Type Cav1.3 Calcium Channels Are Required for Beta-Adrenergic Triggered Automaticity in Dormant Mouse Sinoatrial Pacemaker Cells. ” Cells. 2022 Mar 25;11(7):1114. (IF=6,00). Cell Biology (Q2).
Luque-Paz D, Tattevin P, Loubet P, Bénézit F, Thibault V, Lainé F, Vanhems P, Amour S, Lina B, Duval X, L’Honneur AS, Fidouh N, Vallejo C, Alain S, Galtier F, Foulongne V, Lagathu G, Lenzi N, Lesieur Z, Launay O, Jouneau S; FLUVAC Study Group.(avec parmi les collaborateurs Bourdin, A , Klouche K ) Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study. Sci Rep. 2022 Mar 10;12(1):4199. (IF= 4,60). Multidisciplinary Sciences (Q1).
Maggiore SM, Jaber S, Grieco DL, Mancebo J, Zakynthinos S, Demoule A, Ricard JD, Navalesi P, Vaschetto R, Hraiech S, Klouche K, Frat JP, Lemiale V, Fanelli V, Chanques G, Natalini D, Ischaki E, Reuter D, Morán I, La Combe B, Longhini F, De Gaetano A, Ranieri VM, Brochard LJ, Antonelli M; RINO trial study group (2022). ” High-Flow Versus VenturiMask Oxygen Therapy to Prevent Re-Intubation in Hypoxemic Patients After Extubation: A Multicenter, Randomized Clinical Trial. ”Am J Respir Crit Care Med. 2022 Dec 15;206(12):1452-1462 (IF=24,70). Critical Care Medicine (Q1) ; Respiratory System (Q1).
Maïmoun L, Serrand C, Mura T, Renard E, Nocca D, Lefebvre P, Boudousq V, Avignon A, Mariano-Goulart D, Sultan A.(2022). “Definition of an adapted cut-off for determining low lean tissue mass in older women with obesity: a comparison to current cut-offs. “ Sci Rep. 2022 Oct 7;12(1):16905. (IF=4,60). Multidisciplinary Sciences (Q1).
Maïmoun L, Mahadea KK, Boudousq V, Mura T, Mariano-Goulart D. (2022). ” Comparison of the Lunar Prodigy and Stratos DR dual-energy X-ray absorptiometers to assess regional bone mineral density. ” Journal of Clinical Densitometry 2022 Oct-Dec;25(4):569-576. (IF=2,96). Endocrinology and Metabolism (Q3).
Maïmoun L, Mariano-Goulart D, Huguet H, Renard E, Lefebvre P, Picot MC, Dupuy AM, Cristol JP, Courtet P, Boudousq V, Avignon A, Guillaume S, Sultan A. (2022). “In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration. “ Endocr Connect. 2022 May 10;11(5):e210488. (IF=2,90). Endocrinology and Metabolism (Q3).
Maria ATJ, Delmas C, Coustal C, Palassin P, Roubille F. (2022). “Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye! “ Eur J Cancer. 2022 Dec;177:194-196. (IF=8,40). Oncology (Q1).
Mekontso Dessap A, Bagate F, Delmas C, Morichau-Beauchant T, Cholley B, Cariou A, Lattuca B, Moussa M, Mongardon N, Fard D, Schmidt M, Bouglé A, Kerneis M, Vivier E, Roubille F, Duprey M, Decalf V, Genet T, Merzoug M, Audureau E, Squara P (2022). “Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): study protocol for a randomized controlled trial. “ .Trials. 2022 Jan 3;23(1):4. (IF=2,50). Medicine, Research and Experimental (Q3).
Mielle J, Morel J, ElHmioui J, Combe B, Macia L, Dardalhon V, Taylor N, Audo R, Daien C . (2021). “Glutamine promotes the generation of B10+ cells via the mTOR/GSK3 pathway. “ Eur J Immunol. 2022 Mar;52(3):418-430. (IF=5,40). Immunology (Q2).
Nasr B, Crespy V, Penasse E, Gaudry M, Rosset E, Feugier P, Gouëffic Y, Maurel B, Hostalrich A, Alric P, Sadaghianloo N, Settembre N, Chevallier J, Ben Ahmed S, Gouny P, Steinmetz E; Association Universitaire Pour la Recherche en Chirurgie (AURC) Group (2022). “Late Outcomes of Carotid Artery Stenting for Radiation Therapy-Induced Carotid Stenosis.” . J Endovasc Ther. 2022 Dec;29(6):921-928. (IF=3,09). Surgery (Q2) ; Peripheral Vascular Diseases (Q2).
Nassib J, Hireche K, Ozdemir BA, Alric P, Canaud L. (2022). “Fate of the Dissected Thoraco-Abdominal Aorta Distal to TEVAR (Thoracic Endovascular Aortic Repair) for Complicated Acute and Subacute Type B Aortic Dissection. “ J Endovasc Ther. 2022 Oct;29(5):773-779. (IF=3,09). Surgery (Q2) ; Peripheral Vascular Diseases (Q2).
Otman H, Farce J, Meneret P, Palard-Novello X, Le Reste PJ, Lecouillard I, Vauleon E, Chanchou M, Carsin Nicol B, Bertaux M, Devillers A, Mariano-Goulart D, Cachin F, Girard A, Le Jeune F (2022). “Delayed [18F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From Radionecrosis. “ Clin Nucl Med. 2022 Sep 1;47(9):800-806.(IF=10,60) Radiology, Nuclear Medicine and Medical Imaging ( Q1).
Palassin P, Maria ATJ, Ladhari C, Quantin X, Montani D, Bourdin A, Boissin C, Fesler P, Hillaire-Buys D, Guilpain P, Faillie JL. (2022). “Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study. “ Cancer Immunol Immunother. 2022 Dec;71(12):3093-3097. (IF=5,80). Immunolgy (Q1); Oncology (Q1).
Paysal J, Thireau J, Terral D, Rochette E , Obert P,Merlin E and Nottin S (2022). “Cardiac Remodeling and Its Determinants in Anorexia Nervosa Adolescents: Impact of Weight Recovery. “ Children 2022, 9,458. (IF=2,40). Pediatrics (Q2).
Pinget GV, Tan JK, Ni D, Taitz J, Daien CI, Mielle J, Moore RJ, Stanley D, Simpson S, King NJC, Macia L. (2022). “Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development. “ Cell Rep. 2022 Aug 16;40(7):111191.(IF=8,80). Cell Biology (Q1).
Pommier V, Abassi H, Lavastre K, Calderon J, Guillaumont S, Dulac Y, Auriol F, Ovaert C, Blondelon A, Hascoet S, Lecerf F, Jore C, Avesani M, Thambo JB, Amedro P (2022). “Impact of COVID-19 disease on clinical research in pediatric and congenital cardiology. “. Arch Pediatr. . 2022 Jul;29(5):347-353.. (IF=1,80). Pediatrics ( Q4).
Reisqs JB, Moreau A, Charrabi A, Sleiman Y, Meli AC, Millat G, Briand V, Beauverger P, Richard S, Chevalier P (2022). “ The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy. “Clin Transl Med. 2022 Mar;12(3):e748. (IF=10,60). Oncology (Q1); Medicine, Research andExperimental (Q1).
Rempenault C, Lukas C, Combe B, Herrero A, Pane I, Schaeverbeke T, Wendling D, Pham T, Gottenberg JE, Mariette X, Morel J; French Society of Rheumatology and the investigators participating in AIR-PR, ORA and REGATE registries. (2022) “Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept. . “ Rheumatology (Oxford). 2022 Mar 2;61(3):953-962. (IF=5,50). Rheumatology (Q1); Experimental (Q1).
Rempenault C, Mielle J, Schreiber K, Corbeau P, Macia L, Combe B, Morel J, Daien CI, Audo R. (2022).“#CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis.“ Rheumatology (Oxford). 2022 May 5;61(5):2185-2196. (IF=5,50). Rheumatology (Q1).
Ricci JE, Aguilhon S, Occean BV, Soullier C, Solecki K, Robert C, Huet F, Cornillet L, Schmutz L, Chevallier T, Akodad M, Leclercq F, Cayla G, Lattuca B, Roubille F. (2022). “Impact of Daily Bedside Echocardiographic Assessment on Readmissions in Acute Heart Failure: A Randomized Clinical Trial. “ J Clin Med. 2022 Apr 6;11(7):2047. (IF=3,90). Medicine, General and Internal (Q1).
Roubille C, Eduin B, Breuker C, Zerkowski L, Letertre S, Mercuzot C, Bigot J, Du Cailar G, Roubille F, Fesler P. (2022). “Predictive risk factors for death in elderly patients after hospitalization for acute heart failure in an internal medicine unit. “ Intern Emerg Med. 2022 Sep;17(6):1661-1668. (IF=5,47). Medicine General and Internal (Q2).
Roubille F, Delmas C, Roubille C (2022). ”Idiopathic Recurrent Pericarditis: Not Really So Idiopathic? ”. J Am Heart Assoc. 2022 Jun 7;11(11):e026218.. (IF=6,11). Cardiac and Cardiovascular Systems (Q1).
Rusidzé M, Faure MC, Sicard P, Raymond-Letron I, Giton F, Vessieres E, Prevot V, Henrion D, Arnal JF, Cornil CA, Lenfant F. (2022). “Loss of function of the maternal membrane oestrogen receptor ERα alters expansion of trophoblast cells and impacts mouse fertility. “ Development. 2022 Oct 1;149(19) (IF=4,60). Developental Biology ( Q1).
Sadhwani A, Wypij D, Rofeberg V, Gholipour A, Mittleman M, Rohde J, Velasco-Annis C, Calderon J, Friedman KG, Tworetzky W, Grant PE, Soul JS, Warfield SK, Newburger JW, Ortinau CM, Rollins CK (2022). “Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease. “ .Circulation. 2022 Apr 12;145(15):1108-1119. (IF=37,80). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).
Sanchez P, Letarouilly JG, Nguyen Y, Sigaux J, Barnetche T, Czernichow S, Flipo RM, Sellam J, Daïen C. (2022). “Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. “ Nutrients. 2022 Jan 14;14(2):354. (IF=5,90). Nutrition and Dietetics (Q1).
Sicard P, Falco A, Faure S, Thireau J, Lindsey SE, Chauvet N, de Santa Barbara P. (2022). “High-resolution ultrasound and speckle tracking: a non-invasive approach to assess in vivo gastrointestinal motility during development. “ Development. 2022 Aug 15;149(16):dev200625.. (IF=4,60). Developental Biology ( Q1).
Sigaux J, Mathieu S, Nguyen Y, Sanchez P, Letarouilly JG, Soubrier M, Czernichow S, Flipo RM, Sellam J, Daïen C. (2022). “ Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis. “ Arthritis Res Ther. 2022 May 7;24(1):100. (IF=4,90). Rheumatology (Q1)
Sleth C, Bauzou F, De Cristo C, Alkar F, Joly-Monrigal P, Jeandel C, Cottalorda J, Louahem M’Sabah D, Delpont M. (2022). Is there a persistent capital femoral epiphysis growth after screw fixation for slipped capital femoral epiphysis? J Hip Preserv Surg. 2022 Apr 9;9(2):90-94. (IF=2,00). Orthopedics (Q3).
Soum E, Timsit JF, Ruckly S, Gruson D, Canet E, Klouche K, Argaud L, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Darmon M, Bohé J, Schwebel C, Bouadma L, Dupuis C, Souweine B, Lautrette A. (2022). “Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial. “ Crit Care. 2022 Nov 29;26(1):367. (IF=15,10). Critical Care Medicine (Q1).
Tortigue M, Nield LE, Karakachoff M, McLeod CJ, Belli E, Babu-Narayan S, Prigent S, Boet A, Conway M, Elder RW, Ladouceur M, Khairy P, Kowalik E, Kalfa DM, Barron DJ, Mussa S, Hiippala A, Temple J, Abadir S, Le Gloan L, Lachaud M, Sanatani S, Thambo JB, Gronier CG, Amedro P, Vaksmann G, Charbonneau A, Koutbi L, Ovaert C, Houeijeh A, Combes N, Maury P, Duthoit G, Hiel B, Erickson CC, Bonnet C, Van Hare GF, Dina C, Karsenty C, Fournier E, Le Bloa M, Pass RH, Liberman L, Happonen JM, Perry JC, Romefort B, Benbrik N, Hauet Q, Fraisse A, Gatzoulis MA, Abrams DJ, Dubin AM, Ho SY, Redon R, Bacha EA, Schott JJ, Baruteau AE (2022). “Familial Recurrence Patterns in Congenitally Corrected Transposition of the Great Arteries: an International Study. “ . Circ Genom Precis Med. 2022 Jun;15(3):e003464. (IF=7,40). Cardiac and Cardiovascular Systems (Q1); Genetics and Heredity (Q1).
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Avec comme collaborateur F. Roubille (2022) “Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial“ .Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. (IF=44,50). Endocrinology and Metabolism (Q1)
Vincenti M, Farah C, Amedro P, Scheuermann V, Lacampagne A, Cazorla O. (2022). “Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice. “ Cardiovasc Drugs Ther. 2022 Oct;36(5):793-803. (IF=3,40). Cardiac and Cardiovascular Systems (Q2) : Pharmacology and Pharmacy (Q1).
Waldmann V, Marquié C, Bouzeman A, Duthoit G, Thambo JB, Koutbi L, Maltret A, Pasquié JL, Combes N, Marijon E. (2022). “Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot “journal of american college of cardiology2022 Oct, 80 (17) 1701–1703. (IF=27,21). Cardiac ad Ca rdiovascular Systems (Q1).
Waldmann V, Bouzeman A, Duthoit G, Koutbi L, Bessière F, Labombarda F, Marquié C, Gourraud JB, Mondoly P, Sellal JM, Bordachar P, Hermida A, Al Arnaout A, Anselme F, Audinet C, Bernard Y, Boveda S, Bun SS, Chassignolle M, Clerici G, Da Costa A, de Guillebon M, Defaye P, Elbaz N, Eschalier R, Garcia R, Guenancia C, Guy-Moyat B, Halimi F, Irles D, Iserin L, Jourda F, Ladouceur M, Lagrange P, Laredo M, Mansourati J, Massoulié G, Mathiron A, Maury P, Messali A, Narayanan K, Nguyen C, Ninni S, Perier MC, Pierre B, Pujadas P, Sacher F, Sagnol P, Sharifzadehgan A, Walton C, Winum P, Zakine C, Fauchier L, Martins R, Pasquié JL, Thambo JB, Jouven X, Combes N, Marijon E (2022). Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators. . JACC Clin Electrophysiol. 2022 Oct;8(10):1304-1314. (IF=7,00). Cardiology and Cardiovascular Medicine (Q1); Physiology (medical) (Q1)
Wyplosz B, Fernandes J, Sultan A, Roche N, Roubille F, Loubet P, Fougère B, Moulin B, Duhot D, Vainchtock A, Raguideau F, Lortet-Tieulent J, Blanc E, Moïsi J, Goussiaume G. (2022). “Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study. “Vaccine. 2022 Aug 5;40(33):4911-4921. (IF=5,50). Immunology (Q3) ; Medicine , Research and Experimental (Q3).
Xavier D, Floris C, Fabrice P, Angoulvant D, Mewton N, Roubille F, Pascal R, Marc F, Valérie M, Laurane C, Alain F, Gabriel G, Loïc B, Delphine MP (2022). “Post-infarct cardiac remodeling predictions with machine learning. “ .Int J Cardiol. 2022 May 15;355:1-4. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Aarab Y, Flatres A, Garnier F, Capdevila M, Raynaud F, Lacampagne A, Chapeau D, Klouche K, Etienne P, Jaber S, Molinari N, Gamon L, Matecki S, Jung B (2021). “Shear Wave Elastography, A New Tool for Diaphragmatic Qualitative Assessment. A Translational Study. “. Am J Respir Crit Care Med. 2021 Oct 1;204(7):797-806. (IF=30,53). Critical Care Medicine (Q1) ; Respiratory System (Q1)).
Akodad M, Aldhaheri E, Marin G, Roubille F, Macia JC, Gandet T, Delseny D, Schmutz L, Lattuca B, Robert P, Dubard A, Robert G, Targosz F, Maupas E, Albat B, Cayla G, Leclercq F. (2021). “Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective study. “ Int J Cardiol. 2021 May 1;330:158-163. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).
Allimant C, Deshayes E, Kafrouni M, Santoro L, de Verbizier D, Fourcade M, Cassinotto C, Hermida M, Guillot C, Mariano-Goulart D, Guiu B. (2021). “ Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver. “ Diagnostics (Basel). 2021 May 21;11(6):931 (IF=4,00). Medicine General and Internal (Q1).
Amedro P, Werner O, Abassi H, Boisson A, Souilla L, Guillaumont S, Calderon J, Requirand A, Vincenti M, Pommier V, Matecki S, De La Villeon G, Lavastre K, Lacampagne A, Picot MC, Beyler C, Delclaux C, Dulac Y, Guitarte A, Charron P, Denjoy-Urbain I, Probst V, Baruteau AE, Chevalier P, Di Filippo S, Thambo JB, Bonnet D, Pasquie JL (2021). ”Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods. . ” Health Qual Life Outcomes. 2021 Jul 28;19(1):187. (IF=3,10). Health Policy and Services (Q2).
Amedro P, Huguet H, Macioce V, Dorka R, Auer A, Guillaumont S, Auquier P, Abassi H, Picot MC (2021). “Psychometric validation of the French self and proxy versions of the PedsQL™ 4.0 generic health-related quality of life questionnaire for 8-12 year-old children. “. Health Qual Life Outcomes. 2021 Mar 4;19(1):75. (IF=3,10). Health Policy and Services (Q2).
Amedro P, Werner O, Abassi H, Boisson A, Souilla L, Guillaumont S, Calderon J, Matecki S, De La Villeon G, Requirand A, Vincenti M, Pommier V, Lavastre K, Lacampagne A. Picot MC, Beyler C, Delclaux C, Dulac Y, Guitarte A, Charron P, Denjoy-Urbain I, Probst V, Elouen Baruteau A, Chevalier P, Di Filippo S, Thambo JB, Bonnet D, Pasquie JL. (2021). Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods. ” Health and Quality of Life Outcomes BMC 2021 Jul 28;19(1):187. (IF=3,10). Health Policy and Services (Q2).
Angebault C, Panel M, Lacôte M, Rieusset J, Lacampagne A, Fauconnier J (2021). ”Metformin Reverses the Enhanced Myocardial SR/ER-Mitochondria Interaction and Impaired Complex I-Driven Respiration in Dystrophin-Deficient Mice. ” Front Cell Dev Biol. 2021 Jan 25;8:609493. (IF=6,08). Cell Biology (Q2); Developmental Biology (Q1).
Audurier Y, Roubille C, Manna F, Zerkowski L, Faucanie M, Macioce V, Castet-Nicolas A, Jalabert A, Villiet M, Fesler P, Lohan-Descamps L, Breuker C. (2021). “Development and validation of a Score to Assess Risk of Medication Errors detected during medication reconciliation process at admission in Internal Medicine Unit: SCOREM study. “ Int J Clin Pract. 2021 Feb;75(2):e13663. (IF=3,15). Medicine General and Internal (Q2) .
Banuls L, Vanoverschelde J, Garnier F, Amalric M, Jaber S , Charbit J, Chalard K , Mourad M, Benchabane N, Benomar R, Besnard N, Daubin D, BrunotV, Klouche K and Larcher R (2021). “Interstitial Lung Disease Worsens Short-and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study“ J Clin Med , 2021, 10,1037 (IF=4,96). Medicine, General and Internal (Q1).
Berger M, Fesler P, Roubille C (2021). ”Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases. ” Autoimmun Rev. 2021 Sep;20(9):102891. (IF=17,39). Immunology (Q1).
Berger M, Fesler P, Roubille C (2021). “ Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases. “ .Autoimmun Rev. 2021 Sep;20(9):102891.(IF=17,39). Immunology (Q1).
Bergeret B, Secco LP, Pallure V, Daien C, Pers YM, Gottlieb J, Barete S, Girard C, Lipsker D, Bessis D; Study Group of Systemic Diseases in Dermatology (EMSED: Étude des Maladies Systémiques en Dermatologie).(2021). Palmoplantar lichen planus-like lupus erythematosus keratoderma: an underrecognized and distinctive cutaneous manifestation of systemic or subacute lupus erythematosus. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e124-e126. (IF=9,23). Dermatology (Q1); Dermatology and Venereal Diseases ((Q1)
Bessière F, Gardey K, Bouzeman A, Duthoit G, Koutbi L, Labombarda F, Marquié C, Gourraud JB, Mondoly P, Sellal JM, Bordachar P, Hermida A, Anselme F, Asselin A, Audinet C, Bernard Y, Boveda S, Chevalier P, Clerici G, da Costa A, de Guillebon M, Defaye P, Eschalier R, Garcia R, Guenancia C, Guy-Moyat B, Henaine R, Irles D, Iserin L, Jourda F, Ladouceur M, Lagrange P, Laredo M, Mansourati J, Massoulié G, Mathiron A, Maury P, Nguyen C, Ninni S, Perier MC, Pierre B, Sacher F, Walton C, Winum P, Martins R, Pasquié JL, Thambo JB, Jouven X, Combes N, Di Filippo S, Marijon E, Waldmann V (2021). ”Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator. ” . JACC Clin Electrophysiol. 2021 Apr 21:S2405-500X(21)00220-6 (IF=6,12). Cardiology and Cardiovascular Medicine (Q1); Physiology (medical) (Q1)
Boheler KR, Meli AC, Yang HT. (2021). “Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapy. “ Pflugers Arch. 2021 Jul;473(7):983-988.. (IF=4,46). Physiology (Q2).
Boisson A, De La Villeon G, Huguet M, Abassi H, Pasquie JL,,Lavastre K, aMatecki S, Guillaumont S, Requirand A, Calderon J, Amedro P. (2021). “Physical activity and aerobic fitness in children with inherited cardiac diseases. “ Archives of Cardiovascular Diseases…, 2021 Nov;114(11):727-736. (IF=3,20). Cardiac ad Cardiovascular Systems (Q2).
Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S. (2021). “Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies. “ Front Cardiovasc Med. 2021 Jun 30;8:690533. (IF=5,85). Cardiac and Cardiovascular Systems (Q2).
Bresson D, Roubille F, Prieur C, Biere L, Ivanes F, Bouleti C, Dubreuil O, Rioufol G, Boutitie F, Sideris G, Elbaz M, Bochaton T, De Bourguignon C, El Jonhy N, Dufay N, Dhelens C, Croisille P, Prunier F, Angoulvant D, Ovize M, Maucort-Boulch D, Mewton N. (2021). “Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol – The COVERT-MI Study. “ Cardiology. 2021 Feb 12:1-10. (IF=2,34). Cardiac and Cardiovascular Systems (Q4).
Breuker C, Guedj AM, Allan M, Coinus L, Molinari N, Chapet N, Roubille F, Le Quintrec M, Duhalde V, Jouglen J, Cestac P, Kinowski JM, Faure S, Faucanie M, Lohan L, Villiet M, Altwegg R, Sultan A. (2021). “The COVID-19 Pandemic Led to a Small Increase in Changed Mentality Regarding Infection Risk without Any Change in Willingness to Be Vaccinated in Chronic Diseases Patients. “ J Clin Med. 2021 Sep 1;10(17):3967.(IF=4,96). Medicine, General and Internal (Q1).
Bughin F, Jaussent I, Ayoub B, Aguilhon S, Chapet N, Soltani S, Mercier J, Dauvilliers Y, Roubille F. (2021). “Prognostic Impact of Sleep Patterns and Related-Drugs in Patients with Heart Failure. “ J Clin Med. 2021 Nov 18;10(22):5387. (IF=4,96). Medicine, General and Internal (Q1).
Bughin F, Bui G, Ayoub B, Blervaque L, Saey D, Avignon A, Brun JF, Molinari N, Pomies P, Mercier J, Gouzi F, Hayot M (2021).”Impact of a Mobile Telerehabilitation Solution on Metabolic Health Outcomes and Rehabilitation Adherence in Patients With Obesity: Randomized Controlled Trial.”.JMIR Mhealth Uhealth. 2021 Dec 6;9(12):e28242. (IF=4,97). Health Care Sciences and Services (Q1) ; Medical Informatics (Q2).
Cazorla O, Barthélémy I, Su JB, Meli AC, Chetboul V, Scheuermann V, Gouni V, Anglerot C, Richard S, Blot S, Ghaleh B, Lacampagne A (2021). “Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy. “ J Am Coll Cardiol. 2021 Dec 14;78(24):2439-2453. (IF=27,20). Cardiac ad Ca rdiovascular Systems (Q1).
Chaigne S, Cardouat G, Louradour J, Vaillant F, Charron S, Sacher F, Ducret T, Guinamard R, Vigmond E, Hof T. (2021). ”Transient Receptor Potential Vanilloid 4 channel participates in mouse ventricular electrical activity. ”Am J Physiol Heart Circ Physiol. 2021 Mar 1;320(3):H1156-H1169. (IF=5,12). Cardiac and Cardiovascular Systems (Q2); Physiology (Q1) ; Peripheral Vascular Diseases (Q2).
Chelly J, Plantefève G, Kamel T, Bruel C, Nseir S, Lai C, Cirillo G, Skripkina E, Ehrminger S, Berdaguer-Ferrari FD, Le Marec J, Paul M, Autret A, Deye N; ACICOVID-19 study group avec Larcher R comme collaborateur. (2021). “Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry. “ .Ann Intensive Care. 2021 Nov 13;11(1):155. (IF=10,32). Critical Care Medicine (Q1).
Chetboun M, Raverdy V, Labreuche J, Simonnet A, Wallet F, Caussy C, Antonelli M, Artigas A, Goma G, Meziani F, Helms J, Mylonakis E, Levy MM, Kalligeros M, Latronico N, Piva S, Cerf C, Neuville M, Klouche K, Larcher R, Tamion F, Occhiali E, Snacken M, Preiser JC, Kontar L, Riviere A, Silva S, Sarton B, Krouchi R, Dubar V, Palaiodimos L, Karamanis D, Perche J, L’her E, Busetto L, Dicker D, Lev S, Duhamel A, Jourdain M, Pattou F; (2021). « BMI and pneumonia outcomes in critically ill COVID-19 patients: an international multicenter study. « LICORNE Lille Intensive Care COVID-19, Obesity Study Group », the « COVID-19 Toulouse ICU Network », the « Hasharon Hospital-Rabin Medical Center Covid-19, Obesity Study Group », the « ID, ICU Covid-19 Study Group », the « Rouen Covid-19, Obesity Study », the « COVID-O-HCL Consortium », the « MICU Lapeyronie », the « Bronx COVID-19, Obesity Study Group », the « MIR Amiens Covid19 », the « Strasbourg NHC », the « Foch COVID-19 Study Group ». Obesity (Silver Spring) 2021 Sep;29(9):1477-1486. (IF=9,30). Endocrinology and Metabolism (Q2); Nutrition and Dietetics (Q2)
Coustal C, Du Thanh A, Roubille F, Assenat E, Maria ATJ (2021). ”Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis. ” Eur J Cancer. 2021 Jul 28;155:25-27. (IF=10,00). Oncology (Q1).
David H, Ughetto A, Gaudard P, Plawecki M, Paiyabhroma N, Zub E, Colson P, Richard S, Marchi N, Sicard P. (2021). “Experimental Myocardial Infarction Elicits Time-Dependent Patterns of Vascular Hypoxia in Peripheral Organs and in the Brain. “ Front Cardiovasc Med. 2021 Jan 27;7:615507. (IF=5,85). Cardiac and Cardiovascular Systems (Q2).
Decarriere G, Barnetche T, Combe B, Gaujoux-Viala C, Lukas C, Morel J, Daien C (2021). “The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis. “ Arthritis Care Res (Hoboken). 2021 Jun;73(6):873-884. (IF=5,18). Rheumatology (Q2).
Denormandie P, Simon T, Cayla G, Steg PG, Montalescot G, Durand-Zaleski I, Le Bras A, Le Breton H, Valy Y, Schiele F, Cuisset T, Vanzetto G, Levesque S, Goube P, Nallet O, Angoulvant D, Roubille F, Charles-Nelson A, Chatellier G, Danchin N, Puymirat E. (2021). “Compared Outcomes of ST-Elevation Myocardial Infarction Patients with Multivessel Disease Treated with Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Non-Culprit Lesions Treated Conservatively and of Those with Low Fractional Flow Reserve Managed Invasively: Insights from the FLOWER MI trial. “ Circ Cardiovasc Interv. 2021 Nov;14(11):e011314. (IF=7,51). Cardiac and Cardiovascular Systemms (Q1).
Doecke JD, Francois C, Fowler CJ, Stoops E, Bourgeat P, Rainey-Smith SR, Li QX, Masters CL, Martins RN, Villemagne VL, Collins SJ, Vanderstichele HM (2021). “Core Alzheimer’s disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. “Alzheimers Res Ther. 2021 Apr 16;13(1):79. (IF=8,83). Clinical Neurology (Q1); Neurosciences (Q1).
Dubé MP, Legault MA, Lemaçon A, Lemieux Perreault LP, Fouodjio R, Waters DD, Kouz S, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GS, Asselin G, Provost S, Barhdadi A, Sun M, Cossette M, Blondeau L, Mongrain I, Dubois A, Rhainds D, Bouabdallaoui N, Samuel M, de Denus S, L’Allier PL, Guertin MC, Roubille F, Tardif JC. (2021). “Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT. “ Circ Genom Precis Med. 2021 Apr;14(2):e003183. (IF=7,46). Cardiac and Cardiovascular Systems (Q2) ; Genetics and Heredity (Q2).
Duflos C, Solecki K, Galinier M, Itier R, Roncalli J, Goger AL, Mandoraah B, Kalmanovich E, Huet F, Agullo A, Delseny D, Macia JC, Leclercq F, Mercier G, Roubille F. (2021). ”Conception and bicentric validation of the proSCANNED score, a simplified bedside prognostic score for Heart Failure patients. ” Sci Rep. 2021 Mar 17;11(1):6179. (IF=5,00). Multidisciplinary Sciences (Q1).
Duflos C, Labarre JP, Ologeanu R, Robin M, Cayla G, Galinier M, Georger F, Petroni T, Alarcon C, Aguilhon S, Delonca C, Battistella P, Agullo A, Leclercq F, Pasquie JL, Papinaud L, Mercier G, Ricci JE, Roubille F. (2021). “PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France. “ ESC Heart Fail. 2021 Apr;8(2):1649-1655. (IF=3,61). Cardiac and Cardiovascular Systems (Q1).
Dupuy AM, Badiou S, Montagnon V, Beaufils O, Sebbane M, Roubille F, Cristol JP (2021). “ Analytical assessment and performance of the 0/3h algorithm with novel high sensitivity cardiac troponin I. “Clin Chim Acta. 2021 Aug;519:111-117. (IF=6,31). Medical Laboratory Technology (Q2).
Dupuy AM, Pasquier G, Thiebaut L, Roubille F, Sebbane M, Cristol JP (2021). “Additive value of bioclinical risk scores to high sensitivity troponins-only strategy in acute coronary syndrome. “ .Clin Chim Acta. 2021 Oct 12;523:273-284.. (IF=6,31). Medical Laboratory Technology (Q2).
Faroux L, Lhermusier T, Vincent F, Nombela-Franco L, Tchétché D, Barbanti M, Abdel-Wahab M, Windecker S, Auffret V, Campanha-Borges DC, Fischer Q, Muñoz-Garcia E, Trillo-Nouche R, Jorgensen T, Serra V, Toggweiler S, Tarantini G, Saia F, Durand E, Donaint P, Gutierrez-Ibanes E, Wijeysundera HC, Veiga G, Patti G, D’Ascenzo F, Moreno R, Hengstenberg C, Chamandi C, Asmarats L, Hernandez-Antolin R, Gomez-Hospital JA, Cordoba-Soriano JG, Landes U, Jimenez-Diaz VA, Cruz-Gonzalez I, Nejjari M, Roubille F, Van Belle É, Armijo G, Siddiqui S, Costa G, Elsaify S, Pilgrim T, le Breton H, Urena M, Muñoz-Garcia AJ, Sondergaard L, Bach-Oller M, Fraccaro C, Eltchaninoff H, Metz D, Tamargo M, Fradejas-Sastre V, Rognoni A, Bruno F, Goliasch G, Santaló-Corcoy M, Jimenez-Mazuecos J, Webb JG, Muntané-Carol G, Paradis JM, Mangieri A, Ribeiro HB, Campelo-Parada F, Rodés-Cabau J. (2021). “ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement. “ J Am Coll Cardiol. 2021 May 4;77(17):2187-2199. (IF=27,20). Cardiac ad Ca rdiovascular Systems (Q1).
Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. (2020). “Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial. “ Ann Rheum Dis. 2021 Mar;80(3):329-338. (IF=27,97). Rheumatolgy (Q1).
Fossier L, Panel M, Meli AC, Fauconnier J, Lacampagne A (2021). “Single Channel Biophysical Properties of the Left Ventricular Mitochondrial Calcium Uniporter Complex “ Biophysical Journal, 2021 25 Fev. 246a Poster abstract. (IF=3,70). Biophysics (Q1).
Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasquié JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E. (2021). ”Wearable cardioverter-defibrillator in patients with a transient risk of Sudden cardiac death: the WEARIT-France cohort study. ” Europace. 2021 Jan 27;23(1):73-81. (IF=5,49). Cardiac and Cardiovascular Systems (Q2).
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, Assenat E, Tacher V, Robert C, Terroir-Cassou-Mounat M, Mariano-Goulart D, Amaddeo G, Palard X, Hollebecque A, Kafrouni M, Regnault H, Boudjema K, Grimaldi S, Fourcade M, Kobeiter H, Vibert E, Le Sourd S, Piron L, Sommacale D, Laffont S, Campillo-Gimenez B, Rolland Y; DOSISPHERE-01 Study Group. (2021). “Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.” Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. (IF=202,73); Medicine, General and Internal (Q1). .
Gavotto A, Rivière B, Degravi L. (2021). “Gastrointestinal bleeding and acute liver failure. “ Gastroenterology. 2021 Dec;161(6):1811-1812.. (IF=33,88). Gastroenterology and Hepatology (Q1).
Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, Lamblin N, Gueffet JP, Damy T, Galinier M, Tartiere JM, Janssen C, Berthelot E, Aguilhon S, Escamilla R, Roubille F. (2021). “Vaccination for Respiratory Infections in Patients with Heart Failure. “ J Clin Med. 2021 Sep 22;10(19):4311. (IF=4,96). Medicine, General and Internal (Q1).
Goulabchand R, Roubille C, Montani D, Fesler P, Bourdin A, Malafaye N, Morel J, Arnaud E, Lattuca B, Barateau L, Guilpain P, Mura T (2021); “Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database. “.J Clin Med. 2021 Oct 30;10(21):5115. (IF=4,96); Medicine, General and Internal (Q1).
Grandperrin A, Schuster I, Rupp T, Izem O, Obert P, Nottin S (2021). “Left ventricular dyssynchrony and post-systolic shortening in young bodybuilders using anabolic-androgenic steroids. “ Am J Physiol Heart Circ Physiol. 2021 Sep 1;321(3):H509-H517. (IF= 5,12). Cardiac and Cardiovascular Systems (Q2); Physiology (Q1) ; Peripheral Vascular Diseases (Q2).
Gueguen N, Piarroux J, Sarzi E, Benkirane M, Manes G, Delettre C, Amedro P, Leboucq N, Koenig M, Meyer P, Meunier I, Reynier P, Lenaers G, Roubertie A. (2021). “Optic neuropathy linked to ACAD9 pathogenic variants: a potentially riboflavin-responsive disorder? “ Mitochondrion. 2021 Jul;59:169-174. (IF=4,53). Cell Biology (Q2) ; Genetics and Heredity (Q2).
Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V. (2021). “Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. “ Ann Rheum Dis. 2020 2021 Jan;80(1):e10. (IF=27,97). Rheumatolgy (Q1).
Hedon C, Lambert K, Chakouri N, Thireau J, Aimond F, Cassan C, Bideaux P, Richard S, Faucherre A, Le Guennec JY, Demion M. (2020). .”New role of TRPM4 channel in the cardiac excitation-contraction coupling in response to physiological and pathological hypertrophy in mouse. .” Prog Biophys Mol Biol.. 2021 Jan;159:105-117. (IF=4,80). Biochemistry and Molecular Biology (Q3) ; Biophysics (Q3).
Homan T, Delanoë-Ayari H, Meli AC, Cazorla O, Gergely C, Mejat A, Chevalier P, Moreau A.(2021). “MorphoScript: a dedicated analysis to assess the morphology and contractile structures of cardiomyocytes derived from stem cells. “ Bioinformatics. 2021 May 28;btab400. (IF=6,93). Biochemical Research Methods (Q1); Biotechnology and Applied Microbiology (Q1); Mathematical and Computational Biology (Q1; Computer Science and Interdisciplinary applications (Q1); Statistics and Probability (Q1).
Huet F , Dupuy AM, Duflos C, Azara Reis C, Kuster N , Aguilhon S, Cristol JP & Roubille F, (2021). “Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry. “ Future Sci. OA 2021 Mar 29;7(5):FSO697. (IF=2,61). Biotechnology (Q3) ; Medicine (Miscellaneous) (Q3).
Huet F, Delbaere Q, Aguilhon S, Dupasquier V, Delseny D, Gervasoni R, Macia JC, Leclercq F, Jammoul N, Kahlouche S, Soltani S, Cardon F, Dupuy AM, Cristol JP, Mariano-Goulart D, Akodad M, Nagot N, Roubille F. “Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol. “ Medicina (Kaunas). 2021 Sep 30;57(10):1047. (IF=2,95). Generzl Medicine (Q2).
Itier R, Guillaume M, Ricci JE, Roubille F, Delarche N, Picard F, Galinier M, Roncalli J.(2021). ”Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues. ” ESC Heart Fail. 2021 Apr;8(2):789-798. (IF=3,61). Cardiac and Cardiovascular Systems (Q1).
Jaffuel D, Nogue E, Berdague P, Galinier M, Fournier P, Dupuis M, Georger F, Cadars MP, Ricci JE, Plouvier N, Picard F, Puel V, Mallet JP, Suehs CM, Molinari N, Bourdin A, Roubille F (2021). “Sacubitril-valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO-SAS study. “ ESC Heart Fail. 2021 Aug;8(4):2513-2526. (IF=3,61). Cardiac and Cardiovascular Systems (Q1).
Jelinkova S, Sleiman Y, Fojtík P, Aimond F, Finan A, Hugon G, Scheuermann V, Beckerová D, Cazorla O, Vincenti M, Amedro P, Richard S, Jaros J, Dvorak P, Lacampagne A, Carnac G, Rotrekl V, Meli AC. (2021). “Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart. Int J Mol Sci. 2021 May 10;22(9):5025.(IF=6,21). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary (Q2).
Kalmanovich E, Battistella P, Rouviere P, Albat B, Frapier JM, Demaria R, Huet F, Agullo A, Mourad M, Colson P, Leclercq F, Gaudard P and RoubIille F.(2021). ” Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients ”Future Science OA, 2021 Feb 15;7(4):FSO689 (IF=2,61). Biotechnology (Q3) ; Medicine (Miscellaneous) (Q3).
Koutsoukis A, Delmas C, Roubille F, Bonello L, Schurtz G, Manzo-Silberman S, Puymirat E, Elbaz M, Bouisset F, Meunier PA, Huet F, Paganelli F, Laine M, Lemesle G, Lamblin N, Henry P, Tea V, Gallet R, Teiger E, Huguet R, Fard D, Lim P (2021). “Acute Coronary Syndromes in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care. “ . CJC Open. 2021 Mar;3(3):311-317. (IF=1,90). Cardiac and Cardiovascular Systems (Q2).
Lambert K, Demion M, Lagacé JC, Hokayem M, Dass M, Virsolvy A, Jover B, Bourret A, Bisbal C. (2021) Grape polyphenols and exercise training have distinct molecular effects on cardiac hypertrophy in a model of obese insulin-resistant rats. J Nutr Biochem. 2021 Jan;87:108522 (IF=6,12). Biochemistry and Molecular Biology (Q1) ; Nutrition and dietetics (Q1).
Lanot N, Adda J, Roubille F, Akodad M. (2021). “Pheochromocytoma in a patient presenting with ventricular fibrillation and carotid dissection: a case report. “ Eur Heart J Case Rep. 2021 Feb 4;5(2):ytab012. (IS=0,78). Cardiology and Cardiovascular Medicine (Q4).
Larcher R, Platon L, Amalric M, Brunot V, Besnard N, Benomar R, Daubin D, Ceballos P, Rispail P, Lachaud L, Bourgeois N, Klouche K. (2021). “Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study. “ J Fungi (Basel). 2021 Apr 24;7(5):330. (IF= 5,72). Microbiology(Q1) ; Mycology (Q1).
Larcher R, Besnard N, Akouz A, Rabier E, Teule L, Vandercamere T, Zozor S, Amalric M, Benomar R, Brunot V, Corne P, Barbot O, Dupuy AM, Cristol JP, Klouche K. (2021). “Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study. “ J Clin Med. 2021 Apr 13;10(8):1656. (IF=4,96). Medicine, General and Internal (Q1).
Larcher R, Kuster N, Bargnoux AS, Klouche K, Pieroni L, Cristol JP. (2021). “Discrepant post-filter ionized calcium concentrations by 2 common gas analyzers in continuous renal replacement therapy using regional citrate anticoagulation: another piece of the puzzle. “ Kidney Int. 2021 Jan;99(1):268-269. (IF=19,00). Urology and Nephrology (Q1).
Laudette M, Sainte-Marie Y, Cousin G, Bergonnier D, Belhabib I, Brun S, Formoso K, Laib L, Tortosa F, Bergoglio C, Marcheix B, Borén J, Lairez O, Fauconnier J, Lucas A, Mialet-Perez J, Moro C, Lezoualc’h F. (2021). “ Cyclic AMP-binding protein Epac1 acts as a metabolic sensor to promote cardiomyocyte lipotoxicity. “ Cell Death Dis. 2021 Sep 1;12(9):824. (IF=12,08). Cell Biology” (Q1).
Leclercq F, Odorico X, Marin G, Christophe Macia J, Delseny D, Agullo A, Pages L, Robert P, Lattuca B, Cayla G, Roubille F, Gaillard N, Arquizan C, Akodad M (2021). “Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study. “ .Int J Cardiol Heart Vasc. 2021 Nov 20;37:100919. (IF=3,30). Cardiac and Cardiovascular Systems (Q2).
Lellouche N, Arrouasse R, Ternacle J, Gallet R, Hermida JS, Hamon D, Juliard JM, Pasquié JL, Dhanjal T, Teiger E, Le Corvoisier P. (2021). ”Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry. ” BMC Cardiovasc Disord. 2021 May 3;21(1):227 (IF=2,17). Cardiology and Cardiovascular Medicine (Q2)
Le Roy J, Azais B, Zarqane H, Vernhet Kovacsik H, Mura T, Lacampagne A, Amedro P. (2021). «Selection of optimal cardiac phases for ECG-triggered coronary CT angiography in pediatrics. Phys Med. 2021 Jan 15;81:155-161. (IF=3,12). Radiology Nuclear Medicine and Medical Imaging (Q2).
Le Tanno P, Folacci M, Revilloud J, Faivre L, Laurent G, Pinson L, Amedro P, Millat G, Janin A, Vivaudou M, Roux-Buisson N, Fauré J (2021). ”Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome. ” Front Genet. 2021 Nov 2021 Nov 25;12:773177. (IF=4,77). Genetics and Heredity (Q2).
Letertre S, Fesler P, Zerkowski L, Picot MC, Ribstein J, Guilpain P, Le Moing V, Mariano-Goulart D, Roubille C (2021) “Place of the 18F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO). “ J Clin Med. 2021 Aug 26;10(17):3831. . (IF=4,96). Medicine, General and Internal (Q1).
Lohan L, Galtier F, Manson T, Mura T, Castet-Nicolas A, Faure D, Chapet N, Leclercq F, Pasquié JL, Roubille F, Roubille C, Blain H, Guilpain P, Villiet M, Avignon A, Sultan A and Breuker C. (2021) “Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine“Medicina, 2021 Dec 17;57(12):1376 (IF=2,95). General Medicine (Q2).
Lotierzo M, Bruno R, Finan-Marchi A, Huet F, Kalmanovich E, Rodrigues G, Dupuy AM, Adda J, Piquemal D, Richard S, Cristol JP, Roubille F (2021). “ Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure? “ .Medicina (Kaunas). 2021 Sep 22;57(10):996. . (IF=2,95). Generzl Medicine (Q2).
Loubet P, Laureillard D, Martin A, Larcher R, Sotto A (2021). “Why promoting a COVID-19 vaccine booster dose? “ .Anaesth Crit Care Pain Med. 2021 Dec;40(6):100967. (IF=7,02). Anaesthesiology (Q2) ; Critical Care Medicine ( Q3).
Lukas C, Redondin M, Pane I, Soubrier M, Houvenagel E, Sibilia J, Combe B, Morel J. (2021). “Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry. “ Clin Exp Rheumatol. May-Jun 2021;39(3):501-507. (IF=4,86). Rheumatology (Q2)
Maïmoun L, Renard E, Huguet H, Lefebvre P, Boudousq V, Mahadea K, Picot MC, Doré R, Philibert P, Seneque M, Gaspari L, Courtet P, Sultan C, Sultan A, Laux D, Guillaume S, Mariano-Goulart D (2021). The quantitative ultrasound method for assessing low bone mass in women with anorexia nervosa. Arch Osteoporos. 2021 Jan 14;16(1):13. (IF=2,88). Endocrinology and Metabolism (Q4) ; Orthopedics (Q2).
Maïmoun L, Renard E, Humbert L, Aouinti S, Mura T, Boudousq V, Lefebvre P, Mahadea K, Philibert P, de Santa-Barbara P, Avignon A, Guillaume S, Sultan A, Nocca D, Mariano-Goulart D. (2021). ” Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesity. ” Bone. 2021 Sep;150:116005.. (IF=4,63). Endocrinology and Metabolism (Q2).
Mandoorah B, Granier M, Pasquié JL. (2021). “Vertebral osteophyte as an unexpected cause of atrial substrate modification in atrial fibrillation. “ Europace. 2021 Jan 27;23(1):146. (IF=5,49). Cardiac and Cardiovascular Systems (Q2).
Mankia K, Siddle HJ, Kerschbaumer A, Alpizar Rodriguez D, Catrina AI, Cañete JD, Cope AP, Daien CI, Deane KD, El Gabalawy H, Finckh A, Holers VM, Koloumas M, Ometto F, Raza K, Zabalan C, van der Helm-van Mil A, van Schaardenburg D, Aletaha D, Emery P. (2021). “EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. “ Ann Rheum Dis. 2021 Oct;80(10):1286-1298. (IF=27,97). Rheumatolgy (Q1).
Meghoufel ZF, Cherifi F, Boukra A, Terki F.(2021).” Ab-initioinvestigation on the electronic and thermoelectric properties of new half-Heusler compounds KBiX(X= Ba and Sr). ” J Phys Condens Matter. 2021 Jul 23;33(39). (IF=2,74). Condensed Matter Physics (Q1); Materials Science (miscellaneous) (Q1)
Melhem N, Chajadine M, Gomez I, Howangyin KY, Bouvet M, Knosp C, Sun Y, Rouanet M, Laurans L, Cazorla O, Lemitre M, Vilar J, Mallat Z, Tedgui A, Ait-Oufella H, Hulot JS, Callebert J, Launay JM, Fauconnier J, Silvestre JS, and Taleb S. (2020) “ Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine. “Circulation, 2021 Feb 9;143(6):566-580. (IF= 29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).
Meli AC, Fischmeister R. (2021). ”Scientists on the spot: Phosphodiesterases and heart failure. ” Cardiovasc Res. 2021 Jan 21;117(2):e24-e25. (IF=13,08). Cardiac and Cardiovascular Systems (Q1).
Mercuzot C, Debien B, Riviere É, Martis N, Sanges S, Galland J, Kouchit Y, Fesler P, Roubille C (2021). ‘Impact of a simulation-based training on the experience of the beginning of residency. ‘Rev Med Interne. 2021 Nov;42(11):756-763.. (IF=0,88). Medicine General and Internal (Q4).
Mercuzot C, Letertre S, Daien C, Zerkowski L, Guilpain P, Terrier B, Fesler P, Roubille C. (2021). “Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) – associated vasculitis. “ Autoimmun Rev. 2021 Jan;20(1):102708. (IF=17,39). Immunology (Q1).
Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, Ivanes F, Dubreuil O, Bière L, Hayek A, Derimay F, Akodad M, Alos B, Haider L, El Jonhy N, Daw R, De Bourguignon C, Dhelens C, Finet G, Bonnefoy-Cudraz E, Bidaux G, Boutitie F, Maucort-Boulch D, Croisille P, Rioufol G, Prunier F, Angoulvant D; (2021). “Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. “COVERT-MI Study Investigators. Circulation. 2021 Sep 14;144(11):859-869. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).
Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G (2021). “Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. “ Int J Mol Sci. 2021 Nov 30;22(23):12985. (IF=6,21). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary (Q2).
Milési C, Requirand A, Douillard A, Baleine J, Nogué E, Matecki S, Amedro P, Pons-Odena M, Cambonie G (2021). “Assessment of Peak Inspiratory Flow in Young Infants with Acute Viral Bronchiolitis: Physiological Basis for Initial Flow Setting in Patients Supported with High-Flow Nasal Cannula. “ J Pediatr. 2021 Apr;231:239-245.e1. (IF=6,31). Pediatrics (Q1).
Moreau A, Reisqs JB, Delanoe‐Ayari H, Pierre M, Janin A, Deliniere A, Bessière F, Meli AC, Charrabi A, Lafont E, Valla C, Bauer D, Morel E, Gache V, Millat G, Nissan X, Faucherre A, Jopling C, Richard S, Mejat A, Chevalier P. (2021). “Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy “ Clinical and Translational Medicine…2021 Mar;11(3):e319. (IF=8,55). Oncology (Q1); Medicine, Research and Experimental (Q1).
Mounier S, Gavotto A, Tenenbaum J, Meyer P, Fila M, Baleine J (2021). “Hemolytic uremic syndrome related to Shiga-like toxin-producing Escherichia coli with encephalitis hiding a human herpesvirus-6 infection: a case report. “ J Med Case Rep. 2021 May 25;15(1):300. (IF=0,88). Medical (miscellaneaous) (Q3).
Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI, Esbensen BA, Ferreira RJO, Fragoulis GE, Holmes P, McBain H, Metsios GS, Moe RH, Stamm TA, de Thurah A, Zabalan C, Carmona L, Bosworth A. (2021). “2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. “ Ann Rheum Dis. 2021 Oct;80(10):1278-1285. (IF=27,97). Rheumatolgy (Q1).
O’Jeanson A, Larcher R, Le Souder C, Djebli N, Khier S (2021). “Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation. “ .Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):695-705. (IF=2,57). Pharmacology and Pharmacy (Q3).
Palasset TL, Chaumais MC, Weatherald J, Savale L, Jaïs X, Price LC, Khouri C, Bulifon S, Seferian A, Jevnikar M, Boucly A, Manaud G, Pancic S, Chabanne C, Ahmad K, Volpato M, Favrolt N, Guillaumot A, Horeau-Langlard D, Prévot G, Fesler P, Bertoletti L, Reynaud-Gaubert M, Lamblin N, Launay D, Simonneau G, Sitbon O, Perros F, Humbert M, Montani D (2021). “Association between Leflunomide and Pulmonary Hypertension. “ Ann Am Thorac Soc. 2021 Aug;18(8):1306-1315. (IF=8,78). Respiratory System (Q1).
Pezel T, Audureau E, Mansourati J, Baudry G, Ben Driss A, Durup F, Fertin M, Godreuil C, Jeanneteau J, Kloeckner M, Koukoui F, Kesri-Tartière L, Laperche T, Roubille F, Cohen-Solal A, Damy T (2021). “Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group. “ ESC Heart Fail. 2021 Apr;8(2):1509-1521. (IF=3,61). Cardiac and Cardiovascular Systems (Q1).
Pommier V, Bredy C, Abassi H, Huguet H, Picot MC, Pierard S, Pasquet A, Iriart X, Thambo JB, Amedro P. (2021). ”Reliability of echocardiographic parameters of the systemic right ventricle systolic function: A prospective multicentre study” International Journal of Cardiology Congenital Heart Disease Volume 4, August 2021, 100139 (IF=2,24).Cardiac and Cardiovascular ystems (Q2).
Porcher R, Desguerre I, Amthor H, Chabrol B, Audic F, Rivier F, Isapof A, Tiffreau V, Campana-Salort E, Leturcq F, Tuffery-Giraud S, Ben Yaou R, Annane D, Amédro P, Barnerias C, Bécane HM, Béhin A, Bonnet D, Bassez G, Cossée M, de La Villéon G, Delcourte C, Fayssoil A, Fontaine B, Godart F, Guillaumont S, Jaillette E, Laforêt P, Leonard-Louis S, Lofaso F, Mayer M, Morales RJ, Meune C, Orlikowski D, Ovaert C, Prigent H, Saadi M, Sochala M, Tard C, Vaksmann G, Walther-Louvier U, Eymard B, Stojkovic T, Ravaud P, Duboc D, Wahbi K. (2021). “Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data. . “ Eur Heart J. 2021 May 21;42(20):1976-1984.. (IF=35,85). Cardiac ad Cardiovascular Systems (Q1).
Rioufol G, Dérimay F, Roubille F, Perret T, Motreff P, Angoulvant D, Cottin Y, Meunier L, Cetran L, Cayla G, Harbaoui B, Wiedemann JY, Van Belle É, Pouillot C, Noirclerc N, Morelle JF, Soto FX, Caussin C, Bertrand B, Lefèvre T, Dupouy P, Lesault PF, Albert F, Barthelemy O, Koning R, Leborgne L, Barnay P, Chapon P, Armero S, Lafont A, Piot C, Amaz C, Vaz B, Benyahya L, Varillon Y, Ovize M, Mewton N, Finet G; FUTURE Trial Investigators (2021). “Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease. “ . J Am Coll Cardiol. 2021 Nov 9;78(19):1875-1885. (IF=27,20). Cardiac and Cardiovascular Systems (Q1).
Rouhana S, Virsolvy A, Fares N, Richard S, Thireau J. (2021). “Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. “ Pharmaceuticals (Basel). 2021 Dec 25;15(1):31. (IF=5,21). Pharmacology and Pharmacy (Q1) ; Chemistry, Medicinal (Q1).
Roubille C, Coffy A, Rincheval N, Dougados M, Flipo RM, Daurès JP, Combe B. (2021). “Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early Rheumatoid Arthritis. “ Rheumatology (Oxford). 2021 Aug 2;60(8):3738-3746.. (IF=7,05). Rheumatology (Q1)
Roubille C, Coste J, Sellam J, Rat AC, Guillemin F, Roux CH (2021). “ Association of Baseline Cardiovascular Diseases with 5-Year Knee and Hip Osteoarthritis Progression in Non-Obese Patients: Data from the KHOALA Cohort. “ .J Clin Med. 2021 Jul 29;10(15):3353. (IF=4,96). Medicine, General and Internal (Q1).
Roubille C, Ribstein J, Hurpin G, Fesler P, Fiat E, Roubille F. (2021)” Confidence vanished or impaired until distrust in the doctor-patient relationship because of COVID-19: Confidence vanished or impaired until distrust: « COVID » in relationship. ”La Revue de médecine interne 2021 Jan;42(1):58-60.. (IF=0,88). Medicine General and Internal (Q4).
Roubille F, Lamblin N. (2021); “A New Requirement for Publication: Access to Effective Drugs for Ethical Reasons, The Example of Heart Failure. “ ESC Heart Fail. 2021 Apr;8(2):799-801. (IF=3,61). Cardiac and Cardiovascular Systems (Q2).
Rubenstein E, Larcher R, Altwegg R, Pers YM (2021). ”Exceptional Paraspinal Localization of Myositis in a Patient With Crohn Disease Under Tumor Necrosis Factor α Inhibitor Treatment: A Case Report”. J Clin Rheumatol. 2021 Oct 1;27(7):e291-e292 (IF=3,90). Rheumatology (Q3).
Ryckebusch F, Peterschmitt M, Granier M, Sauvion N.(2021). “Alfalfa leaf curl virus is efficiently acquired by its aphid vector Aphis craccivora but inefficiently transmitted. “ J Gen Virol. 2021 Feb;102(2). (IF= 5,14). Biotechnology and Applied Microbiology (Q2) ; Virology (Q2).
Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Grégoire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, Dubé MP, Provencher M, Orfanos A, Blondeau L, Kouz S, L’Allier PL, Ibrahim R, Bouabdallaoui N, Mitchell D, Guertin MC, Lelorier J (2021). “Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). “ Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):486-495. (IF=7,06). Envinronmental and Occupationnal Health (Q1).
Sauer F, Jesel L, Marchandot B, Derimay F, Bochaton T, Amaz C, Roubille F, Cayla G, Rioufol G, Garcia-Dorado D, Claeys M, Angoulvant D, Bonnefoy-Cudraz E, Guérin P, Trinh A, Matsushita K, Ohlmann P, Jossan C, Mewton N, Ovize M, Morel O. (2021). “Life-threatening arrhythmias in anterior ST-segment elevation myocardial infarction patients treated by percutaneous coronary intervention: adverse impact of morphine. “ Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):427-436. (IF=4,77). Cardiac and Cardiovascular Systems (Q2).
Schaaf M, Croisille P, Py A, Roubille F, Biere L, Bochaton T, Perret T, Belle L, De Poli F, Hovasse T, Lairez O, Boussaha I, Rioufol G, Prunier F, Ovize M, Mewton N. (2021). “Non-culprit artery myocardial infarction and complex coronary lesions in anterior ST-elevated myocardial infarction patients. “ Cardiology. 2021;146(6):728-736. (IF=2,34). Cardiac and Cardiovascular Systems (Q4).
Sleiman Y, Lacampagne A, Meli AC (2021). « Ryanopathies » and RyR2 dysfunctions: can we further decipher them using in vitro human disease models? ” .Cell Death Dis. 2021 Nov 1;12(11):1041. (IF=12,08). Cell Biology (Q1).
Sentenac P, Samarani G, Bideaux P, Sicard P, Bourdois B, Richard S, Colson PH, Eddahibi S. (2021). “Pulmonary hypertension after pneumonectomy: a preclinical model in rats and human pulmonary endothelial cells. “ Eur J Cardiothorac Surg. 2021 Jan 4;59(1):147-154. (IF= 4,53). Cardiac and Cardiovascular Systems (Q2); Respiratory Sytems (Q2) ; Surgery (Q1).
Socchi F, Bigorre M, Normandin M, Captier G, Bessis D, Mondain M, Blanchet C, Akkari M, Amedro P, Gavotto A (2021). ” Hemangiol® in infantile haemangioma: A paediatric post-marketing surveillance drug study. ” Br J Clin Pharmacol. 2021 Apr;87(4):1970-1980 (IF=3,72). Pharmacy and Pharmacology (Q2).
Souidi M, Sleiman Y, Acimovic I, Pribyl J, Charrabi A, Baecker V, Scheuermann V, Pesl M, Jelinkova S, Skladal P, Dvorak P, Lacampagne A, Rotrekl V, Meli AC. (2021). ”Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids. ” Int J Mol Sci. 2021 Jan 11;22(2):E662. (IF=6,21). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary (Q2).
Svobodova B, Jelinkova S, Pesl M, Beckerová D, Lacampagne A, Meli AC, Rotrekl V (2021). “Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling. “ Pflugers Arch. 2021 Jul;473(7):1099-1115. (IF=4,46). Physiology (Q2).
Valdeyron C, Soubrier M, Pereira B, Constantin A, Morel J, Gaudin P, Combe B, Gremeau AS, Dejou-Bouillet L, Pouly JL, Sapin V, Oris C, Brugnon F (2021). “Impact of disease activity and treatments on ovarian reserve in patients with rheumatoid arthritis in the ESPOIR cohort. “ Rheumatology (Oxford). 2021 Apr 6;60(4):1863-1870. (IF=7,05). Rheumatology (Q1)
Werner O, Bredy C, Lavastre K, Guillaumont S, De La Villeon G, Vincenti M, Gerl C, Dulac Y, Souletie N, Acar P, Pages L, Picot MC, Bourrel G, Oude Engberink A, Million E, Abassi H, Amedro P. (2021). ” Impact of a transition education program on health-related quality of life in pediatric patients with congenital heart disease: study design for a randomised controlled trial. ” Health Qual Life Outcomes. 2021 Jan 19;19(1):23. (IF=3,10). Health Policy and Services (Q2).
Xu T, Yehya M, Singh A, Gil T, Bideaux P, Thireau J, Lacampagne A, Charlot B, Todri-Sanial A ;(2021). “Dedicated Wearable Sensitive Strain Sensor, based on Carbon Nanotubes, for Monitoring the Rat Respiration Rate “ Eng. Proc. 2021, 3, , sous presse. (IF= en attente).
Abassi H, Bajolle F, Werner O, Auer A, Marquina A, Mura T, Lavastre K, Guillaumont S, Manna F, Auquier P, Bonnet D, Amedro P. (2020).. “ Health-related quality of life correlates with time in therapeutic range in children on anticoagulants with International Normalised Ratio self-monitoring. ” Arch Cardiovasc Dis. 2020 Nov 12;18(1):366. (IF=2,34). Cardiac ad Cardiovascular Systems (Q2).
Abassi H, Huguet H, Picot MC, Vincenti M, Guillaumont S, Auer A, Werner O, De La Villeon G, Lavastre K, Gavotto A, Auquier P, Amedro P. (2020). “Health-related quality of life in children with congenital heart disease aged 5 to 7 years: a multicentre controlled cross-sectional study. “ Health Qual Life Outcomes. 2020 Nov 12;18(1):366. (IF=3,19). Health Policy and Services (Q2).
Akodad M, Delmas C, Bonello L, Duflos C, Roubille F. (2020). “Intra-aortic balloon pump: is the technique really outdated? “ ESC Heart Fail. 202020 Jun;7(3):1025-1030.. (IF= 4,41). Cardiac ad Cardiovascular Systems (Q2).
Akodad M, Sicard P, Fauconnier J, Roubille F (2020). ”Colchicine and myocardial infarction: A review. ” Arch Cardiovasc Dis. 2020 Oct;113(10):652-659. (IF=2,34). Cardiac ad Cardiovascular Systems (Q2)
Akodad M, Roubille F, Marin G, Lattuca B, Macia JC, Delseny D, Gandet T, Robert P, Schmutz L, Piot C, Maupas E, Robert G, Targosz F, Albat B, Cayla G, Leclercq F. (2020). Myocardial Injury After Balloon Predilatation Versus Direct Transcatheter Aortic Valve Replacement: Insights From the DIRECTAVI Trial. J Am Heart Assoc. 2020 Dec 10:e018405. (IF=5,50). Cardiac and Cardiovascular Systems (Q1).
Alunno A, Nikiphorou E, Philippou E, Daien C, Wiek D, Kouloumas M, Cutolo M (2020). «Nutrition in RMDs: is it really food for thought? Focus on rheumatoid arthritis. BMC Rheumatol. 2020 Mar 10;4:10. (IF=1,47). Rheumatology (Q3).
Amalric M, Larcher R, Brunot V, Garnier F, De Jong A, Moulaire Rigollet V, Corne P, Klouche K, Jung B. (2020). “Impact of Videolaryngoscopy Expertise on First-Attempt Intubation Success in Critically Ill Patients. “ Crit Care Med. 2020 Oct;48(10):e889-e896. (IF= 7,60). Critical Care Medicine (Q1).
Amedro P, Gavotto A, Abassi H, Picot MC, Matecki S, Malekzadeh-Milani S, Levy M, Ladouceur M, Ovaert C, Aldebert P, Thambo JB, Fraisse A, Humbert M, Cohen S, Baruteau AE, Karsenty C, Bonnet D, Hascoet S and on behalf of the SV-INHIBITION study investigators. (2020). “Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV-INHIBITION study design “ESC Heart Fail 2020 Apr;7(2):747-756. (IF= 4,41). Cardiac and Cardiovascular systems (Q2).
Audurier Y, Chapet N, Renaudin P, Bons C, Mathieu B, Theret S, de Barry G, Jalabert A, Breuker C, Leclercq F, Pasquie JL, Agullo A, Roubille F, Castet-Nicolas A (2020). ”Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients? ” Int J Clin Pract. 2020 Sep;74(9):e13531. (IF=2,50). Medicine General and Internal (Q2) .
Baudot M, Torre E, Bidaud I, Louradour J, Torrente AG, Fossier L, Talssi L, Nargeot J, Barrère-Lemaire S, Mesirca P, Mangoni ME (2020). «Concomitant genetic ablation of L-type Cav1.3 (α1D) and T-type Cav3.1 (α1G) Ca2+ channels disrupts heart automaticity. . Sci Rep. 2020 Nov 3;10(1):18906. (IF=4,38). Multidisciplinary Sciences (Q1).
Bonello L, Delmas C, Gaubert M, Schurtz G, Ouattara A, Roubille F (2020). ”Trials of mechanical circulatory support with percutaneous axial flow pumps in cardiogenic shock complicating acute myocardial infarction: Mission impossible? ” . Arch Cardiovasc Dis. Jun-Jul 2020;113(6-7):448-460. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).
Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GGS, Blondeau L, Orfanos A, Ibrahim R, Grégoire JC, Dube´MP, Samuel M, Morel O, Lim P, Bertrand OF, Kouz S, Guertin MC, L’Allier PL, and Roubille F. (2020). “Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). “European Heart Journal (2020 Nov 7;41(42):4092-4099. (IF=29,98) Cardiac and Cardiovascular Systems (Q1)
Boulghobra D, Grillet PE, Mickaël L, Mathieu T, Fauconnier J, Fança-Berthon P, Reboul C, Cazorla O (2020).“ Sinapine, but not sinapic acid, counteracts mitochondrial oxidative stress in cardiomyocytes. “- Redox Biology, Volume 34, July 2020, 101554 IF=11,80). Biochemistry and Molecular Biology (Q1).
Bughin F, Desplan M, Mestejanot C, Picot MC, Roubille F, Jaffuel D, Mercier J, Jaussent I, Dauvilliers Y. (2020). “Effects of an individualized exercise training program on severity markers of obstructive sleep apnea syndrome: a randomised controlled trial. “ Sleep Med. 2020 Feb 18;70:33-42. (IF=3,49). Clinical Neurology (Q2).
Calderon J, Wypij D, Rofeberg V, Stopp C, Roseman A, Albers D, Newburger JW, Bellinger DC. (2020). “Randomized Controlled Trial of Working Memory Intervention in Congenital Heart Disease. “ J Pediatr. 2020 Dec;227:191-198.e3. (IF=4,41). Domaine de Recherche: ” Pediatrics” (10/128, Q1).
Catteau M, Gouzi F, Blervaque L, Passerieux E, Blaquière M, Ayoub B, Bughin F, Mercier J, Hayot M, Pomiès P (2020). ”Effects of a human microenvironment on the differentiation of human myoblasts. ” Biochem Biophys Res Commun. 2020 May 14;525(4):968-973. (IF=3,57). Biochemistry and Molecular Biology (Q3); Biophysics (Q2).
Cautela J, Tartiere JM, Cohen-Solal A, Bellemain-Appaix A, Theron A, Tibi T, Januzzi JL Jr, Roubille F, Girerd N. (2020). ”Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients. ”Eur J Heart Fail. 2020 Aug;22(8):1357-1365. (IF=15,53). Cardiac and Cardiovascular Systems (Q2).
Chadet S, Ternant D, Roubille F, Bejan-Angoulvant T, Prunier F, Mewton N, Paintaud G, Ovize M, Dupuy AM, Angoulvant D, Ivanes F. (2020). “Kinetic modelling of myocardial necrosis biomarkers offers an easier, reliable and more acceptable assessment of infarct size. “ Sci Rep. 2020 Aug 12;10(1):13597. (IF=4,38). Multidisciplinary Sciences (Q1).
Chakouri N, Farah C, Matecki S, Amedro P, Vincenti M, Saumet L, Vergely L, Sirvent N, Lacampagne A, Cazorla O. (2020). “Screening for in-vivo regional contractile defaults to predict the delayed Doxorubicin Cardiotoxicity in Juvenile Rat. “ Theranostics. 2020 Jul 9;10(18):8130-8142. (IF=11,56). Medicine, Research and Experimental (Q1).
Cinotti R, Besnard N, Desmedi L, Floch R, Perrot P, Bekara F, Klouche K, Larcher R, Mahé PJ, Frasca D, Asehnoune K, Jung B, Roquilly A. (2020). “Feasibility and impact of the implementation of a clinical scale-based sedation-analgesia protocol in severe burn patients undergoing mechanical ventilation. A before-after bi-center study“ Burns 2020 Sep;46(6):1310-1317. (IF= 2,74). Critical Care Medicine (Q3) ; Dermatology (Q2) ; Surgery (Q2).
Claeys MJ, Roubille F, Casella G, Zukermann R, Nikolaou N, De Luca L, Gierlotkaa M, Iakobishvili Z, Thiele H, Koutouzis M, Sionis A, Monteiro S, Beauloye C, Held C, Tint D, Zakke I, Serpytis P, Babic Z, Belohlavev J, Magdy A, Sivagowry Rasalingam M, Daly K, Arroyo D, Vavlukis M, Radovanovic N, Trendafilova E, Marandi T, Hassenger C, Lettino M, Price S, Bonnefoy E. (2020). “Organization of intensive cardiac care units in Europe: Results of a multinational survey. Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):993-1001. (IF=4,70).. Cardiac ad Cardiovascular Systems (Q2).
Claustre J, Larcher R, Jouve T, Truche AS, Nseir S, Cadiet J, Zerbib Y, Lautrette A, Constantin JM, Charles PE, Daubin C, Coudroy R, Dellamonica J, Argaud L, Phelouzat P, Contou D, Pocquet J, Voiriot G, Navellou JC, Lavagne P, Durand M, Cornet M, Schwebel C, Terzi N. (2020). “Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. “ Ann Intensive Care. 2020 Jun 8;10(1):74. (IF=6,92). Critical Care Medicine (Q1).
Couderc M, Pereira B, Schaeverbeke T, Thomas T, Chapurlat R, Gaudin P, Morel J, Dougados M, Soubrier M. (2020). “GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis. “ BMJ Open. 2020 Nov 20;10(11):e038715. (IF=2,69). Medicine General and Internal (Q2).
Dadouch M , Ladner Y , Bich C , Larroque M , Larroque C , Morel J , Bonnet PA , Perrin C. (2020). “An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis. “ Analyst. 2020 Mar 7;145(5):1759-1767. (IF=4,62). Chemistry, Analytical (Q1).
Dahiya, A. S., Gil, T., Thireau, J., Azemard, N., Lacampagne, A., Charlot, B., Todri‐Sanial (2020). “1D Nanomaterial‐Based Highly Stretchable Strain Sensors for Human Movement Monitoring and Human–Robotic Interactive Systems. “ Adv. Electron. Mater. 2020, vol 6 issue 10 (IF=7,29). Nanoscience and Nanotechnology (Q2) ; Materials Science Multidisciplinary (Q1) ; Physics Applied (Q1).
Dahiya AS, Gil T, Azemard N, Thireau J, Lacampagne A, Todri-Sanial A, Chariot B. (2020)- “Stretchable Strain Sensors for Human Movement Monitoring“2020 Symposium on Design, Test, Integration & Packaging of MEMS and MOEMS (DTIP), Lyon, France, 2020, pp. 1-4,
Dahiya A-S, Thireau J, Boudaden J, Lal S, Gulzar U, Zhang Y, Gil T, Azemard N, Ramm P, Kiessling T, O’Murchu C, Sebelius F, Tilly J, Glynn C, Geary S, O’Dwyer C, Razeeb K-M, Lacampagne A, Charlot B, and Todri-Sanial A. (2020). “Energy Autonomous Wearable Sensors for Smart Healthcare: A Review“ Journal of The Electrochemical Society, 2020 167 037516 (IF=4,32). Electrochemistry(Q2) ; Materials Science, Coating and Films (Q1).
Danchin N, Popovic B, Puymirat E, Goldstein P, Belle L, Cayla G, Roubille F, Lemesle G, Ferrières J, Schiele F, Simon T; FAST-MI Investigators. (2020). “Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme. “ Eur Heart J. 2020, 41 (7), 858-866 (IF=29,98). Cardiac ad Cardiovascular Systems (Q1).
Delmas C, Aissaoui N, Meneveau N, Bouvaist H, Rousseau H, Puymirat E, Sapoval M, Flecher E, Meyer G, Sanchez O, Del Giudice C, Roubille F, Bonello L. (2020). “Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: A position paper from the « Unité de Soins Intensifs de Cardiologie » group of the French Society of Cardiology. “Arch Cardiovasc Dis. 2020 Nov;113(11):749-759. (IF=2,34). Cardiac ad Cardiovascular Systems (Q2).
Dupuy AM, Bargnoux AS, Larcher R, Merindol A, Masetto T, Badiou S, Cristol JP. (2020). “Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin. “Diagnostics (Basel). 2020 Jul 7;10(7):E461.(IF=3,71). Medicine General and Internal (Q1).
Dupuy AM, Bargnoux AS, Roubille F, Cristol JP. (2020). “Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title « Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome ». “ Clin Chem Lab Med. 2020 Aug 3;59(4):e125-e127. (IF=3,69). Medical Laboratory Technology (Q1).
Dridi H, Yehya M, Barsotti R, Reiken S, Angebault C, Jung B, Jaber S, Marks AR, Lacampagne A, Matecki S. (2020). “Mitochondrial oxidative stress induces leaky ryanodine receptor during mechanical ventilation. “ Free Radic Biol Med. 2020 Jan;146:383-391 (IF=7,38). Biochemistry and Molecular Biology (Q1) ; Endocrinology and Metabolism (Q1).
Dridi H, Liu X, Yuan Q, Reiken S, Yehya M, Sittenfeld LR, Apostolou P, Buron J, Sicard P, Matecki S, Thireau J, Menuet C, Lacampagne A, Marks AR (2020). “Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington’s disease. “ JCI Insight. 2020 Oct 2;5(19):140614. (IF=8,31). Medicine, Research and Experimental (Q1) .
Dridi H, Jung B, Yehya M, Daurat A, Reiken S, Moreau J, Marks AR, Matecki S, Lacampagne A, Jaber S. (2020). “Late Ventilator-Induced Diaphragmatic Dysfunction After Extubation. “Crit Care Med. 2020 Dec;48(12):e1300-e1305. (IF=7,60). Critical Care Medicine (Q1).
Duflos C, Roubille C, Roubille F (2020). “By half decrease of cardiovascular mortality in a Western country between 2000 and 2015: A contrasted picture advocating for a better management of comorbidities. “ Int J Cardiol. 2020 Nov 1;318:145-146. (IF=4,16). Critical Care Medicine (Q3).
Dupuy AM, Bargnoux AS, Roubille F, Cristol JP . (2020). “Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title « Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome ». “ Clin Chem Lab Med. 2020 Aug 1sous presse. (IF=3,69). Medical Laboratory Technology (Q1).
Ebstein E, Forien M, Norkuviene E, Richette P, Mouterde G, Daien C, Ea HK, Brière C, Lioté F, Petraitis M, Bardin T, Ora J, Dieudé P, Ottaviani S. (2020). «UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis. Joint Bone Spine. 2020 Dec;87(6):647-651. (IF=4,93). Rheumatology (Q2).
Eiden C, Pinzani V, Laureau M, Chapet N, Beringer J, Roubille F, Sebbane M, Peyrière H. (2020). ”Clomiphene misuse and risk of severe cardiovascular events. ” Eur J Clin Pharmacol. 2020 Jun;76(6):901-902. (IF=2,95). Pharmacology and Pharmacy ( Q2).
Elayi CS, Erath-Honold JW, Jabbari R, Roubille F, Silvain J, Barra S, Providencia R, Njein M, Narayanan K, Deharo JC, Defaye P, Boveda S, Leclercq C, Marijon E. (2020). ”Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease . ” Europace 2020 Oct 1;22(10):1600. (IF=5,21). Cardiac and Cardiovascular Systems (Q1).
Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. (2020). “Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial. “ Ann Rheum Dis. 2020 Nov 18sous presse. (IF=19,10). Rheumatolgy (Q1).
Flattres A, Aarab Y, Nougaret S, Garnier F, Larcher R, Amalric M, Klouche K, Etienne P, Subra G, Jaber S, Molinari N, Matecki S, Jung B. (2020). “Real-time shear wave ultrasound elastography: a new tool for the evaluation of diaphragm and limb muscle stiffness in critically ill patients. “ Crit Care. 2020 Feb 3;24(1):34.(IF=9,10). Cardiac and Cardiovascular Systems (Q1).
Galinier M, Roubille F, Berdague P, Brierre G, Cantie P, Dary P, Ferradou JM, Fondard O, Labarre JP, Mansourati J, Picard F, Ricci JE, Salvat M, Tartière L, Ruidavets JB, Bongard V, Delval C, Lancman G, Pasche H, Ramirez-Gil JF, Pathak A; (2020). “Telemonitoring versus standard of care in heart failure: a randomised multicentre trial. “ OSICAT Investigators. Eur J Heart Fail. 2020 Jun;22(6):985-994. (IF=15,53). Cardiac and Cardiovascular Systems (Q1).
Garnier F, Daubin D, Larcher R, Bargnoux AS, Platon L, Brunot V, Aarab Y, Besnard N, Dupuy AM, Jung B, Cristol JP, Klouche K. (2020). “Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index. “Crit Care Med. 2020 Apr;48(4):e277-e284.. (IF=7,60). Critical Care Medicine (Q1).
Gavotto A, Huguet H, Picot MC, Guillaumont S, Matecki S, Amedro P. (2020). “The VE/VCO2 slope: a useful tool to evaluate the physiological status of children with congenital heart disease. “ J Appl Physiol (1985). 2020 Nov 1;129(5):1102-1110. (IF=3,53). Critical Care Medicine (Q1).
Gavotto A, Gauthier A, Werner O (2020). “Cardiac abnormality in a prechemotherapy assessment for leukaemia in a 14-year-old girl. “ Heart. 2020 Sep;106(18):1406-1450. (IF=5,99). Cardiac ad Cardiovascular Systems (Q1)
Gavotto A, Werner O, Amedro P. (2020). “Late infective endocarditis after transcatheter tricuspid valve-in-valve implantation: A pediatric case report. “Arch Pediatr. Feb;27(2):107-109. (IF=0,59). Pediatrics (Q4).
Gavotto A , Thomas F, Werner O, Moreau J, Amedro P (2020). ” Use of treprostinil in pediatric pulmonary hypertension: case reports and review of the literature ” . J Cardiovasc Pharmacol 2020 Jul;76(1):23-31. (IF=2,46). Cardiac and Cardiovascular Systems (Q3); Pharmacology and Pharmacy (Q3).
Gavotto A, Vandenberghe D, Abassi H, Huguet H, Macioce V, Picot MC, Guillaumont S, Matecki S, Amedro P. (2020). “Oxygen uptake efficiency slope: a reliable surrogate parameter for exercise capacity in healthy and cardiac children? “ Arch Dis Child. 2020 Dec;105(12):1167-1174. (IF=3,79). Pediatrics (Q1).
Gerges C, Gerges M, Friewald R, Fesler P, Dorfmüller P, Sharma S, Karlocai K, Skoro-Sajer N, Jakowitsch J, Moser B, Taghavi S, Klepetko W, Lang IM. (2020); “Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment. “Circulation. 2020 Feb 4;141(5):376-386. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1) ; Peripheral Vascular disease (Q1).
Ghaleh B, Thireau J, Cazorla O, Soleti R, Scheuermann V, Bizé A, Sambin L, Roubille F, Andriantsitohaina R, Martinez M-C, Lacampagne A (2020). ” Cardioprotective effect of sonic hedgehog ligand in pig models of ischemia reperfusion. ” Theranostics 2020; 10(9): 4006-4016. (IF=11,56). Medicine, Research and Experimental (Q1).
Goulabchand R, Hafidi A, Van de Perre P, Millet I, Maria ATJ, Morel J, Quellec AL, Perrochia H, Guilpain P. (2020). “Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players. “ J Clin Med. 2020 Mar 30;9(4):958. (IF=4,24). Medicine, General and Internal (Q1).
Hamm CW, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Bergland J, Piot C, Roubille F, Schult I, Allocco DJ, Nef H. (2020). “Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study. “ EuroIntervention. 2020 Jul 17;16(4):e328-e334. (IF=6,53). Cardiac and cCardiovascular Systems (Q2).
Huet F, Dupuy AM, Cristol JP, Roubille F. (2020). “Absolute Change in High Sensitivity Cardiac Troponin I for Three Hours is Useful for Diagnosing Acute Myocardial Infarction in the Emergency Department: How to Get to Best Benefit From HS-Troponins in Clinical Practice? “ Ann Lab Med. 2020 Nov;40(6):488-489. (IF=3,46). Medical Laboratory Technology (Q2).
Huet F, Prieur C, Schurtz G, Gerbaud E, Manzo-Silberman S, Vanzetto G, Elbaz M, Tea V, Mercier G, Lattuca B, Duflos C, Roubille F. (2020). “Acute cardiovascular diseases may be less likely to be considered because of the COVID-19 pandemic-our duty is first to alert, then to analyse more deeply: Response to a letter entitled « Severity of cardiovascular diseases during the COVID-19 pandemic » from T. Imamura. “ Arch Cardiovasc Dis. Jun-Jul 2020;113(6-7):486-487. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).
Huet F, Fauconnier J, Legall M, Sicard P, Lozza C, Lacampagne A, Roubille F. (2020). “Low-dose colchicine prevents sympathetic denervation after myocardial ischemia-reperfusion: a new potential protective mechanism. “ Future Sci OA. 2020 Nov 23;7(2):FSO656. (IF=2,18). Biotechnology (Q3) ; Medicine (Miscellaneous) (Q3).
Huet F, Nicoleau J, Dupuy AM, Curinier C, Breuker C, Castet-Nicolas A, Lotierzo M, Kalmanovich E, Zekowski L, Akodad M, Adda J, Agullo A, Leclercq F, Pasquié JL, Battistella P, Roubille C, Fesler P, Mercier G, Bourel G, Cristol JP, Roubille F. (2020).”STADE-HF (sST2 As a help for management of HF): a pilot study ” ESC Heart Fail 2020 Apr;7(2):774-778 (IF=4,41). Cardiac and Cardiovascular Systems (Q2).
Huet F, Prieur C, Schurtz G, Gerbaud E, Manzo-Silberman S, Vanzetto G, Elbaz M, Tea V, Mercier G, Lattuca B, Duflos C, Roubille F. (2020). “One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic. “ Arch Cardiovasc Dis. 2020 May;113(5):303-307. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).
Ichkova A, Rodriguez-Grande B, Zub E, Saudi A, Fournier ML, Aussudre J, Sicard P, Obenaus A, Marchi N, Badaut J. (2020). “Early cerebrovascular and long-term neurological modifications ensue following juvenile mild traumatic brain injury in male mice. “ Neurobiol Dis. 2020 Jul;141:104952. (IF=6,00). Neurosciences (Q1).
Jelinkova S, Vilotic A, Pribyl J, Aimond F, Salykin A, Acimovic I, Pesl M, Caluori G, Klimovic S, Urban T, Dobrovolna H, Soska V, Skladal P, Lacampagne A, Dvorak P, Meli AC, Rotrekl V. (2020).”DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology. .” Front Bioeng Biotechnol. 2020 Jun 19;8:535. (IF=5,89). Multidisciplinary Sciences (Q2).
Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F, Zemour G, Delarche N, Harbaoui B, Schampaert E, Kouz S, Cayla G, Roubille F, Boueri Z, Mansour S, Marcaggi X, Tardif JC, McGillion M, Tanguay JF, Brophy J, Yu CW, Berry C, Carrick D, Høfsten DE, Engstrøm T, Kober L, Kelbæk H, Belle L. (2020). ” Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial. ” Can J Cardiol. 2020 Nov;36(11):1805-1814. (IF=5,22). Cardiac and Cardiovascular Systems (Q1).
Kalmanovich E, Roubille F, Castet-Nicolas A. (2020). “Response to ‘Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial’. “ Eur J Heart Fail. 2020 Mar;22(3):565. (IF=15,53). Cardiac and Cardiovascular Systems (Q1).
Khoury G, Morel J, Combe B, Lukas C (2020). “Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort. “ Arthritis Res Ther. 2020 Apr 26;22(1):94. (IF=4,10). Rheumatology (Q1)
Kollen L, Werner O, Gavotto A (2020) « Uncommon Cause of Chest Pain in a 9-Year-Old Boy with Crohn’s Disease. Gastroenterology. 2020 Jun;158(8):2055-2057.. (IF=22,68). Gastroenterology and Hepatology (Q1).
Kucharczak F, Suau M, Strauss O, Ben Bouallègue F, Mariano-Goulart D (2020). ” Brain 18F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer’s disease diagnosis. ” Ann Nucl Med. 2020 Aug;34(8):565-574.(IF=2,67). Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2)
Kumar ST, Jagannath S, Francois C, Vanderstichele H, Stoops E, Lashuel HA. (2020). “.How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology. “. Neurobiol Dis. 2020 Dec;146:105086. (IF=6,00. Domaine de Recherche: ” Neurosciences ” (48/271, Q1).
Kuster N, Huet F, Dupuy AM, Akodad M, Battistella P, Agullo A, Leclercq F, Kalmanovich E, Meilhac A, Aguilhon S, Cristol JP, Roubille F (2020), “Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure. “ ESC Heart Fail. 2020 Jul 10;7(5):2230-2239.(IF=4,41). Cardiac and Cardiovascular Systems (Q2).
Lambert K, Gondeau C, Briolotti P, Scheuermann V, Daujat-Chavanieu M, Aimond F (2020). “Biocompatible modified water as a non-pharmaceutical approach to prevent metabolic syndrome features in obesogenic diet-fed mice“ Food and Chemical Toxicology Volume 141, July 2020, 111403. (IF=6,02). Food Science and Technology (Q1) ; Toxicology (Q1).
Larcher R, Pineton de Chambrun M, Garnier F, Rubenstein E, Carr J, Charbit J, Chalard K, Mourad M, Amalric M, Platon L, Brunot V, Amoura Z, Jaber S, Jung B, Luyt CE, Klouche K. (2020). “One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study. “ Chest. 2020 Sep;158(3):1017-1026 (IF=9,41). Critical Care Medicine (Q1) ; Respiratory System (Q1).
Lavilledieu D, Abassi H, Mercier G, Guiraud M, Chaffaut GD, Milesi C, Cambonie G, Gavotto A, Jeziorski E, Amedro P. (2020). “Implementation of an organizational infrastructure paediatric plan adapted to bronchiolitis epidemics. “Journal of Infection and Public Health 2020 Feb;13(2):167-172. (IF=3,72). Public, Environnemental and Occupational Health (Q2) ; Infectious Diseases (Q3).
Leclercq F, Robert P, Akodad M, Macia JC, Gandet T, Delseny D, Chettouh M, Schumtz L, Robert G, Levy G, Targosz F, Maupas E, Roubille F, Marin G, Nagot N, Albat B, Lattuca B, Caylac G (2020). ” Prior Balloon Valvuloplasty Versus Direct Transcatheter Aortic Valve Replacement: Results From the DIRECTAVI Trial ” JACC Cardiovasc Interv 2020. 13 (5), 594-602 (IF=11,19). Cardiac and Cardiovascular Systems (Q1).
Leclercq F, Lonjon C, Marin G, Akodad M, Roubille F, Macia JC, Cornillet L, Gervasoni R, Schmutz L, Ledermann B, Colson P, Cayla G, Lattuca B (2020). “Post resuscitation electrocardiogram for coronary angiography indication after out-of-hospital cardiac arrest. “ Int J Cardiol. 2020 Mar 19:S0167-5273(19)36007-3. (IF=4,16). Cardiac and Cardiovascular Systems (Q2).
Letarouilly JG, Sanchez P, Nguyen Y, Sigaux J, Czernichow S, Flipo RM, Sellam J, Daïen C. (2021).”Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review. ” Nutrients. 2020 Dec 11;12(12):3800. (IF=5,72). Nutrition and Dietetics (Q1).
Leurent G, Clément Delmas C, Auffret V, Bonnefoy E, Puymirat E, Roubille F, (2020). “The 50-year-old pulmonary artery catheter: the tale of a foretold death? “ESC Heart Fail. 2020 2020 Jun;7(3):783-785. (IF= 4,41). Cardiac ad Cardiovascular Systems (Q2).
Lotierzo M, Dupuy AM, Kalmanovich E, Roubille F, Cristol JP. (2020). “sST2 as a value-added biomarker in heart failure. “ Clin Chim Acta. 2020 Feb;501:120-130 (IF=3,79). Medical Laboratory Technology (Q2).
Maïmoun L, Garnero P, Mura T, Nocca D, Lefebvre P, Philibert P, Seneque M, Gaspari L, Vauchot F, Courtet P, Sultan A, Piketty ML, Sultan C, Renard E, Guillaume S, Mariano-Goulart D. (2020). ”Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women. ” J Clin Endocrinol Metab. 2020 Apr 1;105(4). (IF=5,80). Endocrinology and Metabolism (Q1).
Maïmoun L, Mura T, Avignon A, Mariano-Goulart D, Sultan A. (2020). ”Body Composition in Individuals with Obesity According to Age and Sex: A Cross-Sectional Study. ”J Clin Med. 2020 Apr 21;9(4):E1188.(IF=4,24). Medicine, General and Internal (Q1).
Maïmoun L, Mura T, Attalin V, Dupuy AM, Cristol JP, Avignon A, Mariano-Goulart D, Sultan A. (2020). “ Modification of Muscle-Related Hormones in Women with Obesity: Potential Impact on Bone Metabolism. “. J Clin Med. 2020 Apr 17;9(4):E1150. (IF=4,24). Medicine, General and Internal (Q1).
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. (2020).”Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. ” Lancet Haematol. 2020 Jan;7(1):e18-e27 (IF=18,96). Hematology (Q1).
Margarido AS, Le Guen L, Falco A, Faure S, Chauvet N, de Santa Barbara P. (2020). “PROX1 is a specific and dynamic marker of sacral neural crest cells in the chicken intestine. “ J Comp Neurol. 2020 Apr 1;528(5):879-889. (IF=3,21). Zoology (Q1) ; Neurosciences (Q2).
Maury P, Thambo JB, Maltret A, Combes N, Hascoet S, Derval N, Ladouceur M, Acar P, Amedro P, Anselme F, Bajolle F, Basquin A, Belli E, Bordachar P, Duthoit G, Di Filippo S, Fauchier L, Gandjbakhch E, Gras D, Gronier C, Karsenty C, Klug D, Koutbi L, Lacotte J, Laurent G, Laux D, Mansourati J, Marijon E, Ovaert C, Sacher F, Sadoul N, Taieb J, Waldmann V, Warinfresse K, Defaye P, Piot O, Boveda S; Working Group of Pacing, Electrophysiology of the French Society of Cardiology, the Affiliate Group of Paediatric, Adult Congenital Cardiology of the French Society of Cardiology (2020). “Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease. “ Arch Cardiovasc Dis. Aug-Sep 2020;113(8-9):492-502. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).
Meli AC. (2020). ”Genome protection on the move. ” Cardiovasc Res. 2020 Aug 1;116(10):e109-e111. (IF=10,79). Cardiac and Cardiovascular Systems (Q1).
Meli AC, Kranias EG. (2020). “Scientists on the Spot: calcium dynamics in heart function. “Cardiovasc Res. 2020 Jun 1;116(7):e73-e74. (IF=10,79). Cardiac and Cardiovascular Systems (Q1).
Meli AC. (2020). “When immune cells are coached by intestinal microbiota. “ Cardiovasc Res. 2020 Feb 1;116(2):e21-e22. ((IF=10,79). Cardiac and Cardiovascular Systems (Q1)
Meli AC, de Tombe P. (2019). “Scientists on the spot: Myocardium and myofilaments. “ Cardiovasc Res. 2020 Jul 1;116(8):e96-e97 (IF=10,79) Cardiac and Cardiovascular Systems (Q1).
Meli AC, Seidman CE. (2020). “Scientists on the Spot: Putting a halt to hypertrophic cardiomyopathy. “ Cardiovasc Res. 2020 Mar 1;116(3):e42-e43. (IF=10,79). Cardiac and Cardiovascular Systems (Q1).
Mercier G, Arquizan C, Roubille F. (2020). ” Understanding the effects of COVID-19 on health care and systems. ” Lancet Public Health. 2020 Oct;5(10):e524. (IF=21,65). Envinronmental and Occupationnal Health (Q1).
Meszaros M, Meunier L, Morquin D, Klouche K, Fesler P, Malezieux E, Makinson A, le Moing V, Reynes J, Pageaux GP. (2020). “Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry? “ Liver Int. 2020 Aug;40(8):1860-1864.. (IF=5,54). Gastroenterology and Hepatolog (Q1).
Moreau J, Lavastre K, Romieu H, Charbonnier F, Guillaumont S, Bredy C, Abassi H, Werner O, De La Villeon G, Requirand A, Auer A, Matecki S, Karsenty C, Guitarte A, Hadeed K, Dulac Y, Soulette N, Acar P, Bajolle F, Bonnet D, Negre-Pages L, Mura T, Mounier M, Seguela PE, Thomas J, Iriart X, Thambo JB, Amedro P. (2020). “Impact of Sophrology on cardiopulmonary fitness in teenagers and young adults with a congenital heart disease: the SOPHROCARE study rationale, design and methods “IJC Heart & Vasculature, Volume 27, April 2020, 100489. (IF=4,16). Cardiology and Cardiovascular Medicine (Q3).
Morel J, Locci M, Banal F, Combe B, Cormier G, Dougados M, Flipo RM, Marcelli C, Pham T, Rist S, Solau Gervais E, Sibilia J, Lukas C (2020). “Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry. “ Clin Exp Rheumatol. 2020 May-Jun;38(3):405-410. (IF=4,47). Rheumatology (Q2)
Moreira Souza AC, Grabe-Guimaraes A, Cruz JDS, Santos-Miranda A, Farah C, Teixeira Oliveira L, Lucas A, Aimond F, Sicard P, Mosqueira VCF, Richard S. (2020). “ARTEMETHER TOXICITY MECHANISMS ON SINGLE CARDIOMYOCYTES AND PROTECTIVE EFFECT OF NANOENCAPSULATION. “ Br J Pharmacol. 2020 Jul 1;177(19):4448-4463 (IF=8,74) Pharmacology and Pharmacy (Q1).
Mouterde G, Gamon E, Rincheval N, Lukas C, Seror R, Berenbaum F, Dupuy AM, Daien C, Daurès JP, Combe B. (2020). .Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort. J Rheumatol. 2020 Nov 1;47(11):1624-1628. (IF=4,67). Rheumatology (Q2)
Najm A, Alunno A, Sivera F, Ramiro S, Haines C; Working Group on Training in Rheumatology across Europe (avec Daien C) . (2020). “Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study. “RMD Open. 2020 Jul;6(2):e001183. (IF=5,12). Immunology (Q1), Immunology and Allergy (Q1), Rheumatology (Q1)
Nguyen TN, Dubreucq E, Perrier V, Tran QH, Charpentier C, Charnay C, Terki F, Jay-Allemand C, Bidel LPR (2020). “Interactions between trans-resveratrol and CpLIP2 lipase/acyltransferase: Evidenced by fluorescence and in silico. “ Food Chem. 2020 Jul 15;318:126482. (IF=7,51). Chemistry Applied (Q1) ; Food Science and Technology (Q1) ; Nutrition and Dietetics (Q1).
Partouche L, Goulabchand R, Maria ATJ, Rivière S, Jorgensen C, Rigau V, Bourgier C, Bessis D, Le Quellec A, Quere I, Morel J, Guilpain P (2020). “Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature. “ J Clin Med. 2020 Mar 20;9(3):853. (IF=4,24). Medicine, General and Internal (Q1).
Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Luyt CE, Combes A, Amoura Z. (2020). ”In-Hospital Mortality-Associated Factors of Thrombotic Antiphospholipid Syndrome Patients Requiring Intensive Care Unit Admission. ” Chest. 2020 May;157(5):1158-1166.. (IF=9,41). Critical Care Medicine (Q1) ; Respiratory System (Q1).
Roncalli J, Roubille F, Lamblin N, Girerd N, Mouquet F, Chapet N, Roubille C, Berthelot E, Galois K, Battistella P, Jondeau G, Tartiere JM, Aguilhon S, Gueffet JP, Salvat M, Damy T, Galinier M; Heart Failure Group of the French Society of Cardiology (2021). “Coronavirus disease vaccination in heart failure: No time to waste. “ Arch Cardiovasc Dis. 2021 May 24:S1875-2136(21)00088-7 (IF=2,34). Cardiac ad Cardiovascular Systems (Q2).
Roubille C, Henriquez S, Mercuzot C, Duflos C, Dunogue B, Briot K, Guillevin L, Terrier B, Fesler P. (2021). “ Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides. “ J Clin Med. 2021 May 25;10(11):2299. (IF=4;24). Medicine, General and Internal (Q1).
Roubille F, Tardif JC (2020). ”Colchicine for Secondary Cardiovascular Prevention in Coronary Disease. ” Circulation. 2020 Nov 17;142(20):1901-1904. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).
Roubille F, Huet F, Duflos C , (2020). “Total Burden of Events: A New Standard Stressing the Positive Impact of Inflammation Modulation. “ JACC, 2020 Oct 6;76(14):1671-1673. (IF=24,09). Cardiac and Cardiovascular Systems (Q1).
Ryckebusch F, Sauvion N, Granier M, Roumagnac P, Peterschmitt M..(2020). “Alfalfa leaf curl virus is transmitted by Aphis craccivora in a highly specific circulative manner. “ Virology. 2020 Jul;546:98-108. (IF=3,62). Virology (Q3).
Sánchez-Huertas C, Bonhomme M, Falco A, Fagotto-Kaufmann C, van Haren J, Jeanneteau F, Galjart N, Debant A, Boudeau J. (2020). The +TIP Navigator-1 is an actin-microtubule crosslinker that regulates axonal growth cone motility. J Cell Biol. 2020 Sep 7;219(9): e201905199. (IF=10,54). Cell Biology (Q1).
Sanges S, Farhat MM, Assaraf M, Galland J, Rivière E, Roubille C, Lambert M, Yelnik C, Maillard H, Sobanski V, Lefèvre G, Launay D, Morell-Dubois S, Hachulla E (2020). “Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis. “. Orphanet J Rare Dis. 2020 Jun 23;15(1):159. (IF=4,12). Medicine, Research and Experimental (Q2); Genetics and Heradity (Q2).
Santin Y, Fazal L, Sainte-Marie Y, Sicard P, Maggiorani D, Tortosa F, Yücel YY, Teyssedre L, Rouquette J, Marcellin M, Vindis C, Shih JC, Lairez O, Burlet-Schiltz O, Parini A, Lezoualc’h F, Mialet-Perez J (2020). “Mitochondrial 4-HNE derived from MAO-A promotes mitoCa2+ overload in chronic postischemic cardiac remodeling. “ Cell Death Differ. 2020 Jun;27(6):1907-1923. (IF=15,83). Biochemistry and Molecular Biology (Q1) ; Cell Biology (Q1).
Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators (avec Roubille F) (2020). ”Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial. ” Lancet. 2020 Nov 28;396(10264):1737-1744. (IF=79,32). Medicine, General and Internal (Q1).
Sleiman Y, Souidi M, Kumar R, Yang E, Jaffré F, Zhou T, Bernardin A, Reiken S, Cazorla O, Kajava AV, Moreau A, Pasquié JL, Marks AR, Lerman BB, Chen S, Cheung JW, Evans T, Lacampagne A, Meli AC. (2020). “Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes. “EBioMedicine. 2020 Oct;60:103024. (IF= 8,14). Medicine Research and Experimental (Q1).
Souidi M, Amédro P, Meyer P, Desprat R, Lemaître JM, Rivier F, Lacampagne A, Meli AC (2020). ” Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). ” Stem Cell Research, 2020 Nov 19;49:102094. (IF=2,02).Biotecnology and Applied Microbiology (Q1) ; Cell and Time engenneering (Q2) ; Cell Biology (Q2).
Tartiere JM, Solal AC, Roubille F, Girerd N, Cautela (2020).”Response to the letter « All rise! Orthostatic Hypotension in Heart Failure ». ” Eur J Heart Fail. 2020 Sep;22(9):1742. (IF=15,53). Cardiac and Cardiovascular Systems (Q1).
Thom K, Lensing AWA, Nurmeev I, Bajolle F, Bonnet D, Kenet G, Massicotte MP, Karakas Z, Palumbo JS, Saracco P, Amedro P, Chain J, Chan AK, Ikeyama T, Lam JCM, Gauger C, Pap ÁF, Majumder M, Kubitza D, Smith WT, Berkowitz SD, Prins MH, Monagle P, Young G, Male C. (2020). “Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE). “ Blood Adv. 2020 Oct 13;4(19):4632-4639. (IF= 6,69). Hematology (Q1).
Trusson R, Brunot V, Larcher R, Platon L, Besnard N, Moranne O, Barbar S, Serre JE, Klouche K. (2020). “Short- and Long-Term Outcome of Chronic Dialyzed Patients Admitted to the ICU and Assessment of Prognosis Factors: Results of a 6-Year Cohort Study. “Crit Care Med. 2020 Aug;48(8):e666-e674. (IF=7,60). Critical Care Medicine (Q1).
Urbino C, Regragui ZF, Granier M, Peterschmitt M. (2020). “Fitness advantage of inter-species TYLCV recombinants induced by beneficial intra-genomic interactions rather than by specific mutations. “ Virology. 2020 Mar;542:20-27. (IF=3,62). Virology (Q3).
Varga B, Meli AC, Radoslavova S, Panel M, Lacampagne A,Gergely C, Cazorla O, Cloitre T. (2020)“ Internal structure and remodeling in dystrophin-deficient cardiomyocytes using second harmonic generation. “.Nanomedicine, Nanotechnology, Biology and Medicine, 2020 Nov;30:102295 (IF=6,46). Nanoscience and Nanotechnology (Q2) ; Medicine, Research and Experimental (Q1).
Verelst J, Geukens N, Eddarkaoui S, Vliegen D, De Smidt E, Rosseels J, Franssens V, Molenberghs S, Francois C, Stoops E, Bjerke M, Engelborghs S, Laghmouchi M, Carmans S, Buée L, Vanmechelen E, Winderickx J, Thomas D (2020). “. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms. “. Front Mol Biosci. 2020 Mar 31;7:48. (IF=5,25). Biochemistry and Molecular Biology (Q2)
Villard O, Morquin D, Molinari N, Raingeard I, Nagot N, Cristol JP, Jung B, Roubille C, Foulongne V, Fesler P, Lamure S, TaourelP, Konate A, Jacques Maria AT , Makinson A, Bertchansky A, Larcher R, Klouche K, Le Moing V, Renard E and Guilpain P (2020). ”The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study. ” Journal of Clinical Medicine, 2020 Jul 21;9(7):E2315. (IF=4,24). Medicine, General and Internal (Q1).
Werner O, Ovaert C, Amedro P. (2020). “Acquired systemic-to-pulmonary shunts in a 6-month-old child: case report and review of the literature. “ Cardiol Young. 2020 Feb 10:1-4. (IF=1,09). Cardiac and Cardiovascular Systems (Q4) ; Pediatry (Q4).
Young G, Lensing AWA, Monagle P, Male C, Thelen K, Willmann S, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bajolle F, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Beyer-Westendorf J, Martinelli I, Patricia Massicotte M, Smith WT, Berkowitz SD, Schmidt S, Price V, Prins MH, Kubitza D; EINSTEIN-Jr. Phase 3 Investigators (2020). ”Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation. ” J Thromb Haemost. 2020 Jul;18(7):1672-1685. (IF=5,82).
Zieleskiewicz L, Claret PG, Muller L, de La Coussaye JE, Lefrant JY, Schuster I, Roger C, Bobbia X. (2020). “Global longitudinal strain changes during hemorrhagic shock: An experimental study. “ Turk J Emerg Med. 2020 Jul 18;20(3):97-104. (IF=1,39). Critical Care and Intensive Care Medicine (Q2); Emergency Medicine (Q2).